EurekaMag Full Text Articles Chapter 51,701

Rudenskaia, G.E.; Kurkina, M.V.; Zakharova, E.I. 2012: Ataxia with oculomotor apraxia: clinical-genetic characteristics and DNA-diagnostic. Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 112(10): 58-63

Schulte, C.; Synofzik, M.; Gasser, T.; Schöls, L. 2009: Ataxia with ophthalmoplegia or sensory neuropathy is frequently caused by POLG mutations. Neurology 73(11): 898-900

Guilloton, L.; Camarasa, C.; Agard, E.; Tondeur, G.; Dot, C.; Drouet, A. 2014: Ataxia with ophthalmoplegia: Miller-Fisher syndrome with anti-GQ1b antibody positivity. Journal Francais d'Ophtalmologie 37(2): 89-92

Bellayou, H.; Dehbi, H.; Bourezgui, M.; Slassi, I.; Nadifi, S. 2009: Ataxia with vitamin e deficiency (AVED); an example of the contribution of research in molecular genetic to counselling in Morocco. Pathologie-Biologie 57(5): 425-426

Hentati, F.ça.; El-Euch, G.; Bouhlal, Y.; Amouri, R. 2012: Ataxia with vitamin e deficiency and abetalipoproteinemia. Handbook of Clinical Neurology 103: 295-305

Kara, B.ül.; Uzümcü, A.; Uyguner, O.; Rosti, R.O.ür.; Koçbaş, A.ça.; Ozmen, M.; Kayserili, H.ül. 2008: Ataxia with vitamin e deficiency associated with deafness. Turkish Journal of Pediatrics 50(5): 471-475

Koht, J.; Bjørnarå, K.A.; Jørum, E.; Tallaksen, C.M.E. 2009: Ataxia with vitamin E deficiency in southeast Norway, case report. Acta Neurologica Scandinavica. Supplementum 2009(189): 42-45

Kono, S.; Otsuji, A.; Hattori, H.; Shirakawa, K.; Suzuki, H.; Miyajima, H. 2009: Ataxia with vitamin e deficiency with a mutation in a phospholipid transfer protein gene. Journal of Neurology 256(7): 1180-1181

Di Donato, I.; Bianchi, S.; Federico, A. 2010: Ataxia with vitamin E deficiency: update of molecular diagnosis. Neurological Sciences: Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 31(4): 511-515

Herman, T.E.; Siegel, M.J. 2009: Ataxia without opsoclonus: right lumbar sympathetic trunk neuroblastoma. Clinical Pediatrics 48(3): 336-340

Scripture, E.W. 1920: Ataxia, Asaphia, and Apraxia in Speech. Journal of Neurology and Psychopathology 1(2): 124-130

Margolin, D.H.; Kousi, M.; Chan, Y-Ming.; Lim, E.T.; Schmahmann, J.D.; Hadjivassiliou, M.; Hall, J.E.; Adam, I.; Dwyer, A.; Plummer, L.; Aldrin, S.V.; O'Rourke, J.; Kirby, A.; Lage, K.; Milunsky, A.; Milunsky, J.M.; Chan, J.; Hedley-Whyte, E.Tessa.; Daly, M.J.; Katsanis, N.; Seminara, S.B. 2013: Ataxia, dementia, and hypogonadotropism caused by disordered ubiquitination. New England Journal of Medicine 368(21): 1992-2003

Amin, O.S.M.; Shwani, S.'a.S. 2010: Ataxia, hyperpnoea and mental retardation: was it the molar tooth?. BMJ Case Reports

Braun, J.S. 2010: Ataxia, hypoacusis, and dementia. BMJ Case Reports 2010: 2399

Amin, O.S.M. 2012: Ataxia, hypoplastic vermis and keyhole connection sign: is it the variant form of Dandy-Walker complex?. BMJ Case Reports

Poretti, A.; Häusler, M.; von Moers, A.; Baumgartner, B.; Zerres, K.; Klein, A.; Aiello, C.; Moro, F.; Zanni, G.; Santorelli, F.M.; Huisman, T.A.G.M.; Weis, J.; Valente, E.M.; Bertini, E.; Boltshauser, E. 2014: Ataxia, intellectual disability, and ocular apraxia with cerebellar cysts: a new disease?. Cerebellum 13(1): 79-88

Gliebus, G.; Faerber, E.N.; Valencia, I.; Khurana, D.S.; Singh, S.B.; Legido, Aín. 2014: Ataxia, ophthalmoplegia, and impairment of consciousness in a 19-month-old American boy. Seminars in pediatric neurology 21(2): 139-143

Verhagen, M.M.M.; van Deuren, M.; Willemsen, M.èl.A.A.P.; Van der Hoeven, H.J.; Heijdra, Y.F.; Yntema, J.-B.; Weemaes, C.M.R.; Neeleman, C. 2009: Ataxia-Telangiectasia and mechanical ventilation: a word of caution. Pediatric Pulmonology 44(1): 101-102

Ai, L.; Skehan, R.R.; Saydi, J.; Lin, T.; Brown, K.D. 2012: Ataxia-Telangiectasia, Mutated (ATM)/Nuclear Factor κ light chain enhancer of activated B cells (NFκB) signaling controls basal and DNA damage-induced transglutaminase 2 expression. Journal of Biological Chemistry 287(22): 18330-18341

Nahas, S.A.; Duquette, A.; Roddier, K.; Gatti, R.A.; Brais, B. 2007: Ataxia-oculomotor apraxia 2 patients show no increased sensitivity to ionizing radiation. Neuromuscular Disorders: Nmd 17(11-12): 968-969

Perlman, S.L.; Boder Deceased, E.; Sedgewick, R.P.; Gatti, R.A. 2012: Ataxia-telangiectasia. Handbook of Clinical Neurology 103: 307-332

Paravisini, A.; Gurbindo, M.ía.D.; Sánchez Román, S. 2012: Ataxia-telangiectasia. Medicina Clinica 138(6): 249-253

Liu, X.; Matsuda, A.; Plunkett, W. 2008: Ataxia-telangiectasia and Rad3-related and DNA-dependent protein kinase cooperate in G2 checkpoint activation by the DNA strand-breaking nucleoside analogue 2'-C-cyano-2'-deoxy-1-beta-D-arabino-pentofuranosylcytosine. Molecular Cancer Therapeutics 7(1): 133-142

Pérez-Villena, A.; Cormenzana, M.ía.; de Prada, I.; Pérez-Martínez, A.; Aleo, E. 2013: Ataxia-telangiectasia and wilms tumor: reduced treatment but early relapse. Journal of Pediatric Hematology/Oncology 35(4): 308-310

Tang, Z-Ping.; Dong, Q-Ze.; Cui, Q-Zhe.; Papavassiliou, P.; Wang, E-Di.; Wang, E-Hua. 2013: Ataxia-telangiectasia group D complementing gene (ATDC) promotes lung cancer cell proliferation by activating NF-κB pathway. Plos one 8(6): E63676

Moin, M.; Aghamohammadi, A.; Kouhi, A.; Tavassoli, S.; Rezaei, N.; Ghaffari, S.-R.; Gharagozlou, M.; Movahedi, M.; Purpak, Z.; Mirsaeid Ghazi, B.; Mahmoudi, M.; Farhoudi, A. 2007: Ataxia-telangiectasia in Iran: clinical and laboratory features of 104 patients. Pediatric Neurology 37(1): 21-28

Aghamohammadi, A.; Imai, K.; Moazzami, K.; Abolhassani, H.; Tabatabaeiyan, M.; Parvaneh, N.; Nasiri Kalmarzi, R.; Nakagawa, N.; Oshima, K.; Ohara, O.; Nonoyama, S.; Rezaei, N. 2010: Ataxia-telangiectasia in a patient presenting with hyper-immunoglobulin M syndrome. Journal of Investigational Allergology and Clinical Immunology 20(5): 442-445

Etzioni, A.; Ben-Barak, A.; Peron, S.; Durandy, A. 2007: Ataxia-telangiectasia in twins presenting as autosomal recessive hyper-immunoglobulin M syndrome. Israel Medical Association Journal: Imaj 9(5): 406-407

Kinoshita, T.; Nagamatsu, G.; Kosaka, T.; Takubo, K.; Hotta, A.; Ellis, J.; Suda, T. 2011: Ataxia-telangiectasia mutated (ATM) deficiency decreases reprogramming efficiency and leads to genomic instability in iPS cells. Biochemical and Biophysical Research Communications 407(2): 321-326

Kuroda, S.; Urata, Y.; Fujiwara, T. 2012: Ataxia-telangiectasia mutated and the Mre11-Rad50-NBS1 complex: promising targets for radiosensitization. Acta Medica Okayama 66(2): 83-92

Zhang, N.; Che, J.; Bai, S.; Wu, Z.; Cui, Y.; Zou, W. 2010: Ataxia-telangiectasia mutated gene and breast cancer susceptibility. Sheng Wu Gong Cheng Xue Bao 26(1): 9-15

Tichý, A.; Vávrová, J.; Pejchal, J.; Rezácová, M. 2010: Ataxia-telangiectasia mutated kinase (ATM) as a central regulator of radiation-induced DNA damage response. Acta Medica 53(1): 13-17

Luis Espinoza, J.; Takami, A.; Trung, L.Q.; Nakao, S. 2013: Ataxia-telangiectasia mutated kinase-mediated upregulation of NKG2D ligands on leukemia cells by resveratrol results in enhanced natural killer cell susceptibility. Cancer Science 104(6): 657-662

Motamed, F.; Benabbas, R.; Ashrafi, M.R.; Aghamohammadi, A.; Rezaei, N. 2013: Ataxia-telangiectasia or neurologic Wilson's disease: when strong family history becomes a diagnostic bias. Acta Neurologica Belgica 113(2): 195-196

Noordzij, J.G.; Wulffraat, N.M.; Haraldsson, A.; Meyts, I.; van't Veer, L.J.; Hogervorst, F.B.L.; Warris, A.; Weemaes, C.M.R. 2009: Ataxia-telangiectasia patients presenting with hyper-IgM syndrome. Archives of Disease in Childhood 94(6): 448-449

Diaconu, G.; Grigore, I.; Moisă, S.M.; Burlea, M. 2007: Ataxia-telangiectasia syndrome. Clinical and diagnostic aspects. Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 111(2): 386-390

Pietrucha, B.M.; Heropolitańska-Pliszka, E.; Wakulińska, A.; Skopczyńska, H.; Gatti, R.A.; Bernatowska, E. 2010: Ataxia-telangiectasia with hyper-IgM and Wilms tumor: fatal reaction to irradiation. Journal of Pediatric Hematology/Oncology 32(1): E28-E30

Jeong, H.; Huh, H.J.; Youn, J.; Kim, J.S.; Cho, J.W.; Ki, C.-S. 2014: Ataxia-telangiectasia with novel splicing mutations in the ATM gene. Annals of Laboratory Medicine 34(1): 80-84

Kim, J.W.; Im, S.-A.; Kim, M.A.; Cho, H.J.; Lee, D.W.; Lee, K.-H.; Kim, T.-Y.; Han, S.-W.; Oh, D.-Y.; Lee, H.-J.; Kim, T.-Y.; Yang, H.-K.; Kim, W.H.; Bang, Y.-J. 2014: Ataxia-telangiectasia-mutated protein expression with microsatellite instability in gastric cancer as prognostic marker. International Journal of Cancer 134(1): 72-80

Kamphues, C.; Bova, R.; Bahra, M.; Klauschen, F.; Muckenhuber, A.; Sinn, B.V.; Warth, A.; Goeppert, B.; Endris, V.; Neuhaus, P.; Weichert, W.; Stenzinger, A. 2015: Ataxia-telangiectasia-mutated protein kinase levels stratify patients with pancreatic adenocarcinoma into prognostic subgroups with loss being a strong indicator of poor survival. Pancreas 44(2): 296-301

Yanofsky, R.A.; Seshia, S.S.; Dawson, A.J.; Stobart, K.; Greenberg, C.R.; Booth, F.A.; Prasad, C.; Del Bigio, M.R.; Wrogemann, J.J.; Fike, F.; Gatti, R.A. 2009: Ataxia-telangiectasia: atypical presentation and toxicity of cancer treatment. Canadian Journal of Neurological Sciences. le Journal Canadien des Sciences Neurologiques 36(4): 462-467

Chaudhary, M.W.; Al-Baradie, R.S. 2014: Ataxia-telangiectasia: future prospects. Application of Clinical Genetics 7: 159-167

Saunders-Pullman, R.J.; Gatti, R. 2009: Ataxia-telangiectasia: without ataxia or telangiectasia?. Neurology 73(6): 414-415

Chaubey, V.K.; Chhabra, L.; Kapila, A. 2013: Ataxia: a diagnostic perplexity and management dilemma. BMJ Case Reports

Rinaldo, L.; Hansel, C. 2010: Ataxias and cerebellar dysfunction: involvement of synaptic plasticity deficits?. Functional Neurology 25(3): 135-139

Riggins, S.; England, J.D. 2012: Ataxias related to sensory neuropathies. Handbook of Clinical Neurology 103: 605-617

Finsterer, J. 2009: Ataxias with autosomal, X-chromosomal or maternal inheritance. Canadian Journal of Neurological Sciences. le Journal Canadien des Sciences Neurologiques 36(4): 409-428

Ito, M.; Matsuno, K.; Sakumoto, Y.; Hirata, K.; Yuki, N. 2011: Ataxic Guillain-Barré syndrome and acute sensory ataxic neuropathy form a continuous spectrum. Journal of Neurology Neurosurgery and Psychiatry 82(3): 294-299

Harris, W. 1946: Ataxic Nystagmus in Disseminated Sclerosis. Proceedings of the Royal Society of Medicine 40(2): 81

Harris, W. 1944: Ataxic Nystagmus: a Pathognomonic Sign in Disseminated Sclerosis. British Journal of Ophthalmology 28(1): 40-42

Loukil, H.; Frikha, F.; Snoussi, M.; Ben Salah, R.; El Aoud, S.; Bahloul, Z. 2015: Ataxic dysarthria revealing Fahr's syndrome and hypoparathyroidism. Joint Bone Spine 82(4): 284

Yoneda, M. 2012: Ataxic form of Hashimoto's encephalopathy. Rinsho Shinkeigaku 52(11): 1369-1371

Cendelín, J.; Voller, J.; Vozeh, F. 2010: Ataxic gait analysis in a mouse model of the olivocerebellar degeneration. Behavioural Brain Research 210(1): 8-15

Shin, D.Hoon.; Lee, S.Wook.; Hong, Y.Hue.; Hong, J.Man.; Lee, J.Soo. 2012: Ataxic hemiparesis in a patient with posterior cortical borderzone infarction. Neurological Sciences: Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 33(6): 1487-1488

Cho, T.-H.; Hermier, M.; Derex, L.; Trouillas, P.; Nighoghossian, N. 2010: Ataxic hemiparesis: the benefit of acute multiparametric magnetic resonance imaging. Archives of Neurology 67(1): 116-117

Anheim, M.; Hannequin, D.; Boulay, C.; Martin, C.; Campion, D.; Tranchant, C. 2007: Ataxic variant of Alzheimer's disease caused by Pro117Ala PSEN1 mutation. Journal of Neurology Neurosurgery and Psychiatry 78(12): 1414-1415

Pirogova, E.; Vojisavljevic, V.; Cáceres, J.L.H.án.; Cosic, I. 2010: Ataxin active site determination using spectral distribution of electron ion interaction potentials of amino acids. Medical and Biological Engineering and Computing 48(4): 303-309

Conforti, F.L.; Spataro, R.; Sproviero, W.; Mazzei, R.; Cavalcanti, F.; Condino, F.; Simone, I.L.; Logroscino, G.; Patitucci, A.; Magariello, A.; Muglia, M.; Rodolico, C.; Valentino, P.; Bono, F.; Colletti, T.; Monsurrò, M.R.; Gambardella, A.; La Bella, V. 2012: Ataxin-1 and ataxin-2 intermediate-length PolyQ expansions in amyotrophic lateral sclerosis. Neurology 79(24): 2315-2320

Rich, T.; Varadaraj, A. 2007: Ataxin-1 fusion partners alter polyQ lethality and aggregation. Plos one 2(10): E1014

Lee, S.; Hong, S.; Kim, S.; Kang, S. 2011: Ataxin-1 occupies the promoter region of E-cadherin in vivo and activates CtBP2-repressed promoter. Biochimica et Biophysica Acta 1813(5): 713-722

Calandria, J.M.; Mukherjee, P.K.; de Rivero Vaccari, J.C.; Zhu, M.; Petasis, N.A.; Bazan, N.G. 2012: Ataxin-1 poly(Q)-induced proteotoxic stress and apoptosis are attenuated in neural cells by docosahexaenoic acid-derived neuroprotectin D1. Journal of Biological Chemistry 287(28): 23726-23739

Van Blitterswijk, M.; Mullen, B.; Heckman, M.G.; Baker, M.C.; DeJesus-Hernandez, M.; Brown, P.H.; Murray, M.E.; Hsiung, G.-Y.R.; Stewart, H.; Karydas, A.M.; Finger, E.; Kertesz, A.; Bigio, E.H.; Weintraub, S.; Mesulam, M.; Hatanpaa, K.J.; White, C.L.; Neumann, M.; Strong, M.J.; Beach, T.G.; Wszolek, Z.K.; Lippa, C.; Caselli, R.; Petrucelli, L.; Josephs, K.A.; Parisi, J.E.; Knopman, D.S.; Petersen, R.C.; Mackenzie, I.R.; Seeley, W.W.; Grinberg, L.T.; Miller, B.L.; Boylan, K.B.; Graff-Radford, N.R.; Boeve, B.F.; Dickson, D.W.; Rademakers, R. 2014: Ataxin-2 as potential disease modifier in C9ORF72 expansion carriers. Neurobiology of Aging 35(10): 2421.E13-17

Van de Loo, S.; Eich, F.; Nonis, D.; Auburger, G.; Nowock, J. 2009: Ataxin-2 associates with rough endoplasmic reticulum. Experimental Neurology 215(1): 110-118

Nonis, D.; Schmidt, M.H.H.; van de Loo, S.; Eich, F.; Dikic, I.; Nowock, J.; Auburger, G. 2008: Ataxin-2 associates with the endocytosis complex and affects EGF receptor trafficking. Cellular Signalling 20(10): 1725-1739

Farg, M.A.; Soo, K.Y.; Warraich, S.T.; Sundaramoorthy, V.; Blair, I.P.; Atkin, J.D. 2013: Ataxin-2 interacts with FUS and intermediate-length polyglutamine expansions enhance FUS-related pathology in amyotrophic lateral sclerosis. Human Molecular Genetics 22(4): 717-728

Lee, T.; Li, Y.R.; Ingre, C.; Weber, M.; Grehl, T.; Gredal, O.; de Carvalho, M.; Meyer, T.; Tysnes, O.-B.ör.; Auburger, G.; Gispert, S.; Bonini, N.M.; Andersen, P.M.; Gitler, A.D. 2011: Ataxin-2 intermediate-length polyglutamine expansions in European ALS patients. Human Molecular Genetics 20(9): 1697-1700

Kaehler, C.; Isensee, J.ör.; Nonhoff, U.; Terrey, M.; Hucho, T.; Lehrach, H.; Krobitsch, S. 2012: Ataxin-2-like is a regulator of stress granules and processing bodies. Plos one 7(11): E50134

Durcan, T.M.; Fon, E.A. 2013: Ataxin-3 and its e3 partners: implications for machado-joseph disease. Frontiers in Neurology 4: 46

Durcan, T.M.; Kontogiannea, M.; Bedard, N.; Wing, S.S.; Fon, E.A. 2012: Ataxin-3 deubiquitination is coupled to Parkin ubiquitination via E2 ubiquitin-conjugating enzyme. Journal of Biological Chemistry 287(1): 531-541

Zeng, L.-X.; Tang, Y.; Ma, Y. 2014: Ataxin-3 expression correlates with the clinicopathologic features of gastric cancer. International Journal of Clinical and Experimental Medicine 7(4): 973-981

Bai, J.J.; Safadi, S.S.; Mercier, P.; Barber, K.R.; Shaw, G.S. 2013: Ataxin-3 is a multivalent ligand for the parkin Ubl domain. Biochemistry 52(42): 7369-7376

Do Carmo Costa, M.; Bajanca, F.; Rodrigues, A.-J.ão.; Tomé, R.J.; Corthals, G.; Macedo-Ribeiro, S.; Paulson, H.L.; Logarinho, E.; Maciel, P.íc. 2010: Ataxin-3 plays a role in mouse myogenic differentiation through regulation of integrin subunit levels. Plos one 5(7): E11728

Evers, M.M.; Toonen, L.J.A.; van Roon-Mom, W.M.C. 2014: Ataxin-3 protein and RNA toxicity in spinocerebellar ataxia type 3: current insights and emerging therapeutic strategies. Molecular Neurobiology 49(3): 1513-1531

Wang, H.; Ying, Z.; Wang, G. 2012: Ataxin-3 regulates aggresome formation of copper-zinc superoxide dismutase (SOD1) by editing K63-linked polyubiquitin chains. Journal of Biological Chemistry 287(34): 28576-28585

Nakamura, Y.; Tagawa, K.; Oka, T.; Sasabe, T.; Ito, H.; Shiwaku, H.; La Spada, A.R.; Okazawa, H. 2012: Ataxin-7 associates with microtubules and stabilizes the cytoskeletal network. Human Molecular Genetics 21(5): 1099-1110

Kahle, J.J.; Souroullas, G.P.; Yu, P.; Zohren, F.; Lee, Y.; Shaw, C.A.; Zoghbi, H.Y.; Goodell, M.A. 2013: Ataxin1L is a regulator of HSC function highlighting the utility of cross-tissue comparisons for gene discovery. PLoS genetics 9(3): e1003359

Kiser, J.J.; Rutstein, R.M.; Samson, P.; Graham, B.; Aldrovandi, G.; Mofenson, L.M.; Smith, E.; Schnittman, S.; Fenton, T.; Brundage, R.C.; Fletcher, C.V. 2011: Atazanavir and atazanavir/ritonavir pharmacokinetics in HIV-infected infants, children, and adolescents. Aids 25(12): 1489-1496

Phillips, M.; Saxon, C.; Lee, V. 2014: Atazanavir and chest pain. International Journal of Std and Aids 25(6): 461-464

Floridia, M.; Ravizza, M.; Masuelli, G.; Giacomet, V.; Martinelli, P.; Degli Antoni, A.; Spinillo, A.; Fiscon, M.; Francisci, D.; Liuzzi, G.; Pinnetti, C.; Marconi, A.Maria.; Tamburrini, E.; Floridia, M.; Ravizza, M.; Tamburrini, E.; Ravizza, M.; Tamburrini, E.; Mori, F.; Ortolani, P.; dalle Nogare, E.R.; Di Lorenzo, F.; Sterrantino, G.; Meli, M.; Polemi, S.; Nocentini, J.; Baldini, M.; Montorzi, G.; Mazzetti, M.; Rogasi, P.; Borchi, B.; Vichi, F.; Del Pin, B.; Pinter, E.; Anzalone, E.; Marocco, R.; Mastroianni, C.; Mercurio, V.S.; Carocci, A.; Grilli, E.; Maccabruni, A.; Zaramella, M.; Mariani, B.; Natalini Raponi, G.; Guaraldi, G.; Nardini, G.; Stentarelli, C.; Beghetto, B 2014: Atazanavir and lopinavir profile in pregnant women with HIV: tolerability, activity and pregnancy outcomes in an observational national study. Journal of Antimicrobial ChemoTherapy 69(5): 1377-1384

Di Giambenedetto, S.; De Luca, A.; Villani, P.; Bacarelli, A.; Ragazzoni, E.; Regazzi, M.; Cauda, R.; Navarra, P. 2008: Atazanavir and lopinavir with ritonavir alone or in combination: analysis of pharmacokinetic interaction and predictors of drug exposure. HIV Medicine 9(4): 239-245

Laprise, C.; Baril, J-Guy.; Dufresne, S.; Trottier, H. 2013: Atazanavir and other determinants of hyperbilirubinemia in a cohort of 1150 HIV-positive patients: results from 9 years of follow-up. AIDS patient care and STDs 27(7): 378-386

Gandhi, M.; Ameli, N.; Bacchetti, P.; Anastos, K.; Gange, S.J.; Minkoff, H.; Young, M.; Milam, J.; Cohen, M.H.; Sharp, G.B.; Huang, Y.; Greenblatt, R.M. 2011: Atazanavir concentration in hair is the strongest predictor of outcomes on antiretroviral therapy. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 52(10): 1267-1275

Izzedine, H.; M'rad, M.Ben.; Bardier, A.; Daudon, M.; Salmon, D. 2007: Atazanavir crystal nephropathy. Aids 21(17): 2357-2358

Colbers, A.; Hawkins, D.; Hidalgo-Tenorio, C.; van der Ende, M.; Gingelmaier, A.; Weizsäcker, K.; Kabeya, K.; Taylor, G.; Rockstroh, J.ür.; Lambert, J.; Moltó, J.é; Wyen, C.; Sadiq, S.T.; Ivanovic, J.; Giaquinto, C.; Burger, D. 2015: Atazanavir exposure is effective during pregnancy regardless of tenofovir use. Antiviral Therapy 20(1): 57-64

Anonymous 2011: Atazanavir in children. Prescrire International 20(118): 177

Cuzin, L.; Flandre, P.; Pugliese, P.; Duvivier, C.; Yazdanpanah, Y.; Billaud, E.; Poizot-Martin, I.; Katlama, C.; Poizot-Martin, I.; Enel, P.; Drogoul-Vey, M.-P.; Druart, P.; Gastaut, J.A.; Cuzin, L.; Marchou, B.; Barone, M.; Pugliese, P.; Pradier, C.; Durand, J.; Mondin, V.ér.; Dellamonica, P.; Billaud, E.; Jovelin, T.; Guerbois, C.; Raffi, F.ço.; Gérard, Y.; Yazdanpallah, Y.; Choisy, P.; Duvivier, C.; Agher, R.; Katlama, C. 2008: Atazanavir in patients with persistent viral replication despite HAART: results from the French prospective NADIS cohort. HIV Clinical Trials 9(3): 147-151

Santimaleeworagun, W.; Pattharachayakul, S.; Chusri, S.; Chayagul, P. 2013: Atazanavir induced first degree atrioventricular block and ventricular tachycardia: a case report. Journal of the Medical Association of Thailand 96(4): 501-503

Monforte, A.d'Arminio.; Reiss, P.; Ryom, L.; El-Sadr, W.; Dabis, F.; De Wit, S.; Worm, S.W.; Law, M.G.; Weber, R.; Kirk, O.; Pradier, C.; Phillips, A.N.; Lundgren, J.D.; Sabin, C.A. 2013: Atazanavir is not associated with an increased risk of cardio- or cerebrovascular disease events. Aids 27(3): 407-415

Wempe, M.F.; Anderson, P.L. 2011: Atazanavir metabolism according to CYP3A5 status: an in vitro-in vivo assessment. Drug Metabolism and Disposition: the Biological Fate of Chemicals 39(3): 522-527

Iwamoto, M.; Wenning, L.A.; Mistry, G.C.; Petry, A.S.; Liou, S.Y.; Ghosh, K.; Breidinger, S.; Azrolan, N.; Gutierrez, M.J.; Bridson, W.E.; Stone, J.A.; Gottesdiener, K.M.; Wagner, J.A. 2008: Atazanavir modestly increases plasma levels of raltegravir in healthy subjects. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 47(1): 137-140

Anderson, P.L.; Aquilante, C.L.; Gardner, E.M.; Predhomme, J.; McDaneld, P.; Bushman, L.R.; Zheng, J.-H.; Ray, M.; MaWhinney, S. 2009: Atazanavir pharmacokinetics in genetically determined CYP3A5 expressors versus non-expressors. Journal of Antimicrobial ChemoTherapy 64(5): 1071-1079

Mirochnick, M.; Best, B.M.; Stek, A.M.; Capparelli, E.V.; Hu, C.; Burchett, S.K.; Rossi, S.S.; Hawkins, E.; Basar, M.; Smith, E.; Read, J.S.; Aweeka, F.; Barr, E.; Braun, K.D.; Bryant, J.; Medvik, K.A.; Jennings, A. 2011: Atazanavir pharmacokinetics with and without tenofovir during pregnancy. Journal of Acquired Immune Deficiency Syndromes 56(5): 412-419

Eley, T.; Bertz, R.; Hardy, H.él.èn.; Burger, D. 2013: Atazanavir pharmacokinetics, efficacy and safety in pregnancy: a systematic review. Antiviral Therapy 18(3): 361-375

Haberl, A.; Moesch, M.; Nisius, G.; Stephan, C.; Bickel, M.; Khaykin, P.; Kurowski, M.; Brodt, R.; von Hentig, N. 2010: Atazanavir plasma concentrations are impaired in HIV-1-infected adults simultaneously taking a methadone oral solution in a once-daily observed therapy setting. European Journal of Clinical Pharmacology 66(4): 375-381

Kuchenbecker, R.S.; Reis, M.Martins.; Barreiro, G. 2011: Atazanavir plus ritonavir or efavirenz as part of a 3-drug regimen for initial treatment of HIV-1. Annals of Internal Medicine 155(6): 402; Author Reply 403

Flandre, P. 2011: Atazanavir plus ritonavir or efavirenz as part of a 3-drug regimen for initial treatment of HIV-1. Annals of Internal Medicine 155(6): 402

Jacques, A.C.; Giguère, P.; Zhang, G.; Touchie, C.; la Porte, C.J.L. 2010: Atazanavir-associated choledocholithiasis leading to acute hepatitis in an HIV-infected adult. Annals of PharmacoTherapy 44(1): 202-206

Rivero-Juarez, A.; Lopez-Cortes, L.F.; Girón-Gonzalez, J.é A.; Pineda, J.A.; Rivero, A. 2014: Atazanavir-based therapy with pegylated interferon and ribavirin for patients with hepatitis C and HIV. LANCET. Infectious Diseases 14(1): 13-14

Lozano, R.; Domeque, N.; Apesteguia, A.-F. 2013: Atazanavir-bilirubin interaction: a pharmacokinetic-pharmacodynamic model. Clinical Pharmacology: Advances and Applications 5: 153-159

Valencia, M.E.; Moreno, V. 2009: Atazanavir-induced nephrolithiasis. Enfermedades Infecciosas y Microbiologia Clinica 27(2): 134-135

Inagaki, I.; Adachi, M.; Ito, H.; Yasuda, M.; Tsurumi, H.; Deguchi, T.; Seishima, M. 2015: Atazanavir-induced urine crystals demonstrated by infrared spectroscopic analysis. Urologia Internationalis 94(1): 121-124

Singh, G.; Pai, R.S. 2016: Atazanavir-loaded Eudragit RL 100 nanoparticles to improve oral bioavailability: optimization and in vitro/in vivo appraisal. Drug Delivery 23(2): 532-539

Bradbeer, C.; Ngwenya, S.; Baker, P.; George, M. 2012: Atazanavir-related hyperbilirubinaemia is not highlighted in the British National Formulary. International Journal of Std and Aids 23(10): 759

Cervero, M.; Navas, E.; Agud, J.é L.; García-Benaya, E.; Mon, C. 2009: Atazanavir-related renal insufficiency without concurrent tenofovir. Enfermedades Infecciosas y Microbiologia Clinica 27(8): 489-490

Spagnuolo, V.; Galli, L.; Bigoloni, A.; Nozza, S.; Monforte, A.d.'A.; Antinori, A.; Di Biagio, A.; Rusconi, S.; Guaraldi, G.; Di Giambenedetto, S.; Lazzarin, A.; Castagna, A. 2014: Atazanavir/ritonavir monotherapy as maintenance strategy in HIV-1 treated subjects with viral suppression: 96-week analysis results of the MODAT study. Journal of the International Aids Society 17(4 Suppl 3: 19806

Achenbach, C.J.; Darin, K.M.; Murphy, R.L.; Katlama, C. 2011: Atazanavir/ritonavir-based combination antiretroviral therapy for treatment of HIV-1 infection in adults. Future Virology 6(2): 157-177

Croom, K.F.; Dhillon, S.; Keam, S.J. 2009: Atazanavir: a review of its use in the management of HIV-1 infection. Drugs 69(8): 1107-1140

Deeks, E.D. 2012: Atazanavir: in pediatric patients with HIV-1 infection. Paediatric Drugs 14(2): 131-141

Wood, R. 2008: Atazanavir: its role in HIV treatment. Expert Review of AntI-Infective Therapy 6(6): 785-796

Anonymous 2009: Atazanavir: new indication. First-line treatment: fewer gastrointestinal disorders but more cases of jaundice and a risk of torsades de pointes. Prescrire International 18(101): 104

Pérez-Elías, M.ía.J.ús. 2007: Atazanavir: simplicity and convenience in different scenarios. Expert Opinion on PharmacoTherapy 8(5): 689-700

Anonymous 2014: Atazanavir: urolithiasis. Prescrire International 23(152): 214

Gibalová, A.ón.; Renák, D.; Matczuk, K.; Dupl'áková, N.; Cháb, D.; Twell, D.; Honys, D. 2009: AtbZIP34 is required for Arabidopsis pollen wall patterning and the control of several metabolic pathways in developing pollen. Plant Molecular Biology 70(5): 581-601

Li, M.; Fu, X.; Ma, G.; Sun, X.; Dong, X.; Nagy, T.; Xing, C.; Li, J.; Dong, J.-T. 2012: Atbf1 regulates pubertal mammary gland development likely by inhibiting the pro-proliferative function of estrogen-ER signaling. Plos one 7(12): E51283

Larouche-Gauthier, R.; Elford, T.G.; Aggarwal, V.K. 2011: Ate complexes of secondary boronic esters as chiral organometallic-type nucleophiles for asymmetric synthesis. Journal of the American Chemical Society 133(42): 16794-16797

Yasin Abd Et Ghaffar 1948: Ateberine in amoebic dysentery. Journal of the Egyptian Medical Association 31(5): 456-460

Orenstein, A.J. 1932: Atebrin in the Treatment of Severe Malaria. British Medical Journal 2(3730): 8-10

Mohanty, J.K. 1945: Atebrine brand of amyl-acridine derivative in human malaria. Antiseptic 42: 692-696

Lo, J.O.; Weber, S.M.; Andersen, P.E.; Gross, N.D.; Gosselin, M.; Wax, M.K. 2008: Atelectasis after free rectus transfer and abdominal wall reconstruction. Head and Neck 30(10): 1339-1343

Shibata, S.; Matsuko, M.; Higa, K.; Shono, S.; Katori, K.; Nitahara, K. 2011: Atelectasis after induction of general anesthesia in an infant with cleft palate. Masui. Japanese Journal of Anesthesiology 60(5): 625-627

Stringer, P. 1947: Atelectasis after partial gastrectomy. Lancet 1: 6443-6445

Farkas, E.; Sonnauer, P. 1949: Atelectasis and emphysema. Paediatria Danubiana . 5(3-4): 151-157

Tusman, G.; Böhm, S.H.; Warner, D.O.; Sprung, J. 2012: Atelectasis and perioperative pulmonary complications in high-risk patients. Current Opinion in Anaesthesiology 25(1): 1-10

Hopkinson, N.S.; Kemp, S.V.; Toma, T.P.; Hansell, D.M.; Geddes, D.M.; Shah, P.L.; Polkey, M.I. 2011: Atelectasis and survival after bronchoscopic lung volume reduction for COPD. European Respiratory Journal 37(6): 1346-1351

Mavros, M.N.; Velmahos, G.C.; Falagas, M.E. 2011: Atelectasis as a cause of postoperative fever: where is the clinical evidence?. Chest 140(2): 418-424

Gray, I.R. 1946: Atelectasis as a complication of pulmonary lobectomy. Thorax 1(4): 263-273

Fleischner, F.G. 1947: Atelectasis as a factor in the medical treatment of pleural empyema; the necessity of combating atelectasis by remedial breathing exercises. New England Journal of Medicine 236(16): 566-572

Malbouisson, L.M.S.á; Humberto, F.áv.; Rodrigues, R.d.R.; Carmona, M.J.é C.; Auler, J.é O.áv.C.J.ún. 2008: Atelectasis during anesthesia: pathophysiology and treatment. Revista Brasileira de Anestesiologia 58(1): 73-83

Barbosa, F.T.ó 2008: Atelectasis during anesthesia: physiology and treatment. Revista Brasileira de Anestesiologia 58(6): 671

Cuthbert, J.; Nagley, N.M. 1948: Atelectasis during collapse therapy for pulmonary tuberculosis. Tubercle 29(7): 154-158

Faulconer, A.; Gaines, T.R.; Grove, J.S. 1946: Atelectasis during operations on the upper urinary tract. Anesthesiology 7(6): 635-643

Martínez, G.; Cruz, P. 2008: Atelectasis in general anesthesia and alveolar recruitment strategies. Revista Espanola de Anestesiologia y Reanimacion 55(8): 493-503

Anderson, W. 1946: Atelectasis in infancy and childhood. Clinical Proceedings - Children's Hospital of the District of Columbia 2: 37-41

Hill, F.T. 1948: Atelectasis in the newborn; case report. Annals of Otology Rhinology and Laryngology 57(1): 220-222

Choi, W.-I.; Kwon, K.Y.; Kim, J.M.; Quinn, D.A.; Hales, C.A.; Seo, J.W. 2008: Atelectasis induced by thoracotomy causes lung injury during mechanical ventilation in endotoxemic rats. Journal of Korean Medical Science 23(3): 406-413

Meira, M.N.C.; Carvalho, C.R.R.; Galizia, M.S.; Borges, J.B.; Kondo, M.M.; Zugaib, M.; Vieira, J.E. 2010: Atelectasis observed by computerized tomography after Caesarean section. British Journal of Anaesthesia 104(6): 746-750

Farris, H.A. 1925: Atelectasis of the Lung. Canadian Medical Association Journal 15(8): 808-815

Borgstein, J.; Gerritsma, T.; Bruce, I.; Feenstra, L. 2009: Atelectasis of the middle ear in pediatric patients: safety of surgical intervention. International Journal of Pediatric Otorhinolaryngology 73(2): 257-261

Owens, H. 1945: Atelectasis of the newborn. California and Western Medicine 63: 225

House, H.P.; Owens, H. 1946: Atelectasis of the newborn; treatment by bronchoscopic drainage. Journal of Pediatrics 28: 207-209

Marengo, J.T.; Martinez, J.M. 1949: Atelectasis of the right upper lobe. Diseases of the Chest 15(2): 226-232

Brehm, W. 1947: Atelectasis: a major postoperative complication. Hahnemann Monthly 82(8): 327-333

Johnston, C.ín.; Carvalho, W.B.d. 2008: Atelectasis: mechanisms, diagnosis and treatment in the pediatric patient. Revista da Associacao Medica Brasileira 54(5): 455-460

Tepavac, A.; Secen, N.; Sazdanic Velikic, D.; Popovic, G.; Perin, B. 2010: Atelectasis: positive or negative prognostic factor on outcome of patients with non-small cell lung cancer?. Journal of BUON: Official Journal of the Balkan Union of Oncology 15(4): 679-683

Bateman, D. 1933: Atelectatic Bronchiectasis. Proceedings of the Royal Society of Medicine 27(2): 121-122

Ellis, R.W. 1932: Atelectatic Bronchiectasis and Displacement of Heart. Proceedings of the Royal Society of Medicine 25(12): 1734-1735

Franklin, A.W. 1938: Atelectatic Bronchiectasis: Recovery. Proceedings of the Royal Society of Medicine 31(4): 354-357

Doig, A.T. 1946: Atelectatic bronchiectasis of the right middle lobe. Tubercle 27(11): 173-190

Findlay, L. 1935: Atelectatic or compensatory bronchiectasis. Archives of Disease in Childhood 10(56): 61-84

Jacob, A.-M.; Gaver, D.P. 2012: Atelectrauma disrupts pulmonary epithelial barrier integrity and alters the distribution of tight junction proteins ZO-1 and claudin 4. Journal of Applied Physiology 113(9): 1377-1387

Dixon, D.-L.; Bersten, A.D. 2012: Atelectrauma: mechanistic insights tempered by clinical relevance?*. Critical Care Medicine 40(3): 1009-1010

Worster-Drought, C.; Archer, B.W. 1927: Ateleiosis (Lorain's Disease). Proceedings of the Royal Society of Medicine 20(6): 771-773

Weber, F.P. 1910: Ateleiosis in a Man, aged 42; Physical Development said to have been Arrested at about the age of 9 years. Proceedings of the Royal Society of Medicine 3(Sect Study Dis Child): 143-146

Weber, F.P. 1913: Ateleiosis in a Man, aged 45. Proceedings of the Royal Society of Medicine 6(Clin Sect): 197-201

Weber, F.P. 1913: Ateliosis in a Woman, aged 20, with a Slight Congenital Malformation of the Hands and Feet. Proceedings of the Royal Society of Medicine 6(Clin Sect): 201-204

Wysocki, T.; Sacewicz, I.; Wiktorska, M.; Niewiarowska, J. 2007: Atelocollagen as a potential carrier of therapeutics. Postepy Higieny i Medycyny Doswiadczalnej 61: 646-654

Ohno, S.; Hirano, S.; Tateya, I.; Kanemaru, S.-i.; Umeda, H.; Suehiro, A.; Kitani, Y.; Kishimoto, Y.; Kojima, T.; Nakamura, T.; Ito, J. 2009: Atelocollagen sponge as a stem cell implantation scaffold for the treatment of scarred vocal folds. Annals of Otology Rhinology and Laryngology 118(11): 805-810

Tohyama, H.; Yasuda, K.; Minami, A.; Majima, T.; Iwasaki, N.; Muneta, T.; Sekiya, I.; Yagishita, K.; Takahashi, S.; Kurokouchi, K.; Uchio, Y.; Iwasa, J.; Deie, M.; Adachi, N.; Sugawara, K.; Ochi, M. 2009: Atelocollagen-associated autologous chondrocyte implantation for the repair of chondral defects of the knee: a prospective multicenter clinical trial in Japan. Journal of Orthopaedic Science: Official Journal of the Japanese Orthopaedic Association 14(5): 579-588

Forootan, S.S.; Bao, Z.Z.; Forootan, F.S.; Kamalian, L.; Zhang, Y.; Bee, A.; Foster, C.S.; Ke, Y. 2010: Atelocollagen-delivered siRNA targeting the FABP5 gene as an experimental therapy for prostate cancer in mouse xenografts. International Journal of Oncology 36(1): 69-76

Ochiya, T.; Honma, K.; Takeshita, F.; Nagahara, S. 2007: Atelocollagen-mediated drug discovery technology. Expert Opinion on Drug Discovery 2(2): 159-167

Fujimoto, I.; Takei, Y. 2014: Atelocollagen-mediated siRNA delivery: future promise for therapeutic application. Therapeutic Delivery 5(4): 369-371

Qiu, X.-f.; Dong, N.-g.; Sun, Z.-q.; Su, W.; Shi, J.-w. 2009: Atelocollagen-mediated small interfering RNA delivery for effective gene silencing in rat vein grafts. Zhonghua Wai Ke Za Zhi 47(13): 1028-1031

Kawakami, E.; Kinouchi, N.; Adachi, T.; Ohsawa, Y.; Ishimaru, N.; Ohuchi, H.; Sunada, Y.; Hayashi, Y.; Tanaka, E.; Noji, S. 2011: Atelocollagen-mediated systemic administration of myostatin-targeting siRNA improves muscular atrophy in caveolin-3-deficient mice. Development Growth and Differentiation 53(1): 48-54

Wessels, A.; Wainwright, H.C.; Beighton, P. 2011: Atelosteogenesis type I: autopsy findings. Pediatric and Developmental Pathology: the Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society 14(6): 496-500

Haas, S.; Schürmann, M. 2007: AtemReich Children's Home. Kinderkrankenschwester: Organ der Sektion Kinderkrankenpflege 26(2): 66-69

Elliott, M.A. 2014: Atemporal equilibria: pro- and retroactive coding in the dynamics of cognitive microstructures. Frontiers in Psychology 5: 990

Youngs, T.G.A. 2010: Aten--an application for the creation, editing, and visualization of coordinates for glasses, liquids, crystals, and molecules. Journal of Computational Chemistry 31(3): 639-648

Martín Zurro, A.; Gené Badia, J.; Jiménez Villa, J.; Batalla Martínez, C. 2008: Atención primaria in the Science Citation Index Expanded. Atencion Primaria 40(6): 275-276

Zacharias, F.J. 1977: Atenolol Compared with other Beta-blocking Agents. Proceedings of the Royal Society of Medicine 70(Suppl 5): 24-26

Sandeep, P.; Ram, R.; Sowgandhi, N.; Reddy, S.A.; Katyarmal, D.T.; Kumar, B.S.; Kumar, V.S. 2014: Atenolol and amlodipine combination overdose managed with continuous venovenous hemodiafiltration: A case report. Indian Journal of Nephrology 24(5): 327-329

Lazebnik, L.B.; Mikheeva, O.M.; Drozdov, V.N.; Petrakov, A.V.; Sil'vestrova, S.I. 2008: Atenolol and metoprolol differentiated therapy of patients with arterial hypertension complicated by pathology of the digestive tract organs. Eksperimental'naia i Klinicheskaia Gastroenterologiia 2: 22-26

Gomides, R.S.; Costa, L.A.R.; Souza, Délia.R.; Queiroz, Aéia.C.C.; Fernandes, Jão.R.C.; Ortega, Kátia.C.; Junior, Décio.Mion.; Tinucci, Tís.; Forjaz, Cáudia.L.M. 2010: Atenolol blunts blood pressure increase during dynamic resistance exercise in hypertensives. British Journal of Clinical Pharmacology 70(5): 664-673

Navare, H.A.; Frye, R.F.; Cooper-Dehoff, R.M.; Shuster, J.J.; Hall, K.; Schmidt, S.O.F.; Turner, S.T.; Johnson, J.A. 2010: Atenolol exposure and risk for development of adverse metabolic effects: a pilot study. PharmacoTherapy 30(9): 872-878

Dumortier, Jérôme.; Guillaud, O.; Gouraud, A.; Pittau, G.; Vial, T.; Boillot, O.; Scoazec, J-Yves. 2009: Atenolol hepatotoxicity: report of a complicated case. Annals of PharmacoTherapy 43(10): 1719-1723

Bassiakou, E.; Xanthos, T.; Koudouna, E.; Goulas, S.; Prapa, V.; Papadimitriou, D.; Rokas, G.; Papadimitriou, L. 2008: Atenolol in combination with epinephrine improves the initial outcome of cardiopulmonary resuscitation in a swine model of ventricular fibrillation. American Journal of Emergency Medicine 26(5): 578-584

Edvardsson, B. 2013: Atenolol in the prophylaxis of chronic migraine: a 3-month open-label study. Springerplus 2: 479

Piddisi, C.; Cerskus, I. 1986: Atenolol in the treatment of essential hypertension. Canadian Family Physician Medecin de Famille Canadien 32: 1802-1806

Salinas, A.Morales. 2010: Atenolol in uncomplicated hypertension: time for changes. Lancet. Neurology 9(7): 652; Author Reply 652-3

McDonough, C.W.; Gillis, N.K.; Alsultan, A.; Chang, S.-W.; Kawaguchi-Suzuki, M.; Lang, J.E.; Shahin, M.H.A.; Buford, T.W.; El Rouby, N.M.; Sá, A.C.C.; Langaee, T.Y.; Gums, J.G.; Chapman, A.B.; Cooper-DeHoff, R.M.; Turner, S.T.; Gong, Y.; Johnson, J.A. 2013: Atenolol induced HDL-C change in the pharmacogenomic evaluation of antihypertensive responses (PEAR) study. Plos one 8(10): E76984

Cockcroft, J.R. 2009: Atenolol is dead: long live beta-blockade. Journal of the American College of Cardiology 53(22): 2102; Author Reply 2106-7

Zacà, V.; Rastogi, S.; Mishra, S.; Wang, M.; Sharov, V.G.; Gupta, R.C.; Goldstein, S.; Sabbah, H.N. 2009: Atenolol is inferior to metoprolol in improving left ventricular function and preventing ventricular remodeling in dogs with heart failure. Cardiology 112(4): 294-302

Eyal, S.; Kim, J.D.; Anderson, G.D.; Buchanan, M.L.; Brateng, D.A.; Carr, D.; Woodrum, D.E.; Easterling, T.R.; Hebert, M.F. 2010: Atenolol pharmacokinetics and excretion in breast milk during the first 6 to 8 months postpartum. Journal of Clinical Pharmacology 50(11): 1301-1309

Neema, P.K.; Waiker, H.D. 2003: Atenolol premedication in patients undergoing closed mitral commissurotomy. Annals of Cardiac Anaesthesia 6(1): 42-46

Lacro, R.V.; Dietz, H.C.; Sleeper, L.A.; Yetman, A.T.; Bradley, T.J.; Colan, S.D.; Pearson, G.D.; Selamet Tierney, E.Seda.; Levine, J.C.; Atz, A.M.; Benson, D.Woodrow.; Braverman, A.C.; Chen, S.; De Backer, J.; Gelb, B.D.; Grossfeld, P.D.; Klein, G.L.; Lai, W.W.; Liou, A.; Loeys, B.L.; Markham, L.W.; Olson, A.K.; Paridon, S.M.; Pemberton, V.L.; Pierpont, M.Ella.; Pyeritz, R.E.; Radojewski, E.; Roman, M.J.; Sharkey, A.M.; Stylianou, M.P.; Wechsler, S.Burns.; Young, L.T.; Mahony, L.; Pearson, G.; Stylianou, M.; Pemberton, V.; Mahony, L.; Sleeper, L.; Tennstedt, S.; Colan, S.; Klein 2014: Atenolol versus losartan in children and young adults with Marfan's syndrome. New England Journal of Medicine 371(22): 2061-2071

Aursnes, I.; Osnes, J-Bjørn. 2009: Atenolol versus other beta-adrenergic blockers. Journal of the American College of Cardiology 53(22): 2101-2; author reply 2106-7

Ábarzúa-Araya, A.; Navarrete-Dechent, C.án.P.; Heusser, F.; Retamal, J.; Zegpi-Trueba, M.ía.S. 2014: Atenolol versus propranolol for the treatment of infantile hemangiomas: a randomized controlled study. Journal of the American Academy of Dermatology 70(6): 1045-1049

Kuyper, L.M.; Khan, N.A. 2014: Atenolol vs nonatenolol β-blockers for the treatment of hypertension: a meta-analysis. Canadian Journal of Cardiology 30(5 Suppl): S47-S53

Marshall, A.J. 1977: Atenolol-Once-daily Dosage. Proceedings of the Royal Society of Medicine 70(Suppl 5): 34-35

Riyaz, N.; Nair, L.V. 1999: Atenolol-induced psoriasiform photodermatitis evolving into sezary syndrome - a case report. Indian Journal of Dermatology Venereology and Leprology 65(2): 88-89

Raphaël, M.F.; de Graaf, M.; Breugem, C.C.; Pasmans, S.G.M.A.; Breur, J.M.P.J. 2011: Atenolol: a promising alternative to propranolol for the treatment of hemangiomas. Journal of the American Academy of Dermatology 65(2): 420-421

Depprich, R.A.; Naujoks, C.D.; Meyer, U.; Kübler, N.R.; Handschel, J.ör.G. 2008: Ateriovenous subclavia-shunt for head and neck reconstruction. Head and Face Medicine 4: 27

Tommasino, N.; Villani, M.; Qureshi, A.; Henry, J.; Luberto, C.; Del Poeta, M. 2008: Atf2 transcription factor binds to the APP1 promoter in Cryptococcus neoformans: stimulatory effect of diacylglycerol. Eukaryotic Cell 7(2): 294-301

Wang, W.; Lian, N.; Li, L.; Moss, H.E.; Wang, W.; Perrien, D.S.; Elefteriou, F.; Yang, X. 2009: Atf4 regulates chondrocyte proliferation and differentiation during endochondral ossification by activating Ihh transcription. Development 136(24): 4143-4153

Seo, J.; Fortuno, E.S.; Suh, J.M.; Stenesen, D.; Tang, W.; Parks, E.J.; Adams, C.M.; Townes, T.; Graff, J.M. 2009: Atf4 regulates obesity, glucose homeostasis, and energy expenditure. Diabetes 58(11): 2565-2573

Balázs, A.; Pócsi, I.; Hamari, Z.; Leiter, E.; Emri, T.ás.; Miskei, M.ár.; Oláh, J.; Tóth, V.ór.; Hegedus, N.; Prade, R.A.; Molnár, M.ón.; Pócsi, I.án. 2010: AtfA bZIP-type transcription factor regulates oxidative and osmotic stress responses in Aspergillus nidulans. Molecular Genetics and Genomics: Mgg 283(3): 289-303

Withers, R.; Doherty, G.P.; Jordan, M.; Yang, X.; Dixon, N.E.; Lewis, P.J. 2014: AtfA, a new factor in global regulation of transcription in Acinetobacter spp. Molecular Microbiology 93(6): 1130-1143

Luciani, M.-F.ço.; Giusti, C.; Harms, B.; Oshima, Y.; Kikuchi, H.; Kubohara, Y.; Golstein, P. 2011: Atg1 allows second-signaled autophagic cell death in Dictyostelium. Autophagy 7(5): 501-508

Papinski, D.; Kraft, C. 2014: Atg1 kinase organizes autophagosome formation by phosphorylating Atg9. Autophagy 10(7): 1338-1340

Kijanska, M.; Peter, M. 2013: Atg1 kinase regulates early and late steps during autophagy. Autophagy 9(2): 249-251

Hosokawa, N.; Sasaki, T.; Iemura, S.-i.; Natsume, T.; Hara, T.; Mizushima, N. 2009: Atg101, a novel mammalian autophagy protein interacting with Atg13. Autophagy 5(7): 973-979

Backues, S.K.; Klionsky, D.J. 2012: Atg11: a Rab-dependent, coiled-coil membrane protein that acts as a tether for autophagy. Autophagy 8(8): 1275-1278

Alers, S.; Löffler, A.S.; Paasch, F.; Dieterle, A.M.; Keppeler, H.; Lauber, K.; Campbell, D.G.; Fehrenbacher, B.; Schaller, M.; Wesselborg, S.; Stork, B.ör. 2011: Atg13 and FIP200 act independently of Ulk1 and Ulk2 in autophagy induction. Autophagy 7(12): 1423-1433

Itakura, E.; Mizushima, N. 2009: Atg14 and UVRAG: mutually exclusive subunits of mammalian Beclin 1-PI3K complexes. Autophagy 5(4): 534-536

Zhong, Y.; Wang, Q.J.; Yue, Z. 2009: Atg14L and Rubicon: yin and yang of Beclin 1-mediated autophagy control. Autophagy 5(6): 890-891

Noda, T.; Matsunaga, K.; Yoshimori, T. 2011: Atg14L recruits PtdIns 3-kinase to the ER for autophagosome formation. Autophagy 7(4): 438-439

Lassen, K.G.; Kuballa, P.; Conway, K.L.; Patel, K.K.; Becker, C.E.; Peloquin, J.M.; Villablanca, E.J.; Norman, J.M.; Liu, T.-C.; Heath, R.J.; Becker, M.L.; Fagbami, L.; Horn, H.; Mercer, J.; Yilmaz, O.H.; Jaffe, J.D.; Shamji, A.F.; Bhan, A.K.; Carr, S.A.; Daly, M.J.; Virgin, H.W.; Schreiber, S.L.; Stappenbeck, T.S.; Xavier, R.J. 2014: Atg16L1 T300A variant decreases selective autophagy resulting in altered cytokine signaling and decreased antibacterial defense. Proceedings of the National Academy of Sciences of the United States of America 111(21): 7741-7746

Wang, C.; Mendonsa, G.R.; Symington, J.W.; Zhang, Q.; Cadwell, K.; Virgin, H.W.; Mysorekar, I.U. 2012: Atg16L1 deficiency confers protection from uropathogenic Escherichia coli infection in vivo. Proceedings of the National Academy of Sciences of the United States of America 109(27): 11008-11013

Ishibashi, K.; Uemura, T.; Waguri, S.; Fukuda, M. 2012: Atg16L1, an essential factor for canonical autophagy, participates in hormone secretion from PC12 cells independently of autophagic activity. Molecular Biology of the Cell 23(16): 3193-3202

Ishibashi, K.; Fujita, N.; Kanno, E.; Omori, H.; Yoshimori, T.; Itoh, T.; Fukuda, M. 2011: Atg16L2, a novel isoform of mammalian Atg16L that is not essential for canonical autophagy despite forming an Atg12–5-16L2 complex. Autophagy 7(12): 1500-1513

Conway, K.L.; Kuballa, P.; Song, J.-H.; Patel, K.K.; Castoreno, A.B.; Yilmaz, O.H.; Jijon, H.B.; Zhang, M.; Aldrich, L.N.; Villablanca, E.J.; Peloquin, J.M.; Goel, G.; Lee, I.-A.; Mizoguchi, E.; Shi, H.N.; Bhan, A.K.; Shaw, S.Y.; Schreiber, S.L.; Virgin, H.W.; Shamji, A.F.; Stappenbeck, T.S.; Reinecker, H.-C.; Xavier, R.J. 2013: Atg16l1 is required for autophagy in intestinal epithelial cells and protection of mice from Salmonella infection. Gastroenterology 145(6): 1347-1357

Nagy, P.ét.; Kárpáti, M.él.; Varga, A.; Pircs, K.; Venkei, Z.; Takáts, S.; Varga, K.; Erdi, B.áz.; Hegedűs, K.; Juhász, G.áb. 2014: Atg17/FIP200 localizes to perilysosomal Ref(2)P aggregates and promotes autophagy by activation of Atg1 in Drosophila. Autophagy 10(3): 453-467

Rieter, E.; Vinke, F.; Bakula, D.; Cebollero, E.; Ungermann, C.; Proikas-Cezanne, T.; Reggiori, F. 2013: Atg18 function in autophagy is regulated by specific sites within its β-propeller. Journal of Cell Science 126(Part 2): 593-604

Oku, M.; Tamura, N.; Sakai, Y. 2013: Atg18 lifts up from and lands on the vacuolar membrane mediated by phosphorylation of its propellers. Autophagy 9(12): 2161-2162

Tamura, N.; Oku, M.; Ito, M.; Noda, N.N.; Inagaki, F.; Sakai, Y. 2013: Atg18 phosphoregulation controls organellar dynamics by modulating its phosphoinositide-binding activity. Journal of Cell Biology 202(4): 685-698

Efe, J.A.; Botelho, R.J.; Emr, S.D. 2007: Atg18 regulates organelle morphology and Fab1 kinase activity independent of its membrane recruitment by phosphatidylinositol 3,5-bisphosphate. Molecular Biology of the Cell 18(11): 4232-4244

Tamura, N.; Oku, M.; Sakai, Y. 2014: Atg21 regulates pexophagy via its PI(3)P-binding activity in Pichia pastoris. Fems Yeast Research 14(3): 435-444

Sugimoto, N.; Iwaki, T.; Chardwiriyapreecha, S.; Shimazu, M.; Kawano, M.; Sekito, T.; Takegawa, K.; Kakinuma, Y. 2011: Atg22p, a vacuolar membrane protein involved in the amino acid compartmentalization of Schizosaccharomyces pombe. Bioscience Biotechnology and Biochemistry 75(2): 385-387

Backues, S.K.; Orban, D.P.; Bernard, A.él.; Singh, K.; Cao, Y.; Klionsky, D.J. 2015: Atg23 and Atg27 act at the early stages of Atg9 trafficking in S. cerevisiae. Traffic 16(2): 172-190

He, Y.; Deng, Y.Z.; Naqvi, N.I. 2013: Atg24-assisted mitophagy in the foot cells is necessary for proper asexual differentiation in Magnaporthe oryzae. Autophagy 9(11): 1818-1827

Takano, Y.; Asakura, M.; Sakai, Y. 2009: Atg26-mediated pexophagy and fungal phytopathogenicity. Autophagy 5(7): 1041-1042

Asakura, M.; Ninomiya, S.; Sugimoto, M.; Oku, M.; Yamashita, S.-I.; Okuno, T.; Sakai, Y.; Takano, Y. 2009: Atg26-mediated pexophagy is required for host invasion by the plant pathogenic fungus Colletotrichum orbiculare. Plant Cell 21(4): 1291-1304

Mao, K.; Chew, L.H.; Inoue-Aono, Y.; Cheong, H.; Nair, U.; Popelka, H.; Yip, C.K.; Klionsky, D.J. 2013: Atg29 phosphorylation regulates coordination of the Atg17-Atg31-Atg29 complex with the Atg11 scaffold during autophagy initiation. Proceedings of the National Academy of Sciences of the United States of America 110(31): E2875-E2884

Moon, E.-K.; Chung, D.-I.; Hong, Y.; Kong, H.-H. 2011: Atg3-mediated lipidation of Atg8 is involved in encystation of Acanthamoeba. Korean Journal of Parasitology 49(2): 103-108

Kanki, T.; Wang, K.; Cao, Y.; Baba, M.; Klionsky, D.J. 2009: Atg32 is a mitochondrial protein that confers selectivity during mitophagy. Developmental Cell 17(1): 98-109

Kanki, T.; Klionsky, D.J. 2009: Atg32 is a tag for mitochondria degradation in yeast. Autophagy 5(8): 1201-1202

Nazarko, V.Y.; Nazarko, T.Y.; Farré, J.-C.; Stasyk, O.V.; Warnecke, D.; Ulaszewski, S.; Cregg, J.M.; Sibirny, A.A.; Subramani, S. 2011: Atg35, a micropexophagy-specific protein that regulates micropexophagic apparatus formation in Pichia pastoris. Autophagy 7(4): 375-385

Motley, A.M.; Nuttall, J.M.; Hettema, E.H. 2012: Atg36: the Saccharomyces cerevisiae receptor for pexophagy. Autophagy 8(11): 1680-1681

Nazarko, T.Y. 2014: Atg37 regulates the assembly of the pexophagic receptor protein complex. Autophagy 10(7): 1348-1349

Araki, Y.; Ku, W-Chi.; Akioka, M.; May, A.I.; Hayashi, Y.; Arisaka, F.; Ishihama, Y.; Ohsumi, Y. 2013: Atg38 is required for autophagy-specific phosphatidylinositol 3-kinase complex integrity. Journal of Cell Biology 203(2): 299-313

Nakatogawa, H.; Ishii, J.; Asai, E.; Ohsumi, Y. 2012: Atg4 recycles inappropriately lipidated Atg8 to promote autophagosome biogenesis. Autophagy 8(2): 177-186

Fujita, N.; Noda, T.; Yoshimori, T. 2009: Atg4B(C74A) hampers autophagosome closure: a useful protein for inhibiting autophagy. Autophagy 5(1): 88-89

Betin, V.M.S.; Lane, J.D. 2009: Atg4D at the interface between autophagy and apoptosis. Autophagy 5(7): 1057-1059

Proenca, C.C.; Stoehr, N.; Bernhard, M.; Seger, S.; Genoud, C.; Roscic, A.; Paganetti, P.; Liu, S.; Murphy, L.O.; Kuhn, R.; Bouwmeester, T.; Galimberti, I. 2013: Atg4b-dependent autophagic flux alleviates Huntington's disease progression. Plos one 8(7): E68357

Vázquez, P.; Arroba, A.I.; Cecconi, F.; de la Rosa, E.J.; Boya, P.; de Pablo, F. 2012: Atg5 and Ambra1 differentially modulate neurogenesis in neural stem cells. Autophagy 8(2): 187-199

Zhao, W.; Li, Y.; Jia, L.; Pan, L.; Li, H.; Du, J. 2014: Atg5 deficiency-mediated mitophagy aggravates cardiac inflammation and injury in response to angiotensin Ii. Free Radical Biology and Medicine 69: 108-115

Lu, N-nan.; Liu, J.; Tian, Y.; Liao, M-hua.; Wang, H.; Lu, Y-mei.; Tao, R-rong.; Hong, L-Juan.; Liu, S-shuang.; Fukunaga, K.; Du, Y-zhong.; Han, F. 2014: Atg5 deficit exaggerates the lysosome formation and cathepsin B activation in mice brain after lipid nanoparticles injection. Nanomedicine: Nanotechnology Biology and Medicine 10(8): 1843-1852

Peng, J.; Zhang, R.; Cui, Y.; Liu, H.; Zhao, X.; Huang, L.; Hu, M.; Yuan, X.; Ma, B.; Ma, X.; Takashi, U.; Masaaki, K.; Liang, X.; Yu, L. 2014: Atg5 regulates late endosome and lysosome biogenesis. Science China. Life Sciences 57(1): 59-68

Bommareddy, A.; Hahm, E.-R.; Xiao, D.; Powolny, A.A.; Fisher, A.L.; Jiang, Y.; Singh, S.V. 2009: Atg5 regulates phenethyl isothiocyanate-induced autophagic and apoptotic cell death in human prostate cancer cells. Cancer Research 69(8): 3704-3712

Collins, C.A.; De Mazière, A.; van Dijk, S.; Carlsson, F.; Klumperman, J.; Brown, E.J. 2009: Atg5-independent sequestration of ubiquitinated mycobacteria. Plos Pathogens 5(5): E1000430

Shravage, B.V.; Hill, J.H.; Powers, C.M.; Wu, L.; Baehrecke, E.H. 2013: Atg6 is required for multiple vesicle trafficking pathways and hematopoiesis in Drosophila. Development 140(6): 1321-1329

Lőrincz, P.ét.; Lakatos, Z.; Maruzs, T.ás.; Szatmári, Z.; Kis, V.; Sass, M.ós. 2014: Atg6/UVRAG/Vps34-containing lipid kinase complex is required for receptor downregulation through endolysosomal degradation and epithelial polarity during Drosophila wing development. Biomed Research International 2014: 851349

Ye, Y.; Li, X.; Wang, W.; Ouedraogo, K.C.; Li, Y.; Gan, C.; Tan, S.; Zhou, X.; Wu, M. 2014: Atg7 deficiency impairs host defense against Klebsiella pneumoniae by impacting bacterial clearance, survival and inflammatory responses in mice. American Journal of Physiology. Lung Cellular and Molecular Physiology 307(5): L355-L363

Xue, L.-Y.; Chiu, S.-M.; Oleinick, N.L. 2010: Atg7 deficiency increases resistance of MCF-7 human breast cancer cells to photodynamic therapy. Autophagy 6(2): 248-255

Pattison, J.S.; Osinska, H.; Robbins, J. 2011: Atg7 induces basal autophagy and rescues autophagic deficiency in CryABR120G cardiomyocytes. Circulation Research 109(2): 151-160

Lee, I.H.; Kawai, Y.; Fergusson, M.M.; Rovira, I.I.; Bishop, A.J.R.; Motoyama, N.; Cao, L.; Finkel, T. 2012: Atg7 modulates p53 activity to regulate cell cycle and survival during metabolic stress. Science 336(6078): 225-228

Gonzalez, Y.; Aryal, B.; Chehab, L.; Rao, V.A. 2014: Atg7- and Keap1-dependent autophagy protects breast cancer cell lines against mitoquinone-induced oxidative stress. Oncotarget 5(6): 1526-1537

Xie, Z.; Nair, U.; Klionsky, D.J. 2008: Atg8 controls phagophore expansion during autophagosome formation. Molecular Biology of the Cell 19(8): 3290-3298

Tamura, N.; Oku, M.; Sakai, Y. 2010: Atg8 regulates vacuolar membrane dynamics in a lipidation-independent manner in Pichia pastoris. Journal of Cell Science 123(Part 23): 4107-4116

Noda, N.N.; Ohsumi, Y.; Inagaki, F. 2010: Atg8-family interacting motif crucial for selective autophagy. Febs Letters 584(7): 1379-1385

Tang, H.-W.; Liao, H.-M.; Peng, W.-H.; Lin, H.-R.; Chen, C.-H.; Chen, G.-C. 2013: Atg9 interacts with dTRAF2/TRAF6 to regulate oxidative stress-induced JNK activation and autophagy induction. Developmental Cell 27(5): 489-503

Mari, M.; Reggiori, F. 2010: Atg9 reservoirs, a new organelle of the yeast endomembrane system?. Autophagy 6(8): 1221-1223

Kakuta, S.; Yamamoto, H.; Negishi, L.; Kondo-Kakuta, C.; Hayashi, N.; Ohsumi, Y. 2012: Atg9 vesicles recruit vesicle-tethering proteins Trs85 and Ypt1 to the autophagosome formation site. Journal of Biological Chemistry 287(53): 44261-44269

Tamura, H.; Shibata, M.; Koike, M.; Sasaki, M.; Uchiyama, Y. 2010: Atg9A protein, an autophagy-related membrane protein, is localized in the neurons of mouse brains. Journal of Histochemistry and Cytochemistry: Official Journal of the Histochemistry Society 58(5): 443-453

Saitoh, T.; Fujita, N.; Hayashi, T.; Takahara, K.; Satoh, T.; Lee, H.; Matsunaga, K.; Kageyama, S.; Omori, H.; Noda, T.; Yamamoto, N.; Kawai, T.; Ishii, K.; Takeuchi, O.; Yoshimori, T.; Akira, S. 2009: Atg9a controls dsDNA-driven dynamic translocation of STING and the innate immune response. Proceedings of the National Academy of Sciences of the United States of America 106(49): 20842-20846

Hehl, R.; Bülow, L. 2014: AthaMap web tools for the analysis of transcriptional and posttranscriptional regulation of gene expression in Arabidopsis thaliana. Methods in Molecular Biology 1158: 139-156

Bülow, L.; Engelmann, S.; Schindler, M.; Hehl, R. 2009: AthaMap, integrating transcriptional and post-transcriptional data. Nucleic Acids Research 37(Database Issue): D983-D986

Bülow, L.; Brill, Y.; Hehl, R. 2010: AthaMap-assisted transcription factor target gene identification in Arabidopsis thaliana. Database: the Journal of Biological Databases and Curation 2010: Baq034

Barrow, M.P.; Witt, M.; Headley, J.V.; Peru, K.M. 2010: Athabasca oil sands process water: characterization by atmospheric pressure photoionization and electrospray ionization fourier transform ion cyclotron resonance mass spectrometry. Analytical Chemistry 82(9): 3727-3735

Duriš, Z.; Anker, A. 2014: Athanas manticolus sp. nov., a new stomatopod-associated alpheid shrimp from Vietnam (Crustacea, Decapoda). Zootaxa 3784: 550-558

Garrison, F.H. 1910: Athanasius Kircher and the Germ Theory of Disease. Science 31(805): 857-859

Sequeiros, L. 2001: Athanasius Kircher's geocosmos: an organicist image of the world in 17th-century natural history. Llull: Boletin de la Sociedad Espanola de Historia de Las Ciencias 24(51): 755-807

Singh, H. 1988: Ethno biological treatment of piles by bhoxas of uttar pradesh. Ancient Science of Life 8(2): 167-170

Whitley, R. 2010: Atheism and mental health. Harvard Review of Psychiatry 18(3): 190-194

Cheson, B.D. 2013: Atheists don't have no songs. Clinical Advances in Hematology and Oncology: H&o 11(6): 332

Swalin, R. 1969: Athelstan spilhaus, president-elect. Science 163(3869): 831-832

Hagland, M. 2009: Athenahealth. Service first. Healthcare Informatics: the Business Magazine for Information and Communication Systems 26(6): 60; 62, 70

A, R. 1887: Athens Letter. Science 9(221): 408

Kattamis, C.; Sofocleous, C.; Ladis, V.; Kattamis, A. 2013: Athens University thalassemia expertise unit: evolution, structure, perspectives and patients' expectations. Georgian Medical News 2013(222): 94-98

Feldman, D.N. 2014: Atherectomy for calcified femoropopliteal disease: are we making progress?. Journal of Invasive Cardiology 26(8): 304-306

Garcia, L.A.; Lyden, S.P. 2009: Atherectomy for infrainguinal peripheral artery disease. Journal of Endovascular Therapy: An Official Journal of the International Society of Endovascular Specialists 16(2 Suppl 2: Ii105-Ii115

Del Giudice, C.; Gandini, R.; Simonetti, G. 2014: Atherectomy for superficial femoral artery in-stent restenosis: can lasers light the way to a better outcome?. Journal of Endovascular Therapy: An Official Journal of the International Society of Endovascular Specialists 21(2): 356-358

Engelberger, S.; van den Berg, J.C. 2015: Atherectomy in complex infrainguinal lesions: a review. Journal of Cardiovascular Surgery 56(1): 43-54

Diamantopoulos, A.; Katsanos, K. 2014: Atherectomy of the femoropopliteal artery: a systematic review and meta-analysis of randomized controlled trials. Journal of Cardiovascular Surgery 55(5): 655-665

Todd, K.E.; Ahanchi, S.S.; Maurer, C.A.; Kim, J.H.; Chipman, C.R.; Panneton, J.M. 2013: Atherectomy offers no benefits over balloon angioplasty in tibial interventions for critical limb ischemia. Journal of Vascular Surgery 58(4): 941-948

Teng, J.; Dumon, P.; Bogaerts, W.; Zhang, H.; Jian, X.; Han, X.; Zhao, M.; Morthier, G.; Baets, R. 2009: Athermal Silicon-on-insulator ring resonators by overlaying a polymer cladding on narrowed waveguides. Optics Express 17(17): 14627-14633

Nakahama, M.; Sakaguchi, T.; Matustani, A.; Koyama, F. 2014: Athermal and widely tunable VCSEL with bimorph micromachined mirror. Optics Express 22(18): 21471-21479

Wang, L.; Bogaerts, W.; Dumon, P.; Selvaraja, S.K.; Teng, J.; Pathak, S.; Han, X.; Wang, J.; Jian, X.; Zhao, M.; Baets, R.; Morthier, G. 2012: Athermal arrayed waveguide gratings in silicon-on-insulator by overlaying a polymer cladding on narrowed arrayed waveguides. Applied Optics 51(9): 1251-1256

Dal Moro, F. 2014: Athermal bladder neck dissection during robot-assisted radical prostatectomy. International Braz J Urol: Official Journal of the Brazilian Society of Urology 40(3): 433; Discussion 434

Dauchot, O.; Karmakar, S.; Procaccia, I.; Zylberg, J. 2011: Athermal brittle-to-ductile transition in amorphous solids. Physical Review. e Statistical Nonlinear and Soft Matter Physics 84(4 Part 2): 046105

Lemarquis, F.éd.ér. 2014: Athermal compensation of the stress-induced surface deflection of optical coatings using iso-admittance layers. Applied Optics 53(4): A229-A236

Zheng, G.; Xu, J.; Chen, L.; Wang, H.; She, W. 2007: Athermal design for the potassium titanyl phosphate electro-optical modulator. Applied Optics 46(27): 6774-6778

Filippov, V.V. 2013: Athermal directions in KGd(WO4)2 and KLu(WO4)2 crystals under uniform heating. Applied Optics 52(18): 4377-4384

Lei, Y.; Alemozaffar, M.; Williams, S.B.; Hevelone, N.; Lipsitz, S.R.; Plaster, B.A.; Amarasekera, C.A.; Ulmer, W.D.; Huang, A.C.; Kowalczyk, K.J.; Hu, J.C. 2011: Athermal division and selective suture ligation of the dorsal vein complex during robot-assisted laparoscopic radical prostatectomy: description of technique and outcomes. European Urology 59(2): 235-243

Fernandez, B.; Tsimring, L.S. 2008: Athermal dynamics of strongly coupled stochastic three-state oscillators. Physical Review Letters 100(16): 165705

Koroshetz, J.; Brickeen, B.; Fahr, S.; Rapaport, A.; Bass, M. 2007: Athermal emission in Yb,Er:glass. Optics Express 15(18): 11530-11535

Mitachi, S.; Tick, P.A. 1991: Athermal glass for the infrared. Applied Optics 30(10): 1285-1289

Smith, K.C.; Alam, M.; Fisher, T.S. 2010: Athermal jamming of soft frictionless Platonic solids. Physical Review. e Statistical Nonlinear and Soft Matter Physics 82(5 Part 1): 051304

Olsson, P.; Teitel, S. 2013: Athermal jamming versus thermalized glassiness in sheared frictionless particles. Physical Review. E Statistical Nonlinear and Soft Matter Physics 88(1): 010301

Bovington, J.; Srinivasan, S.; Bowers, J.E. 2014: Athermal laser design. Optics Express 22(16): 19357-19364

Karmakar, S.; Lerner, E.; Procaccia, I. 2010: Athermal nonlinear elastic constants of amorphous solids. Physical Review. e Statistical Nonlinear and Soft Matter Physics 82(2 Part 2): 026105

Raghunathan, V.; Ye, W.N.; Hu, J.; Izuhara, T.; Michel, J.; Kimerling, L. 2010: Athermal operation of silicon waveguides: spectral, second order and footprint dependencies. Optics Express 18(17): 17631-17639

Alipour, P.; Hosseini, E.S.; Eftekhar, A.A.; Momeni, B.; Adibi, A. 2010: Athermal performance in high-Q polymer-clad silicon microdisk resonators. Optics Letters 35(20): 3462-3464

Fily, Y.; Marchetti, M.Cristina. 2012: Athermal phase separation of self-propelled particles with no alignment. Physical Review Letters 108(23): 235702

Levitas, V.I.; Lee, D.-W. 2007: Athermal resistance to interface motion in the phase-field theory of microstructure evolution. Physical Review Letters 99(24): 245701

Mandhani, A.; Tewari, A.K.; Berryhill, R. 2007: Athermal robotic technique of radical prostatectomy: an assistant's perspective. Archivos Espanoles de Urologia 60(4): 375-382

Bouchbinder, E.; Langer, J.S.; Procaccia, I. 2007: Athermal shear-transformation-zone theory of amorphous plastic deformation. I. Basic principles. Physical Review. E Statistical Nonlinear and Soft Matter Physics 75(3 Part 2): 036107

Bouchbinder, E.; Langer, J.S.; Procaccia, I. 2007: Athermal shear-transformation-zone theory of amorphous plastic deformation. II. Analysis of simulated amorphous silicon. Physical Review. E Statistical Nonlinear and Soft Matter Physics 75(3 Part 2): 036108

Guha, B.; Preston, K.; Lipson, M. 2012: Athermal silicon microring electro-optic modulator. Optics Letters 37(12): 2253-2255

Guha, B.; Cardenas, J.; Lipson, M. 2013: Athermal silicon microring resonators with titanium oxide cladding. Optics Express 21(22): 26557-26563

Qiu, F.; Yu, F.; Spring, A.M.; Yokoyama, S. 2012: Athermal silicon nitride ring resonator by photobleaching of Disperse Red 1-doped poly(methyl methacrylate) polymer. Optics Letters 37(19): 4086-4088

Ibrahim, M.; Schmid, J.H.; Aleali, A.; Cheben, P.; Lapointe, J.; Janz, S.; Bock, P.J.; Densmore, A.; Lamontagne, B.; Ma, R.; Xu, D.-X.; Ye, W.N. 2012: Athermal silicon waveguides with bridged subwavelength gratings for TE and TM polarizations. Optics Express 20(16): 18356-18361

Beck, S.M.; Skarecky, D.; Miller, S.; Ahlering, T.E. 2012: Athermal tension adjustable suture ligation of the vascular pedicle during robot-assisted prostatectomy. Journal of Endourology 26(7): 834-837

Harres, A.; Geshev, J. 2011: Athermal training due to exchange and dipolar coupling within a granular model for exchange bias. Journal of Physics. Condensed Matter: An Institute of Physics Journal 23(21): 216003

Milošević, M.M.; Emerson, N.G.; Gardes, F.Y.; Chen, X.; Adikaari, A.A.D.T.; Mashanovich, G.Z. 2011: Athermal waveguides for optical communication wavelengths. Optics Letters 36(23): 4659-4661

Torun, H.; Finkler, O.; Degertekin, F.L. 2009: Athermalization in atomic force microscope based force spectroscopy using matched microstructure coupling. Review of Scientific Instruments 80(7): 076103

Londoño, C.; Plummer, W.T.; Clark, P.P. 1993: Athermalization of a single-component lens with diffractive optics. Applied Optics 32(13): 2295-2302

Grey, D.S. 1948: Athermalization of optical systems. Journal of the Optical Society of America 38(6): 542-546

Craven-Jones, J.; Way, B.M.; Kudenov, M.W.; Mercier, J.A. 2013: Athermalized channeled spectropolarimetry using a biaxial potassium titanyl phosphate crystal. Optics Letters 38(10): 1657-1659

Hussein, A.; Kasmani, R.; Irani, F.; Mohan, G. 2009: Athero-embolic isolated splenic infarction following left cardiac catheterization. Journal of Cardiovascular Medicine 10(3): 271-272

Chen, K. 2012: Athero-protective actions of two oral antidiabetic drugs: Suppression of inflammation and oxidative stress. Journal of Cardiovascular Disease Research 3(1): 3-4

Cohen, A.; Myerscough, M.R.; Thompson, R.S. 2014: Athero-protective effects of High Density Lipoproteins (HDL): An ODE model of the early stages of atherosclerosis. Bulletin of Mathematical Biology 76(5): 1117-1142

Banerjee, S.; Thatthi, T.; Badhey, N.; Brilakis, E.S. 2009: Atheroemboli during peripheral arterial interventions. Journal of Invasive Cardiology 21(12): 632-633

Fries, C.; Roos, M.; Gaspert, A.; Vogt, P.; Salomon, F.; Wüthrich, R.P.; Vavricka, S.R.; Fehr, T. 2010: Atheroembolic disease--a frequently missed diagnosis: results of a 12-year matched-pair autopsy study. Medicine 89(2): 126-132

Scolari, F.; Ravani, P. 2010: Atheroembolic renal disease. Lancet 375(9726): 1650-1660

Faria, B.; Vidinha, J.; Pêgo, C.át.; Garrido, J.; Lemos, S.ér.; Lima, C.; Sorbo, G.; Gomes, E.L.; Carvalho, T.; Loureiro, P.; Sousa, T.ân. 2011: Atheroembolic renal disease with rapid progression and fatal outcome. Clinical and Experimental Nephrology 15(1): 159-163

Dummer, C.D.; Veronese, F.J.V.; Piana, M. 2010: Atheroembolic renal disease: a cause of acute renal failure not much explored. Revista da Associacao Medica Brasileira 56(5): 510-513

Scolari, F.; Turina, S.; Venturelli, C.; Dallera, N.; Valerio, F.; Mazzola, G.; Faberi, E.; Sottini, L.; Kenou, R. 2008: Atheroembolic renal disease: a diagnostic challenge. Recenti Progressi in Medicina 99(7-8): 377-388

Gutiérrez Solís, E.; Morales, E.; Rodríguez Jornet, A.; Andreu, F.J.; Rivera, F.; Vozmediano, C.; Gutiérrez, E.; Igarzábal, A.; Enguita, A.B.; Praga, M. 2010: Atheroembolic renal disease: analysis of clinical and therapeutic factors that influence its progression. Nefrologia: Publicacion Oficial de la Sociedad Espanola Nefrologia 30(3): 317-323

Olin, J.W. 2007: Atheroembolic renal disease: underdiagnosed and misunderstood. Catheterization and Cardiovascular Interventions: Official Journal of the Society for Cardiac Angiography and Interventions 70(6): 789-790

Aragoncillo, I.; Rodríguez, M.; Niembro, E.; Rengel, M.; Verdalles, U.; Anaya, F. 2009: Atheroembolism in transplanted kidney. Nefrologia: Publicacion Oficial de la Sociedad Espanola Nefrologia 29(3): 274-275

Granata, A.; Insalaco, M.; Di Pietro, F.; Di Rosa, S.; Romano, G.; Scuderi, R. 2012: Atheroembolism renal disease: diagnosis and etiologic factors. La Clinica Terapeutica 163(4): 313-322

Siablis, D. 2009: Atheroembolization and peripheral vascular interventions: the evidence is mounting. Journal of Endovascular Therapy: An Official Journal of the International Society of Endovascular Specialists 16(2): 203-205

Vassiliadis, E.; Barascuk, N.; Karsdal, M.A. 2013: Atherofibrosis - a unique and common process of the disease pathogenesis of atherosclerosis and fibrosis - lessons for biomarker development. American Journal of Translational Research 5(1): 1-14

Stoltzfus, L.; Rubin, E.M. 1993: Atherogenesis Insights from the study of transgenic and gene-targeted mice. Trends in Cardiovascular Medicine 3(4): 130-134

Stratmann, B.; Tschoepe, D. 2009: Atherogenesis and atherothrombosis--focus on diabetes mellitus. Best Practice and Research. Clinical Endocrinology and Metabolism 23(3): 291-303

Madonna, R.; De Caterina, R. 2012: Atherogenesis and diabetes: focus on insulin resistance and hyperinsulinemia. Revista Espanola de Cardiologia 65(4): 309-313

Methe, H.; Weis, M.; Virchow, R. 2007: Atherogenesis and inflammation--was Virchow right?. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 22(7): 1823-1827

Vinchi, F.; Muckenthaler, M.U.; Da Silva, M.C.; Balla, G.ör.; Balla, J.óz.; Jeney, V.ór. 2014: Atherogenesis and iron: from epidemiology to cellular level. Frontiers in Pharmacology 5: 94

Virella, G.; Lopes-Virella, M.F. 2008: Atherogenesis and the humoral immune response to modified lipoproteins. Atherosclerosis 200(2): 239-246

Efstratiadis, G.; Tziomalos, K.; Mikhailidis, D.P.; Athyros, V.G.; Hatzitolios, A. 2008: Atherogenesis in renal patients: a model of vascular disease?. Current Vascular Pharmacology 6(2): 93-107

Fietta, P.; Delsante, G. 2009: Atherogenesis in rheumatoid arthritis: the "rheumatoid vasculopathy"?. Acta Bio-Medica: Atenei Parmensis 80(3): 177-186

Dratva, J.; Probst-Hensch, N.; Schmidt-Trucksäss, A.; Caviezel, S.; de Groot, E.; Bettschart, R.; Saleh, L.; Gapoz, J.-M.; Rothe, T.; Schindler, C.; Stolz, D.; Turk, A.; Rochat, T.; Kuenzli, N.; Zemp, E. 2013: Atherogenesis in youth--early consequence of adolescent smoking. Atherosclerosis 230(2): 304-309

Potor, László.; Bányai, E.; Becs, G.; Soares, M.P.; Balla, Görgy.; Balla, József.; Jeney, Vória. 2013: Atherogenesis may involve the prooxidant and proinflammatory effects of ferryl hemoglobin. Oxidative Medicine and Cellular Longevity 2013: 676425

Gargalovic, P.S. 2009: Atherogenesis on the chopping block. Cell Metabolism 9(5): 399-401

Gómez Rosso, L.; Meroño, T.ás.; Giunta, G.; Boero, L.; Schreier, L.; Cuniberti, L.; Brites, F. 2012: Atherogenic alterations in hypertriglyceridemic patients would not depend on insulin resistance. Clinica Chimica Acta; International Journal of Clinical Chemistry 413(5-6): 620-624

Han, S.G.; Howatt, D.A.; Daugherty, A.; Gairola, C.G. 2012: Atherogenic and pulmonary responses of ApoE- and LDL receptor-deficient mice to sidestream cigarette smoke. Toxicology 299(2-3): 133-138

Kobayashi, K.; Lopez, L.R.; Matsuura, E. 2007: Atherogenic antiphospholipid antibodies in antiphospholipid syndrome. Annals of the new York Academy of Sciences 1108: 489-496

Kim, J.J.; Chae, S.J.; Choi, Y.M.; Hwang, K.R.; Song, S.H.; Yoon, S.H.; Kim, S.M.; Ku, S.Y.; Kim, S.H.; Kim, J.G.; Moon, S.Y. 2013: Atherogenic changes in low-density lipoprotein particle profiles were not observed in non-obese women with polycystic ovary syndrome. Human Reproduction 28(5): 1354-1360

Nezami, N.; Ghorbanihaghjo, A.; Rashtchizadeh, N.; Argani, H.; Tafrishinejad, A.; Ghorashi, S.; Hajhosseini, B. 2011: Atherogenic changes of low-density lipoprotein susceptibility to oxidation, and antioxidant enzymes in pulmonary tuberculosis. Atherosclerosis 217(1): 268-273

Macri, E.; Lifshitz, F.; Ramos, C.; Orzuza, R.; Costa, O.; Zago, V.; Boyer, P.; Friedman, S. 2014: Atherogenic cholesterol-rich diet and periodontal disease. Archives of Oral Biology 59(7): 679-686

Niemeier, A.; Kovacs, W.J.; Strobl, W.; Stangl, H. 2009: Atherogenic diet leads to posttranslational down-regulation of murine hepatocyte SR-BI expression. Atherosclerosis 202(1): 169-175

Gao, Q.; Esworthy, R.S.; Kim, B.-W.; Synold, T.W.; Smith, D.D.; Chu, F.-F. 2010: Atherogenic diets exacerbate colitis in mice deficient in glutathione peroxidase. Inflammatory Bowel Diseases 16(12): 2043-2054

Zozulińska, D. 2006: Atherogenic dyslipidaemia in type 2 diabetes. Kardiologia Polska 64(10 Suppl 6: S567-S571

Hwang, Y.-C.; Ahn, H.-Y.; Yu, S.-H.; Park, S.-W.; Park, C.-Y. 2014: Atherogenic dyslipidaemic profiles associated with the development of Type 2 diabetes: a 3.1-year longitudinal study. Diabetic Medicine: a Journal of the British Diabetic Association 31(1): 24-30

Manjunath, C.N.; Rawal, J.R.; Irani, P.Mehelli.; Madhu, K. 2013: Atherogenic dyslipidemia. Indian Journal of Endocrinology and Metabolism 17(6): 969-976

Ueno, T.; Fukuda, N.; Nagase, H.; Tsunemi, A.; Tahira, K.; Matsumoto, T.; Hiraoka-Yamamoto, J.; Ikeda, K.; Mitsumata, M.; Sato, Y.; Soma, M.; Matsumoto, K.; Yamori, Y. 2009: Atherogenic dyslipidemia and altered hepatic gene expression in SHRSP.Z-Leprfa/IzmDmcr rats. International Journal of Molecular Medicine 23(3): 313-320

Alkhouri, N.; Carter-Kent, C.; Elias, M.; Feldstein, A.E. 2011: Atherogenic dyslipidemia and cardiovascular risk in children with nonalcoholic fatty liver disease. Clinical Lipidology 6(3): 305-314

Hamilton, S.J.; Watts, G.F. 2013: Atherogenic dyslipidemia and combination pharmacotherapy in diabetes: recent clinical trials. Review of Diabetic Studies: Rds 10(2-3): 191-203

Kumar, A.; Singh, V. 2010: Atherogenic dyslipidemia and diabetes mellitus: what's new in the management arena?. Vascular Health and Risk Management 6: 665-669

Rizzo, M.; Kotur-Stevuljevic, J.; Berneis, K.; Spinas, G.; Rini, G.B.; Jelic-Ivanovic, Z.; Spasojevic-Kalimanovska, V.; Vekic, J. 2009: Atherogenic dyslipidemia and oxidative stress: a new look. Translational Research: the Journal of Laboratory and Clinical Medicine 153(5): 217-223

Sirimarco, G.; Labreuche, J.; Bruckert, E.; Goldstein, L.B.; Fox, K.M.; Rothwell, P.M.; Amarenco, P.; Bousser, M.-G.; Chamorro, A.; Ford, I.; Fox, K.; Fisher, M.; Hennerici, M.G.; Mattle, H.; Rothwell, P.M.; Callahan, F.; Goldstein, L.B.; Sillesen, H.; Welch, K.M.A.; Zivin, J.A. 2014: Atherogenic dyslipidemia and residual cardiovascular risk in statin-treated patients. Stroke 45(5): 1429-1436

Zák, A.; Slabý, A. 2008: Atherogenic dyslipidemia and the metabolic syndrome: pathophysiological mechanisms. Casopis Lekaru Ceskych 147(9): 459-470

Bestehorn, K.; Smolka, W.; Pittrow, D.; Schulte, H.; Assmann, G. 2010: Atherogenic dyslipidemia as evidenced by the lipid triad: prevalence and associated risk in statin-treated patients in ambulatory care. Current Medical Research and Opinion 26(12): 2833-2839

Lahoz, C.; Mostaza, J.M.; Tranche, S.; Martin-Jadraque, R.; Mantilla, M.T.; López-Rodriguez, I.; Monteiro, B.; Sanchez-Zamorano, M.A.; Taboada, M. 2012: Atherogenic dyslipidemia in patients with established coronary artery disease. Nutrition Metabolism and Cardiovascular Diseases: Nmcd 22(2): 103-108

Sirimarco, G.; Deplanque, D.; Lavallée, P.C.; Labreuche, J.; Meseguer, E.; Cabrejo, L.; Guidoux, C.él.; Olivot, J.-M.; Abboud, H.; Lapergue, B.; Klein, I.F.; Mazighi, M.; Touboul, P.-J.; Bruckert, E.; Amarenco, P. 2011: Atherogenic dyslipidemia in patients with transient ischemic attack. Stroke 42(8): 2131-2137

Chillarón, J.J.; Sales, M.ía.P.; Flores Le-Roux, J.A.; Castells, I.; Benaiges, D.; Sagarra, E.; Pedro-Botet, J. 2013: Atherogenic dyslipidemia in patients with type 1 diabetes mellitus. Medicina Clinica 141(11): 465-470

Govindarajan, G.; Chowdhury, N.; Flaker, G. 2006: Atherogenic dyslipidemia in the cardiometabolic syndrome. Journal of the Cardiometabolic Syndrome 1(2): 153-155

Mel'nikova, N.V.; Zvenigorodskaia, L.A.; Ovsiannikova, O.N.; Il'chenko, L.I.; Khomeriki, S.G. 2007: Atherogenic dyslipidemia, non-alcohol steatohepatitis, methods of treatment. Eksperimental'naia i Klinicheskaia Gastroenterologiia 1: 28-34

Gleeson, R. 2009: Atherogenic dyslipidemia--a medical underwriter's iceberg. Journal of Insurance Medicine 41(4): 264-269

Pérez Jiménez, F. 2014: Atherogenic dyslipidemia: a condition that should not be overlooked. Revista Clinica Espanola 214(9): 513-514

Anonymous 2013: Atherogenic dyslipidemia: a multidisciplinary consensus panel. Clinica e investigacion en arteriosclerosis: publicacion oficial de la Sociedad Espanola de Arteriosclerosis 25(2): 83-91

Musunuru, K. 2010: Atherogenic dyslipidemia: cardiovascular risk and dietary intervention. Lipids 45(10): 907-914

Pedro-Botet, J.; Flores-Le Roux, J.A.; Mostaza, J.M.; Pintó, X.; de la Cruz, J.J.; Banegas, J.R. 2014: Atherogenic dyslipidemia: prevalence and management in lipid clinics. Revista Clinica Espanola 214(9): 491-498

Choudhury, M.D.; Chetia, P.; Choudhury, K.D.; Talukdar, A.D.; Datta-Choudhari, M. 2012: Atherogenic effect of Arecoline: a computational study. Bioinformation 8(5): 229-232

Hashizume, M.; Mihara, M. 2012: Atherogenic effects of TNF-α and IL-6 via up-regulation of scavenger receptors. Cytokine 58(3): 424-430

Fernandez, A.Z.; Siebel, A.L.; El-Osta, A. 2010: Atherogenic factors and their epigenetic relationships. International Journal of Vascular Medicine 2010: 437809

Berneis, K.; Rizzo, M.; Hersberger, M.; Rini, G.B.; Di Fede, G.; Pepe, I.; Spinas, G.A.; Carmina, E. 2009: Atherogenic forms of dyslipidaemia in women with polycystic ovary syndrome. International Journal of Clinical Practice 63(1): 56-62

Popa, C.D.; Arts, E.; Fransen, J.; van Riel, P.L.C.M. 2012: Atherogenic index and high-density lipoprotein cholesterol as cardiovascular risk determinants in rheumatoid arthritis: the impact of therapy with biologicals. Mediators of Inflammation 2012: 785946

Nwagha, U.I.; Ikekpeazu, E.J.; Ejezie, F.E.; Neboh, E.E.; Maduka, I.C. 2010: Atherogenic index of plasma as useful predictor of cardiovascular risk among postmenopausal women in Enugu, Nigeria. African health sciences 10(3): 248-252

Onyedum, C.C.; Young, E.E.; Iroezindu, M.O.; Chukwuka, C.J.; Nwagha, U.I. 2014: Atherogenic index of plasma in highly active antiretroviral therapy-naïve patients with human immunodeficiency virus infection in Southeast Nigeria. Indian journal of endocrinology and metabolism 18(5): 631-636

Aragon-Charris, J.; Reyna-Villasmil, E.; Guerra-Velasquez, M.; Mejia-Montilla, J.; Torres-Cepeda, D.; Santos-Bolívar, J.; Reyna-Villasmil, N. 2014: Atherogenic index of plasma in patients with preeclampsia and in healthy pregnant women. Medicina clinica 143(3): 104-108

Singh, H.V.; Shrivastava, A.K.; Raizada, A.; Singh, S.K.; Pandey, A.; Singh, N.; Yadav, D.; Sharma, H. 2013: Atherogenic lipid profile and high sensitive C-reactive protein in patients with rheumatoid arthritis. Clinical Biochemistry 46(12): 1007-1012

Pirgon, Özgür.; Atabek, M.Emre.; Oran, Bülent.; Güçlü, Rıdvan. 2008: Atherogenic lipid profile and systolic blood pressure are associated with carotid artery intima-media thickness in children with Turner syndrome. Journal of Clinical Research in Pediatric Endocrinology 1(2): 62-71

Messedi, M.; Jamoussi, K.; Frigui, M.; Laporte, F.ço.; Turki, M.; Chaabouni, K.; Mnif, E.; Jaloulli, M.; Kaddour, N.; Bahloul, Z.; Ayedi, F. 2011: Atherogenic lipid profile in Behçet's disease: evidence of alteration of HDL subclasses. Archives of Medical Research 42(3): 211-218

Nurmohamed, M.T. 2007: Atherogenic lipid profiles and its management in patients with rheumatoid arthritis. Vascular Health and Risk Management 3(6): 845-852

Nandeesha, H.; Sathiyapriya, V.; Bobby, Z.; Selvaraj, N.; Pavithran, P.; Agrawal, A. 2008: Atherogenic lipid risk factors in men classified as overweight and obese according to the preliminary WHO guidelines for Asians. Indian Journal of Physiology and Pharmacology 52(2): 205-208

Seimon, T.A.; Nadolski, M.J.; Liao, X.; Magallon, J.; Nguyen, M.; Feric, N.T.; Koschinsky, M.L.; Harkewicz, R.; Witztum, J.L.; Tsimikas, S.; Golenbock, D.; Moore, K.J.; Tabas, I. 2010: Atherogenic lipids and lipoproteins trigger CD36-TLR2-dependent apoptosis in macrophages undergoing endoplasmic reticulum stress. Cell Metabolism 12(5): 467-482

Kodali, V.R.R. 2014: Atherogenic lipids and vascular complications in a selected diabetic population with normal urinary albumin/creatinine ratios. Diabetes and Metabolic Syndrome 8(2): 124-127

Barlic, J.; Zhang, Y.; Murphy, P.M. 2007: Atherogenic lipids induce adhesion of human coronary artery smooth muscle cells to macrophages by up-regulating chemokine CX3CL1 on smooth muscle cells in a TNFalpha-NFkappaB-dependent manner. Journal of Biological Chemistry 282(26): 19167-19176

Barlic, J.; Zhu, W.; Murphy, P.M. 2009: Atherogenic lipids induce high-density lipoprotein uptake and cholesterol efflux in human macrophages by up-regulating transmembrane chemokine CXCL16 without engaging CXCL16-dependent cell adhesion. Journal of Immunology 182(12): 7928-7936

Rizzo, M.; Spinas, G.A.; Cesur, M.; Ozbalkan, Z.; Rini, G.B.; Berneis, K. 2009: Atherogenic lipoprotein phenotype and LDL size and subclasses in drug-naïve patients with early rheumatoid arthritis. Atherosclerosis 207(2): 502-506

Rizzo, M.; Berneis, K.; Altinova, A.E.; Toruner, F.B.; Akturk, M.; Ayvaz, G.; Rini, G.B.; Spinas, G.A.; Arslan, M. 2008: Atherogenic lipoprotein phenotype and LDL size and subclasses in women with gestational diabetes. Diabetic Medicine: a Journal of the British Diabetic Association 25(12): 1406-1411

Wikinski, R.; Schreier, L.E.; Berg, G.A.; Brites, F.D.; López, G.; González, A.I.; Zago, V. 2010: Atherogenic lipoprotein remnants in humans. Medicina 70(4): 375-380

Ellington, A.A.; Kullo, I.J. 2008: Atherogenic lipoprotein subprofiling. Advances in Clinical Chemistry 46: 295-317

Malhotra, J.; Tonorezos, E.S.; Rozenberg, M.; Vega, G.L.; Sklar, C.A.; Chou, J.; Moskowitz, C.S.; Eshelman-Kent, D.A.; Janiszewski, P.; Ross, R.; Oeffinger, K.C. 2012: Atherogenic low density lipoprotein phenotype in long-term survivors of childhood acute lymphoblastic leukemia. Journal of Lipid Research 53(12): 2747-2754

Castelo-Branco, C.; Steinvarcel, F.; Osorio, A.; Ros, C.; Balasch, J. 2010: Atherogenic metabolic profile in PCOS patients: role of obesity and hyperandrogenism. Gynecological Endocrinology: the Official Journal of the International Society of Gynecological Endocrinology 26(10): 736-742

Schmitt, M.M.N.; Fraemohs, L.; Hackeng, T.M.; Weber, C.; Koenen, R.R. 2014: Atherogenic mononuclear cell recruitment is facilitated by oxidized lipoprotein-induced endothelial junctional adhesion molecule-A redistribution. Atherosclerosis 234(2): 254-264

Oravec, S.; Dukát, A.; Gavorník, P.; Lovásová, Z.; Gruber, K.ín. 2011: Atherogenic normolipidemia - a new phenomenon in the lipoprotein profile of clinically healthy subjects. Neuro Endocrinology Letters 32(3): 317-321

Ragino, I.I.; Polonskaia, I.V.; Semaeva, E.V.; Kashtanova, E.V.; Kulikov, I.V.; Cherniavskiĭ, A.M.; Voevoda, M.I. 2007: Atherogenic oxidative and structural modification of low density lipoproteins in men with coronary atherosclerosis. Kardiologiia 47(11): 14-18

Yoshino, H.; Hasegawa, K.; Yokono, K.; Yoshino, G. 2015: Atherogenic phenotype remains in elderly diabetic patients. Geriatrics and Gerontology International 15(1): 34-37

Eyong, E.U.; Umoh, I.B.; Ogu, T.I.; Edet, E.E.; Eteng, M.U.; Igiri, A.O. 2007: Atherogenic potentials of some Nigerian meals. Nigerian Journal of Physiological Sciences: Official Publication of the Physiological Society of Nigeria 22(1-2): 15-18

Hatzis, C.M.; Papandreou, C.; Vardavas, C.I.; Athanasopoulos, D.; Balomenaki, E.; Kafatos, A.G. 2012: Atherogenic risk factors among preschool children in Crete, Greece. Indian Journal of Endocrinology and Metabolism 16(5): 809-814

Frederiksen, T.W.; Ramlau-Hansen, C.H.øs.; Stokholm, Z.A.; Brødsgaard Grynderup, M.; Hansen, Ås.M.; Lund, S.ør.P.; Medom Vestergaard, J.; Kristiansen, J.; Bonde, J.P.; Kolstad, H.A. 2014: Atherogenic risk factors and hearing thresholds. Audiology and Neuro-Otology 19(5): 310-318

Mak, A.; Ho, R.C.-M.; Tan, J.Y.-S.; Teng, G.G.; Lahiri, M.; Lateef, A.; Vasoo, S.; Boey, M.L.; Koh, D.R.; Feng, P.H. 2009: Atherogenic serum lipid profile is an independent predictor for gouty flares in patients with gouty arthropathy. Rheumatology 48(3): 262-265

Dutheil, F.éd.ér.; Walther, G.; Chapier, R.; Mnatzaganian, G.; Lesourd, B.; Naughton, G.; Verney, J.; Fogli, A.; Sapin, V.; Duclos, M.; Vinet, A.ès.; Obert, P.; Courteix, D.; Lac, G.ér. 2014: Atherogenic subfractions of lipoproteins in the treatment of metabolic syndrome by physical activity and diet - the RESOLVE trial. Lipids in Health and Disease 13: 112

Mukherjee, D. 2012: Atherogenic vascular stiffness and hypertension: cause or effect?. JAMA 308(9): 919-920

Oravec, S.; Dukat, A.; Gavornik, P.; Kucera, M.; Gruber, K.; Gaspar, L.; Rizzo, M.; Toth, P.P.; Mikhailidis, D.P.; Banach, M. 2014: Atherogenic versus non-atherogenic lipoprotein profiles in healthy individuals. is there a need to change our approach to diagnosing dyslipidemia?. Current Medicinal Chemistry 21(25): 2892-2901

Al-aryahi, S.; Kamato, D.; Getachew, R.; Zheng, W.; Potocnik, S.J.; Cohen, N.; Guidone, D.; Osman, N.; Little, P.J. 2014: Atherogenic, fibrotic and glucose utilising actions of glucokinase activators on vascular endothelium and smooth muscle. Cardiovascular Diabetology 13: 80

Nantapo, C.T.W.; Muchenje, V.; Hugo, A. 2014: Atherogenicity index and health-related fatty acids in different stages of lactation from Friesian, Jersey and Friesian×Jersey cross cow milk under a pasture-based dairy system. Food Chemistry 146: 127-133

Bailey, C.H. 1916: Atheroma and other Lesions Produced in Rabbits by Cholesterol Feeding. Journal of Experimental Medicine 23(1): 69-84

Grant, J.; Miller, J.H. 1935: Atheroma of Coronary Artery and Myocardial Fibrosis. British Medical Journal 1(3868): 353-372.3

Yazdani, S.K.; Nakano, M.; Otsuka, F.; Kolodgie, F.D.; Virmani, R. 2010: Atheroma and coronary bifurcations: before and after stenting. Eurointervention: Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 6 Suppl J: J24-J30

Soubrier, M.; Mathieu, S.; Dubost, J.-J. 2007: Atheroma and systemic lupus erythematosus. Joint Bone Spine 74(6): 566-570

De Oliveira, J.úl.C.és.S.; Boos, F.B.D.J.; Rocha, J.F.; Ponzoni, D.; de Souza, F.Áv.; Garcia, I.R. 2014: Atheroma of the carotid artery detected on a lateral radiograph. Journal of Craniofacial Surgery 25(4): 1579-1580

Houénassi, D.-M.; Tchabi, Y.; Amoussouguénou, K.-D.; Djrolo, F.; Azondékon, A.; Sacca-Véhounkpé, J.; Akindès-Dossou Yovo, R.; Dossou Togbé, F.; Massougbodji-d'Almeida, M.; Agboton, H. 2007: Atheroma of the carotid in the diabetic: frequency and clinical expression in a population of 68 diabetics in Benin. Journal des Maladies Vasculaires 32(3): 159-161

Arias-Santiago, S.; Orgaz-Molina, J.; Castellote-Caballero, L.; Arrabal-Polo, M.Án.; García-Rodriguez, S.; Perandrés-López, R.én.; Ruiz, J.é C.; Naranjo-Sintes, R.ón.; Zubiaur, M.; Sancho, J.; Buendía-Eisman, A.ín. 2012: Atheroma plaque, metabolic syndrome and inflammation in patients with psoriasis. European Journal of Dermatology: Ejd 22(3): 337-344

Rigatto, C.; Levin, A.; House, A.A.; Barrett, B.; Carlisle, E.; Fine, A. 2009: Atheroma progression in chronic kidney disease. Clinical Journal of the American Society of Nephrology: Cjasn 4(2): 291-298

Strauss, H.William.; Narula, J. 2007: Atheroma roulette. Journal of Nuclear Cardiology: Official Publication of the American Society of Nuclear Cardiology 14(3): 293-297

Tobis, J.M.; Perlowski, A. 2009: Atheroma volume by intravascular ultrasound as a surrogate for clinical end points. Journal of the American College of Cardiology 53(13): 1116-1118

Griffon, C.; Cohen, C.; Stephan, D. 2007: Atheroma: epidemiology and pathophysiology. the polyatheromatous patient. La Revue du Praticien 57(7): 797-803

Pyle, A.L.; Young, P.P. 2010: Atheromas feel the pressure: biomechanical stress and atherosclerosis. American Journal of Pathology 177(1): 4-9

Friedlander, A.H. 2007: Atheromas on panoramic radiographs often denote stenotic lesions and portend adverse vascular events. Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontics 104(4): 451

Acharya, U.R.; Faust, O.; Sree, S.V.; Alvin, A.P.C.; Krishnamurthi, G.; Seabra, J.é C.R.; Sanches, J.ão.; Suri, J.S. 2011: Atheromatic™: symptomatic vs. asymptomatic classification of carotid ultrasound plaque using a combination of HOS, DWT and texture. Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference 2011: 4489-4492

Anderson, D.E. 1901: Atheromatous Ulceration of the Heart: Perforation: Sudden Death. British Medical Journal 2(2134): 1525

Motoyoshi, N.; Saiki, Y. 2012: Atheromatous aorta: clinical pitfall in cardiovascular surgery. Kyobu Geka. Japanese Journal of Thoracic Surgery 65(8): 636-639

Fineschi, M.; Carrera, A.; Gori, T. 2009: Atheromatous degeneration of the neointima in a bare metal stent: intravascular ultrasound evidence. Journal of Cardiovascular Medicine 10(7): 572-573

Kalaria, R.N.; Perry, R.H.; O'Brien, J.; Jaros, E. 2012: Atheromatous disease in small intracerebral vessels, microinfarcts and dementia. Neuropathology and Applied Neurobiology 38(5): 505-508

Sadat, U. 2009: Atheromatous plaque hemorrhage: early detection and its impact on the management of patients with carotid artery disease. Expert Review of Cardiovascular Therapy 7(1): 25-27

Craiem, D.; Chironi, G.; Graf, S.; Denarié, N.; Armentano, R.L.; Simon, A. 2009: Atheromatous plaque: quantitative analysis of the echogenicity of different layers. Revista Espanola de Cardiologia 62(9): 984-991

Kuwashiro, T.; Toyoda, K.; Yoshimura, S.; Koga, M.; Naganuma, M.; Otsubo, R.; Konaka, K.; Uehara, T.; Naritomi, H.; Minematsu, K. 2010: Atheromatous plaques at the origin of the left subclavian artery in patients with ischemic stroke. Cerebrovascular Diseases 29(3): 290-296

Chrysochou, C.; Kalra, P.A. 2008: Atheromatous renovascular disease: overview and challenges. Journal of Renal Care 34(4): 179-190

Caulfield, M. 2009: Atheromatous vascular disease and ischaemic stroke in the UK. Journal of Dentistry 37(8): S579-S581

Abe, J-ichi.; Berk, B.C. 2013: Atheroprone flow activation of the sterol regulatory element binding protein 2 and nod-like receptor protein 3 inflammasome mediates focal atherosclerosis. Circulation 128(6): 579-582

Feaver, R.E.; Gelfand, B.D.; Wang, C.; Schwartz, M.A.; Blackman, B.R. 2010: Atheroprone hemodynamics regulate fibronectin deposition to create positive feedback that sustains endothelial inflammation. Circulation Research 106(11): 1703-1711

Czepluch, F.S.; Kuschicke, H.; Dellas, C.; Riggert, J.; Hasenfuss, G.; Schäfer, K. 2013: Atheroprotective Krüppel-like factor 4 is downregulated in monocyte subsets of patients with coronary artery disease. Thrombosis and Haemostasis 110(5): 1080-1082

Tse, K.; Gonen, A.; Sidney, J.; Ouyang, H.; Witztum, J.L.; Sette, A.; Tse, H.; Ley, K. 2013: Atheroprotective Vaccination with MHC-Ii Restricted Peptides from ApoB-100. Frontiers in Immunology 4: 493

Motoyama, K.; Koyama, H.; Moriwaki, M.; Emura, K.; Okuyama, S.; Sato, E.; Inoue, M.; Shioi, A.; Nishizawa, Y. 2009: Atheroprotective and plaque-stabilizing effects of enzymatically modified isoquercitrin in atherogenic apoE-deficient mice. Nutrition 25(4): 421-427

Vinson, J.A. 2013: Atheroprotective effect of dietary walnut intake in ApoE-deficient mice: involvement of lipids and coagulation factors. Thrombosis Research 131(5): 375-376

Mansouri, R.M.; Baugé, E.; Gervois, P.; Fruchart-Najib, J.; Fiévet, C.; Staels, B.; Fruchart, J.-C. 2008: Atheroprotective effect of human apolipoprotein A5 in a mouse model of mixed dyslipidemia. Circulation Research 103(5): 450-453

Fan, A.; Wu, X.; Wu, H.; Li, L.; Huang, R.; Zhu, Y.; Qiu, Y.; Fu, J.; Ren, J.; Zhu, C. 2014: Atheroprotective effect of oleoylethanolamide (OEA) targeting oxidized LDL. Plos one 9(1): E85337

Zanotti, I.; Dall'Asta, M.; Mena, P.; Mele, L.; Bruni, R.; Ray, S.; Del Rio, D. 2015: Atheroprotective effects of (poly)phenols: a focus on cell cholesterol metabolism. Food and Function 6(1): 13-31

Wigren, M.; Bengtsson, D.; Dunér, P.; Olofsson, K.; Björkbacka, H.; Bengtsson, E.; Fredrikson, G.N.; Nilsson, J. 2009: Atheroprotective effects of Alum are associated with capture of oxidized LDL antigens and activation of regulatory T cells. Circulation Research 104(12): E62-E70

Mauray, A.; Milenkovic, D.; Besson, C.; Caccia, N.; Morand, C.; Michel, F.; Mazur, A.; Scalbert, A.; Felgines, C. 2009: Atheroprotective effects of bilberry extracts in apo E-deficient mice. Journal of Agricultural and Food Chemistry 57(23): 11106-11111

Cremers, S.G.; Wolffram, S.J.; Weinberg, P.D. 2011: Atheroprotective effects of dietary L-arginine increase with age in cholesterol-fed rabbits. British Journal of Nutrition 105(10): 1439-1447

Reiss, A.B.; Carsons, S.E.; Anwar, K.; Rao, S.; Edelman, S.D.; Zhang, H.; Fernandez, P.; Cronstein, B.N.; Chan, E.S.L. 2008: Atheroprotective effects of methotrexate on reverse cholesterol transport proteins and foam cell transformation in human THP-1 monocyte/macrophages. Arthritis and Rheumatism 58(12): 3675-3683

Gonen, A.; Hansen, L.F.; Turner, W.W.; Montano, E.N.; Que, X.; Rafia, A.їs.; Chou, M.-Y.; Wiesner, P.; Tsiantoulas, D.; Corr, M.; VanNieuwenhze, M.S.; Tsimikas, S.; Binder, C.J.; Witztum, J.L.; Hartvigsen, K. 2014: Atheroprotective immunization with malondialdehyde-modified LDL is hapten specific and dependent on advanced MDA adducts: implications for development of an atheroprotective vaccine. Journal of Lipid Research 55(10): 2137-2155

Airan-Javia, S.L.; Wolf, R.L.; Wolfe, M.L.; Tadesse, M.; Mohler, E.; Reilly, M.P. 2009: Atheroprotective lipoprotein effects of a niacin-simvastatin combination compared to low- and high-dose simvastatin monotherapy. American Heart Journal 157(4): 687.E1-8

Boon, R.A.; Hergenreider, E.; Dimmeler, S. 2012: Atheroprotective mechanisms of shear stress-regulated microRNAs. Thrombosis and Haemostasis 108(4): 616-620

Frostegård, J.; Tao, W.; Georgiades, A.; Råstam, L.; Lindblad, U.; Lindeberg, S. 2007: Atheroprotective natural anti-phosphorylcholine antibodies of IgM subclass are decreased in Swedish controls as compared to non-westernized individuals from new Guinea. Nutrition and Metabolism 4: 7

Elseweidy, M.M.; Younis, N.N.; Elswefy, S.E.; Abdallah, F.R.; El-Dahmy, S.I.; Elnagar, G.; Kassem, H.M. 2015: Atheroprotective potentials of curcuminoids against ginger extract in hypercholesterolaemic rabbits. Natural Product Research 29(10): 961-965

Ge, C.; Song, J.; Chen, L.; Wang, L.; Chen, Y.; Liu, X.; Zhang, Y.; Zhang, L.; Zhang, M. 2014: Atheroprotective pulsatile flow induces ubiquitin-proteasome-mediated degradation of programmed cell death 4 in endothelial cells. Plos one 9(3): E91564

Oberkersch, R.; Maccari, F.; Bravo, A.I.; Volpi, N.; Gazzaniga, S.; Calabrese, G.C. 2014: Atheroprotective remodelling of vascular dermatan sulphate proteoglycans in response to hypercholesterolaemia in a rat model. International Journal of Experimental Pathology 95(3): 181-190

Potì, F.; Simoni, M.; Nofer, J.-R. 2014: Atheroprotective role of high-density lipoprotein (HDL)-associated sphingosine-1-phosphate (S1P). Cardiovascular Research 103(3): 395-404

Silbiger, J.J.; Ashtiani, R.; Attari, M.; Spruill, T.M.; Kamran, M.; Reynolds, D.; Stein, R.; Rubinstein, D. 2011: Atheroscerlotic heart disease in Bangladeshi immigrants: risk factors and angiographic findings. International Journal of Cardiology 146(2): E38-E40

Ai, M. 2012: Atherosclerosis (hypertension). Nihon Rinsho. Japanese Journal of Clinical Medicine 70(5): 840-845

Anonymous 2009: Atherosclerosis 2009. Prague, 9-11 September 2009. Casopis lekaru ceskych 148(11): 561-570

Poupel, L.; Combadière, C. 2010: Atherosclerosis : on the trail of chemokines. Biologie Aujourd'hui 204(4): 285-293

Prendergast, C.; Quayle, J.; Burdyga, T.; Wray, S. 2014: Atherosclerosis affects calcium signalling in endothelial cells from apolipoprotein e knockout mice before plaque formation. Cell Calcium 55(3): 146-154

Nafar, M.; Khatami, F.; Khatami, F.; Kardavani, B.; Farjad, R.; Pour-Reza-Gholi, F.; Firoozan, A. 2007: Atherosclerosis after kidney transplantation: changes of intima-media thickness of carotids during early posttransplant period. Urology Journal 4(2): 105-110

Schramm, R.é; Appel, F.; Reinacher, M.; Schäfers, H.-J.; Bierbach, B.; Slotta, J.; Thorlacius, H.; Menger, M.D. 2011: Atherosclerosis aggravates ischemia/reperfusion injury in the gut and remote damage in the liver and the lung. Inflammation Research: Official Journal of the European Histamine Research Society . 60(6): 555-567

Gil-Bernabe, P.; Boveda-Ruiz, D.; D'Alessandro-Gabazza, C.; Toda, M.; Miyake, Y.; Mifuji-Moroka, R.; Iwasa, M.; Morser, J.; Gabazza, E.C.; Takei, Y. 2011: Atherosclerosis amelioration by moderate alcohol consumption is associated with increased circulating levels of stromal cell-derived factor-1. Circulation Journal: Official Journal of the Japanese Circulation Society 75(9): 2269-2279

Lathe, R.; Sapronova, A.; Kotelevtsev, Y. 2014: Atherosclerosis and Alzheimer--diseases with a common cause? Inflammation, oxysterols, vasculature. Bmc Geriatrics 14: 36

Grown, W. 1958: Atherosclerosis and Myocardial Infarction. Canadian Medical Association Journal 79(12): 1007-1008

Saccucci, P.; Banci, M.; Cozzoli, E.; Neri, A.; Magrini, A.; Bottini, E.; Gloria-Bottini, F. 2011: Atherosclerosis and PTPN22: a study in coronary artery disease. Cardiology 119(1): 54-56

Golledge, J.; Norman, P.E. 2010: Atherosclerosis and abdominal aortic aneurysm: cause, response, or common risk factors?. Arteriosclerosis Thrombosis and Vascular Biology 30(6): 1075-1077

Ozdil, B.; Coşar, A.; Akkız, H.; Sandıkçı, M. 2011: Atherosclerosis and acetylsalicylic acid are independent risk factors for hemorrhage in patients with gastric or duodenal ulcer. Anadolu Kardiyoloji Dergisi: Akd 11(1): 53-56

Lu, H.; Cassis, L.A.; Daugherty, A. 2007: Atherosclerosis and arterial blood pressure in mice. Current Drug Targets 8(11): 1181-1189

Kylintireas, I.; Craig, S.; Nethononda, R.; Kohler, M.; Francis, J.; Choudhury, R.; Stradling, J.; Neubauer, S. 2012: Atherosclerosis and arterial stiffness in obstructive sleep apnea--a cardiovascular magnetic resonance study. Atherosclerosis 222(2): 483-489

Shenhar-Tsarfaty, S.; Waiskopf, N.; Ofek, K.; Shopin, L.; Usher, S.; Berliner, S.; Shapira, I.; Bornstein, N.M.; Ritov, Y.; Soreq, H.; Ben Assayag, E. 2013: Atherosclerosis and arteriosclerosis parameters in stroke patients associate with paraoxonase polymorphism and esterase activities. European Journal of Neurology 20(6): 891-898

Sun, Z. 2014: Atherosclerosis and atheroma plaque rupture: imaging modalities in the visualization of vasa vasorum and atherosclerotic plaques. Thescientificworldjournal 2014: 312764

Sun, Z. 2014: Atherosclerosis and atheroma plaque rupture: normal anatomy of vasa vasorum and their role associated with atherosclerosis. Thescientificworldjournal 2014: 285058

El-Aoufi, S.; Lazourgui, M.-A.; Griene, L.; Maouche, B. 2012: Atherosclerosis and atherosensitivity in two southwest Algerian desert rodents, Psammomys obesus and Gerbillus gerbillus, and in Rattus norvegicus. Diabetes Metabolic Syndrome and Obesity: Targets and Therapy 5: 337-345

Willeit, K.; Kiechl, S. 2014: Atherosclerosis and atrial fibrillation--two closely intertwined diseases. Atherosclerosis 233(2): 679-681

Matsuura, E. 2009: Atherosclerosis and autoimmunity. Clinical Reviews in Allergy and Immunology 37(1): 1-3

Frostegård, J. 2012: Atherosclerosis and cardiovascular disease in rheumatoid arthritis. Journal of Rheumatology 39(12): 2233-2234

Ruiz-Limon, P.; Barbarroja, N.; Perez-Sanchez, C.; Aguirre, M.A.; Bertolaccini, M.L.; Khamashta, M.A.; Rodriguez-Ariza, A.; Almadén, Y.; Segui, P.; Khraiwesh, H.; Gonzalez-Reyes, J.A.; Villalba, J.M.; Collantes-Estevez, E.; Cuadrado, M.J.; Lopez-Pedrera, C. 2015: Atherosclerosis and cardiovascular disease in systemic lupus erythematosus: effects of in vivo statin treatment. Annals of the Rheumatic Diseases 74(7): 1450-1458

Papagoras, C.; Voulgari, P.V.; Drosos, A.A. 2013: Atherosclerosis and cardiovascular disease in the spondyloarthritides, particularly ankylosing spondylitis and psoriatic arthritis. Clinical and Experimental Rheumatology 31(4): 612-620

Kuusisto, J.; Andrulionyte, L.; Laakso, M. 2007: Atherosclerosis and cardiovascular risk reduction with PPAR agonists. Current atherosclerosis reports 9(4): 274-280

Wessely, R. 2010: Atherosclerosis and cell cycle: put the brakes on! Critical role for cyclin-dependent kinase inhibitors. Journal of the American College of Cardiology 55(20): 2269-2271

Von Feldt, J.M. 2007: Atherosclerosis and central nervous system involvement in systemic lupus erythematosus. Journal of Clinical Rheumatology: Practical Reports on Rheumatic and Musculoskeletal Diseases 13(4): 179-180

Dahl, A.; Lund, C.; Russell, D. 2007: Atherosclerosis and cerebral infarction. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 127(7): 892-896

Hull, M.; Kant, P. 2010: Atherosclerosis and colorectal carcinogenesis: shared risk factors or common pathogenesis?. Digestion 81(1): 16-17

Suemoto, C.K.; Nitrini, R.; Grinberg, L.T.; Ferretti, R.E.L.; Farfel, Jé.M.; Leite, R.E.P.; Menezes, P.R.; Fregni, F.; Jacob-Filho, W.; Pasqualucci, C.A. 2011: Atherosclerosis and dementia: a cross-sectional study with pathological analysis of the carotid arteries. Stroke 42(12): 3614-3615

Elkins, J.S. 2007: Atherosclerosis and dementia: leading by association. Annals of Neurology 61(5): 377-379

David, A.R.; Kershaw, A.; Heagerty, A. 2010: Atherosclerosis and diet in ancient Egypt. Lancet 375(9716): 718-719

Kauppila, L.I. 2009: Atherosclerosis and disc degeneration/low-back pain--a systematic review. European Journal of Vascular and Endovascular Surgery: the Official Journal of the European Society for Vascular Surgery 37(6): 661-670

Azevedo, V.F.; Pecoits-Filho, R. 2010: Atherosclerosis and endothelial dysfunction in patients with ankylosing spondylitis. Rheumatology International 30(11): 1411-1416

Henein, M.; Nicoll, R. 2010: Atherosclerosis and extensive arterial calcification: the same condition?. International Journal of Cardiology 141(1): 1-2

Newson, R.S.; Hek, K.; Luijendijk, H.J.; Hofman, A.; Witteman, J.C.M.; Tiemeier, H. 2010: Atherosclerosis and incident depression in late life. Archives of General Psychiatry 67(11): 1144-1151

Chatzidimitriou, D.; Kirmizis, D.; Gavriilaki, E.; Chatzidimitriou, M.; Malisiovas, N. 2012: Atherosclerosis and infection: is the jury still not in?. Future Microbiology 7(10): 1217-1230

Shrubsole-Cockwill, A.; Wojnarowicz, C.; Parker, D. 2008: Atherosclerosis and ischemic cardiomyopathy in a captive, adult red-tailed hawk (Buteo jamaicensis). Avian Diseases 52(3): 537-539

Wright, A.P.; Öhman, M.K.; Hayasaki, T.; Luo, W.; Russo, H.M.; Guo, C.; Eitzman, D.T. 2010: Atherosclerosis and leukocyte-endothelial adhesive interactions are increased following acute myocardial infarction in apolipoprotein e deficient mice. Atherosclerosis 212(2): 414-417

Chen, S.; Rees, A. 2007: Atherosclerosis and lipoproteins: vascular cell senescence and atherosclerosis. Current Opinion in Lipidology 18(5): 600-602

Doria, A. 2009: Atherosclerosis and lupus: what we know and what we should know. Journal of Rheumatology 36(11): 2380-2382

Nussinovitch, U.; Shoenfeld, Y. 2011: Atherosclerosis and macrovascular involvement in systemic sclerosis: myth or reality. Autoimmunity Reviews 10(5): 259-266

Amirbekian, V.; Aguinaldo, J.G.S.; Amirbekian, S.; Hyafil, F.; Vucic, E.; Sirol, M.; Weinreb, D.B.; Le Greneur, S.; Lancelot, E.; Corot, C.; Fisher, E.A.; Galis, Z.S.; Fayad, Z.A. 2009: Atherosclerosis and matrix metalloproteinases: experimental molecular MR imaging in vivo. Radiology 251(2): 429-438

Thej, M.J.; Kalyani, R.; Kiran, J. 2012: Atherosclerosis and myocardial bridging: Not a benign combination. An autopsy case report. Journal of Cardiovascular Disease Research 3(2): 176-178

Dziewas, R.; Ritter, M.; Usta, N.; Boentert, M.; Hor, H.; Dittrich, R.; Schäbitz, W.R.; Ringelstein, E.B.; Young, P. 2007: Atherosclerosis and obstructive sleep apnea in patients with ischemic stroke. Cerebrovascular Diseases 24(1): 122-126

Pérez Castrillón, J.L.; de Luis, D.; Duenas-Laita, A. 2008: Atherosclerosis and osteoporosis. Minerva Medica 99(1): 45-54

Anagnostis, P.; Karagiannis, A.; Kakafika, A.I.; Tziomalos, K.; Athyros, V.G.; Mikhailidis, D.P. 2009: Atherosclerosis and osteoporosis: age-dependent degenerative processes or related entities?. Osteoporosis International: a Journal Established as Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the Usa 20(2): 197-207

Bonomini, F.; Tengattini, S.; Fabiano, A.; Bianchi, R.; Rezzani, R. 2008: Atherosclerosis and oxidative stress. Histology and Histopathology 23(3): 381-390

Al-Mamari, A. 2009: Atherosclerosis and physical activity. Oman Medical Journal 24(3): 173-178

Cavagna, L.; Boffini, N.; Cagnotto, G.; Inverardi, F.; Grosso, V.; Caporali, R. 2012: Atherosclerosis and rheumatoid arthritis: more than a simple association. Mediators of Inflammation 2012: 147354

Saito, Y. 2008: Atherosclerosis and risk factors in elderly. Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics 45(5): 470-473

Villablanca, A.C.; Jayachandran, M.; Banka, C. 2010: Atherosclerosis and sex hormones: current concepts. Clinical Science 119(12): 493-513

McMahon, M.; Hahn, B.H. 2007: Atherosclerosis and systemic lupus erythematosus: mechanistic basis of the association. Current Opinion in Immunology 19(6): 633-639

Vicari, R.M.; Bramlet, D.; Olivera, B.; Barber, L.; Alexander, L.; Parker, L.; Howard, M. 2007: Atherosclerosis and teen eating study. Journal of Clinical Lipidology 1(3): 194-197

Tokgözoğlu, L. 2009: Atherosclerosis and the role of inflammation. Turk Kardiyoloji Dernegi Arsivi: Turk Kardiyoloji Derneginin Yayin Organidir 37(Suppl 4): 1-6

Jover, E.; Marín, F.; Roldán, V.; Montoro-García, S.; Valdés, M.; Lip, G.Y.H. 2013: Atherosclerosis and thromboembolic risk in atrial fibrillation: focus on peripheral vascular disease. Annals of Medicine 45(3): 274-290

Choudhury, R.P. 2007: Atherosclerosis and thrombosis: identification of targets for magnetic resonance imaging. Topics in Magnetic Resonance Imaging: Tmri 18(5): 319-327

Vilahur, G.; Padro, T.; Badimon, L. 2011: Atherosclerosis and thrombosis: insights from large animal models. Journal of Biomedicine and Biotechnology 2011: 907575

Suzuki, M.; Minami, A.; Nakanishi, A.; Kobayashi, K.; Matsuda, S.; Ogura, Y.; Kitagishi, Y. 2014: Atherosclerosis and tumor suppressor molecules (review). International Journal of Molecular Medicine 34(4): 934-940

Ivanovski, O.; Nikolov, I.G.; Drueke, B.T.; Massy, A.Z. 2007: Atherosclerosis and vascular calcification in uraemia - a new experimental model. Prilozi 28(2): 11-24

Abbasi, K.; Anvari, M.S.; Mahdanian, A.; Ahmadi, S.H.; Rabbani, S.; Karimi, A.; Marzban, M.; Shalileh, K.; Ashrafinia, N. 2009: Atherosclerosis and vascular injury: the effect of a perivascular nitric oxide donor in a cholesterol-fed rabbit model. Annals of Vascular Surgery 23(3): 392-397

Undas, A. 2013: Atherosclerosis and venous thromboembolism - similarities. Kardiologia Polska 71(12): 1223-1228

Alexandroff, A.B.; Pauriah, M.; Lang, C.C.; Struthers, A.D.; Armstrong, D.J. 2011: Atherosclerosis as a systemic feature of psoriasis. Clinical and Experimental Dermatology 36(5): 451-452

Schilliger, L.; Lemberger, K.; Chai, N.; Bourgeois, A.; Charpentier, M. 2010: Atherosclerosis associated with pericardial effusion in a central bearded dragon (Pogona vitticeps). Journal of Veterinary Diagnostic Investigation: Official Publication of the American Association of Veterinary Laboratory Diagnosticians Inc 22(5): 789-792

Boynosky, N.A.; Stokking, L. 2014: Atherosclerosis associated with vasculopathic lesions in a golden retriever with hypercholesterolemia. Canadian Veterinary Journal 55(5): 484-488

Kay, M. 2012: Hepatitis outbreak is traced to contaminated needles and barber shop razors, study shows. Bmj 345: E8700

Korkmaz, L.; Adar, A.; Korkmaz, A.A.; Erkan, H.; Agac, M.T.; Acar, Z.; Kurt, I.H.; Akyuz, A.R.; Celik, S. 2012: Atherosclerosis burden and coronary artery lesion complexity in acute coronary syndrome patients. Cardiology Journal 19(3): 295-300

Chaikriangkrai, K.; Kassi, M.; Khaleel Bala, S.; Nabi, F.; Chang, S.M. 2014: Atherosclerosis burden in patients with acute chest pain: obesity paradox. Isrn Obesity 2014: 634717

Marijnissen, R.M.; Bus, B.A.A.; Schoevers, R.A.; Wouts, L.; Holewijn, S.; Franke, B.; de Graaf, J.; den Heijer, M.; Oude Voshaar, R.C. 2014: Atherosclerosis decreases the impact of neuroticism in late-life depression: hypothesis of vascular apathy. American Journal of Geriatric Psychiatry: Official Journal of the American Association for Geriatric Psychiatry 22(8): 801-810

Yassin, L.M.; Londoño, J.án.; Montoya, G.; De Sanctis, J.B.; Rojas, M.; Ramírez, L.A.; García, L.F.; Vásquez, G. 2011: Atherosclerosis development in SLE patients is not determined by monocytes ability to bind/endocytose Ox-LDL. Autoimmunity 44(3): 201-210

Gómez, M.; Sanz-González, S.M.; Abu Nabah, Y.N.; Lamana, A.; Sánchez-Madrid, F.; Andrés, V. 2009: Atherosclerosis development in apolipoprotein E-null mice deficient for CD69. Cardiovascular Research 81(1): 197-205

Prendergast, C.; Quayle, J.; Burdyga, T.; Wray, S. 2014: Atherosclerosis differentially affects calcium signalling in endothelial cells from aortic arch and thoracic aorta in Apolipoprotein e knockout mice. Physiological Reports 2(10)

Fryburg, D.A.; Vassileva, M.T. 2011: Atherosclerosis drug development in jeopardy: the need for predictive biomarkers of treatment response. Science Translational Medicine 3(72): 72cm6

De Jesus, N.M.; Wang, L.; Herren, A.W.; Wang, J.; Shenasa, F.; Bers, D.M.; Lindsey, M.L.; Ripplinger, C.M. 2015: Atherosclerosis exacerbates arrhythmia following myocardial infarction: Role of myocardial inflammation. Heart Rhythm 12(1): 169-178

Yamada, N. 2011: Atherosclerosis from the point of view of hypothesis to evidence based medicine. Nihon Rinsho. Japanese Journal of Clinical Medicine 69(1): 7-12

Anonymous 2012: Atherosclerosis growth process explained. Harvard heart letter: from Harvard Medical School 22(10): 8

Duivenvoorden, R.; Nederveen, A.J.; de Groot, E.; Kastelein, J.J.P. 2007: Atherosclerosis imaging as a benchmark in the development of novel cardiovasular drugs. Current Opinion in Lipidology 18(6): 613-621

Nicholls, S.J.; Kalidindi, S.; Moon, K.-W.; Nissen, S.E. 2007: Atherosclerosis imaging in drug development. Expert Opinion on Drug Discovery 2(9): 1241-1250

Tison, G.H.; Blaha, M.J.; Nasir, K. 2011: Atherosclerosis imaging in multiple vascular beds--enough heterogeneity to improve risk prediction?. Atherosclerosis 214(2): 261-263

Schoenhagen, P.; Tuzcu, E.M. 2008: Atherosclerosis imaging in progression/regression trials: surrogate marker or direct window into the atherosclerotic disease process?. Arquivos Brasileiros de Cardiologia 91(6): 385-398

Wong, S.K.; Mobolaji-Iawal, M.; Arama, L.; Cambe, J.; Biso, S.; Alie, N.; Fayad, Z.A.; Mani, V. 2014: Atherosclerosis imaging using 3D black blood TSE SPACE vs 2D TSE. World Journal of Radiology 6(5): 192-202

Kaul, P.; Douglas, P.S. 2009: Atherosclerosis imaging: prognostically useful or merely more of what we know?. CIRCULATION. Cardiovascular Imaging 2(2): 150-160

Jawień, J. 2012: Atherosclerosis in 2012: what is new?. Polskie Archiwum Medycyny Wewnetrznej 122(4): 170-173

Pagnoux, C.; Chironi, G.; Simon, A.; Guillevin, L.ïc. 2007: Atherosclerosis in ANCA-associated vasculitides. Annals of the new York Academy of Sciences 1107: 11-21

Seyahi, E.; Yazici, H. 2007: Atherosclerosis in Behçet's syndrome. Clinical and Experimental Rheumatology 25(4 Suppl 45: S1-S5

Nakaya, H.; Summers, B.D.; Nicholson, A.C.; Gotto, A.M.; Hajjar, D.P.; Han, J. 2009: Atherosclerosis in LDLR-knockout mice is inhibited, but not reversed, by the PPARgamma ligand pioglitazone. American journal of pathology 174(6): 2007-2014

Homan, R.; Hanselman, J.C.; Bak-Mueller, S.; Washburn, M.; Lester, P.; Jensen, H.E.; Pinkosky, S.L.; Castle, C.; Taylor, B. 2010: Atherosclerosis in Octodon degus (degu) as a model for human disease. Atherosclerosis 212(1): 48-54

Hatri, A.; Otmani, M.F. 2009: Atherosclerosis in Takayasu's disease. La Revue de Medecine Interne 30(Suppl 4): S258

McKenney, J.; Gandhi, S.K.; Fox, K.M.; Ohsfeldt, R.L. 2009: Atherosclerosis in a managed care plan: hypercholesterolemia treatment patterns and low-density lipoprotein cholesterol monitoring. Journal of Clinical Lipidology 3(6): 385-392

Johnsen, S.Harald.; Forsdahl, S.Helene.; Singh, K.; Jacobsen, B.Koster. 2010: Atherosclerosis in abdominal aortic aneurysms: a causal event or a process running in parallel? The Tromsø study. Arteriosclerosis Thrombosis and Vascular Biology 30(6): 1263-1268

Allam, A.H.; Thompson, R.C.; Wann, L.S.; Miyamoto, M.I.; Nur El-Din, A.E.-H.; El-Maksoud, G.A.; Al-Tohamy Soliman, M.; Badr, I.; El-Rahman Amer, H.A.; Sutherland, M.L.; Sutherland, J.D.; Thomas, G.S. 2011: Atherosclerosis in ancient Egyptian mummies: the Horus study. JACC. Cardiovascular Imaging 4(4): 315-327

Fornaciari, G.; Gaeta, R. 2013: Atherosclerosis in ancient populations. Lancet 382(9887): 123

Matsuura, E.; Kobayashi, K.; Lopez, L.R. 2009: Atherosclerosis in autoimmune diseases. Current Rheumatology Reports 11(1): 61-69

Zinger, H.; Sherer, Y.; Shoenfeld, Y. 2009: Atherosclerosis in autoimmune rheumatic diseases-mechanisms and clinical findings. Clinical Reviews in Allergy and Immunology 37(1): 20-28

Modi, G.K.; Naik, N. 2013: Atherosclerosis in chronic kidney disease: Striking while the Iron is labile. Indian Journal of Nephrology 23(5): 337-339

Mohar, D.S.; Barseghian, A.; Haider, N.; Domanski, M.; Narula, J. 2012: Atherosclerosis in chronic kidney disease: lessons learned from glycation in diabetes. Medical Clinics of North America 96(1): 57-65

Thej, M.Jagadish.; Kalyani, R.; Kiran, J. 2012: Atherosclerosis in coronary artery and aorta in a semi-urban population by applying modified American Heart Association classification of atherosclerosis: An autopsy study. Journal of cardiovascular disease research 3(4): 265-271

Maiti, R.; Agrawal, N.K. 2007: Atherosclerosis in diabetes mellitus: role of inflammation. Indian Journal of Medical Sciences 61(5): 292-306

Södergren, A.; Karp, K.; Boman, K.; Eriksson, C.; Lundström, E.; Smedby, T.; Söderlund, L.; Rantapää-Dahlqvist, S.; Wållberg-Jonsson, S. 2010: Atherosclerosis in early rheumatoid arthritis: very early endothelial activation and rapid progression of intima media thickness. Arthritis Research and Therapy 12(4): R158

Hamed, S.A. 2014: Atherosclerosis in epilepsy: its causes and implications. Epilepsy and Behavior: E&b 41: 290-296

Bevc, S.; Sabic, S.; Hojs, R. 2008: Atherosclerosis in hemodialysis patients--the role of microinflammation. Renal Failure 30(10): 1012-1016

Bevc, S.; Hojs, R.; Ekart, R.; Hojs-Fabjan, T. 2006: Atherosclerosis in hemodialysis patients: traditional and nontraditional risk factors. Acta Dermatovenerologica Alpina Pannonica et Adriatica 15(4): 151-157

Páramo, J.é A.; Rodríguez, J.é A.; Orbe, J. 2007: Atherosclerosis in inflammatory diseases. Medicina Clinica 128(19): 749-756

Chatzikonstantinou, A.; Ebert, A.D.; Schoenberg, S.O.; Hennerici, M.G.; Henzler, T. 2015: Atherosclerosis in intracranial, extracranial, and coronary arteries with aortic plaques in patients with ischemic stroke of undetermined etiology. International Journal of Neuroscience 125(9): 663-670

Jednacz, E.; Rutkowska-Sak, L. 2012: Atherosclerosis in juvenile idiopathic arthritis. Mediators of Inflammation 2012: 714732

Piombino-Mascali, D.; Jankauskas, R.; Tamošiūnas, A.; Valančius, R.ūn.; Thompson, R.C.; Panzer, S. 2014: Atherosclerosis in mummified human remains from Vilnius, Lithuania (18th-19th centuries AD): a computed tomographic investigation. American Journal of Human Biology: the Official Journal of the Human Biology Council 26(5): 676-681

Drager, L.F.; Bortolotto, L.A.; Maki-Nunes, C.; Trombetta, I.C.; Negrão, C.E.; Krieger, E.M.; Lorenzi-Filho, G. 2010: Atherosclerosis in obstructive sleep apnoea: it does not matter whether patients are sleepy or not. Atherosclerosis 211(1): 30-31

Duffels, M.ël.G.J.; Mulder, K.M.; Trip, M.D.; de Groot, E.; Gort, J.; van Dijk, A.P.J.; Hoendermis, E.S.; Daliento, L.; Zwinderman, A.H.; Berger, R.M.F.; Mulder, B.J.M. 2010: Atherosclerosis in patients with cyanotic congenital heart disease. Circulation Journal: Official Journal of the Japanese Circulation Society 74(7): 1436-1441

Ames, P.R.J.; Scenna, G.; Antinolfi, I.; Lopez, L.; Iannaccone, L.; Matsuura, E.; Margarita, A. 2008: Atherosclerosis in primary antiphospholipid syndrome. Expert Review of Clinical Immunology 4(1): 53-60

Naeem, A.; Hanif, R. 2010: Atherosclerosis in relation to fat penniculus (obesity) between xiphoid and umbilicus. Journal of Ayub Medical College Abbottabad: Jamc 22(1): 84-86

González-Gay, M.A.; Szekanecz, Z.; Popa, C.D.; Dessein, P. 2012: Atherosclerosis in rheumatoid arthritis. Mediators of Inflammation 2012: 489608

Avalos, I.; Rho, Y.H.; Chung, C.P.; Stein, C.M. 2008: Atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus. Clinical and Experimental Rheumatology 26(5 Suppl 51): S5-S13

Stamatelopoulos, K.S.; Kitas, G.D.; Papamichael, C.M.; Chryssohoou, E.; Kyrkou, K.; Georgiopoulos, G.; Protogerou, A.; Panoulas, V.F.; Sandoo, A.; Tentolouris, N.; Mavrikakis, M.; Sfikakis, P.P. 2009: Atherosclerosis in rheumatoid arthritis versus diabetes: a comparative study. Arteriosclerosis Thrombosis and Vascular Biology 29(10): 1702-1708

Carotti, M.; Salaffi, F.; Mangiacotti, M.; Cerioni, A.; Giuseppetti, G.M.; Grassi, W. 2007: Atherosclerosis in rheumatoid arthritis: the role of high-resolution B mode ultrasound in the measurement of the arterial intima-media thickness. Reumatismo 59(1): 38-49

Del Rincon, I. 2010: Atherosclerosis in rheumatoid arthritis: what to look for in studies using carotid ultrasound. Journal of Rheumatology 37(5): 890-893

Gupta-Malhotra, M.; Gruber, D.; Abraham, S.S.; Roman, M.J.; Zabriskie, J.B.; Hudgins, L.C.; Flynn, P.A.; Levine, D.M.; Okorie, U.; Baday, A.; Schiller, M.S.; Maturi, J.; Meehan, D.; Dyme, J.; Parker, T.S.; Wittkowski, K.M.; Gersony, W.M.; Cooper, R.S. 2009: Atherosclerosis in survivors of Kawasaki disease. Journal of Pediatrics 155(4): 572-577

Tazi Mezalek, Z.; Harmouche, H.; Ammouri, W.; Maamar, M.; Adnaoui, M.; Cacoub, P. 2014: Atherosclerosis in systemic lupus erythematosus. Presse Medicale 43(10 Part 1): 1034-1047

Simonacci, F.; Grieco, M.P.; Bertozzi, N.; Raposio, E. 2017: Autologous fat transplantation for secondary breast reconstruction: our experience. Il Giornale di Chirurgia 38(3): 117-123

Gaeta, R.; Giuffra, V.; Fornaciari, G.; King Ferdinand I 2013: Atherosclerosis in the Renaissance elite: Ferdinand I King of Naples (1431-1494). Virchows Archiv: an international journal of pathology 462(5): 593-595

Herrmann, J.; Lerman, A. 2007: Atherosclerosis in the back yard. Journal of the American College of Cardiology 49(21): 2102-2104

Luzzi, S.; Vella, L.; Bartolini, M.; Provinciali, L.; Silvestrini, M. 2010: Atherosclerosis in the evolution of Alzheimer's disease: can treatment reduce cognitive decline?. Journal of Alzheimer's Disease: Jad 20(3): 893-901

Ames, P.R.J.; Antinolfi, I.; Scenna, G.; Gaeta, G.; Margaglione, M.; Margarita, A. 2009: Atherosclerosis in thrombotic primary antiphospholipid syndrome. Journal of Thrombosis and Haemostasis: Jth 7(4): 537-542

Steiner, G. 2007: Atherosclerosis in type 2 diabetes: a role for fibrate therapy?. Diabetes and Vascular Disease Research 4(4): 368-374

Bitigen, A.; Erkol, A.; Oduncu, V.; Akgün, T.; Mansuroglu, D.; Ozdemir, N. 2007: Atherosclerosis in type IV dual left anterior descending artery and anomalous aortic origin of the left circumflex artery in association with rheumatic valve disease: a case report. heart surgery forum 10(4): E276-E278

Modelli, M.E.; Cherulli, A.S.; Gandolfi, L.; Pratesi, R. 2011: Atherosclerosis in young Brazilians suffering violent deaths: a pathological study. Bmc Research Notes 4: 531

Choi, S.-E.; Jang, H.-J.; Kang, Y.; Jung, J.G.; Han, S.J.; Kim, H.J.; Kim, D.J.; Lee, K.-W. 2010: Atherosclerosis induced by a high-fat diet is alleviated by lithium chloride via reduction of VCAM expression in ApoE-deficient mice. Vascular Pharmacology 53(5-6): 264-272

Kitahara, M.; Kanaki, T.; Ishii, I.; Saito, Y. 2010: Atherosclerosis induced by chronic inhibition of the synthesis of nitric oxide in moderately hypercholesterolaemic rabbits is suppressed by pitavastatin. British Journal of Pharmacology 159(7): 1418-1428

Santos, M.J.é 2008: Atherosclerosis inflammation and rheumatic diseases. Acta Reumatologica Portuguesa 33(1): 9-11

Rudd, J.H.F.; Myers, K.S.; Bansilal, S.; Machac, J.; Pinto, C.Anne.; Tong, C.; Rafique, A.; Hargeaves, R.; Farkouh, M.; Fuster, V.; Fayad, Z.A. 2008: Atherosclerosis inflammation imaging with 18F-FDG PET: carotid, iliac, and femoral uptake reproducibility, quantification methods, and recommendations. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 49(6): 871-878

Montecucco, F.; Mach, F.ço. 2009: Atherosclerosis is an inflammatory disease. Seminars in Immunopathology 31(1): 1-3

Piconi, S.; Parisotto, S.; Rizzardini, G.; Passerini, S.; Meraviglia, P.; Schiavini, M.; Niero, F.; Biasin, M.; Bonfanti, P.; Ricci, E.D.; Trabattoni, D.; Clerici, M. 2013: Atherosclerosis is associated with multiple pathogenic mechanisms in HIV-infected antiretroviral-naive or treated individuals. Aids 27(3): 381-389

Peng, Y.; Liu, H.; Liu, F.; Ouyang, L.; Cheng, M.; Gao, L.; Pan, F.; Liu, Y.; Chen, X.; Li, J. 2008: Atherosclerosis is associated with plasminogen activator inhibitor type-1 in chronic haemodialysis patients. Nephrology 13(7): 579-586

Cuker, A.; Rauova, L.; Bolgiano, D.; Matthai, W.H.; Poncz, M.; Konkle, B.A. 2014: Atherosclerosis is not a risk factor for anti-platelet factor 4/heparin antibody formation after cardiopulmonary bypass surgery. Thrombosis and Haemostasis 111(6): 1191-1193

Lazebnik, L.B. 2011: Atherosclerosis is the disease of hepatocyte. Eksperimental'naia i Klinicheskaia Gastroenterologiia 11: 3-8

Chen, L.Chi.; Quan, C.; Hwang, J.Shiang.; Jin, X.; Li, Q.; Zhong, M.; Rajagopalan, S.; Sun, Q. 2010: Atherosclerosis lesion progression during inhalation exposure to environmental tobacco smoke: a comparison to concentrated ambient air fine particles exposure. Inhalation Toxicology 22(6): 449-459

Massin, M.M.; Hövels-Gürich, H.; Seghaye, M.-C. 2007: Atherosclerosis lifestyle risk factors in children with congenital heart disease. European Journal of Cardiovascular Prevention and Rehabilitation: Official Journal of the European Society of Cardiology Working Groups on Epidemiology and Prevention and Cardiac Rehabilitation and Exercise Physiology 14(2): 349-351

Lind, L.; Andersson, J.; Hansen, T.; Johansson, L.; Ahlström, H.åk. 2009: Atherosclerosis measured by whole body magnetic resonance angiography and carotid artery ultrasound is related to arterial compliance, but not to endothelium-dependent vasodilation - the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study. Clinical Physiology and Functional Imaging 29(5): 321-329

Cheng, C.-C.; Pan, N.-H.; Chen, Y.-C.; Yeh, H.-I.; Lin, C.-I.; Chen, S.-A.; Chen, Y.-J. 2010: Atherosclerosis modulates the electrophysiological effects of a peroxisome proliferator-activated receptor-gamma activator on pulmonary veins. International Journal of Cardiology 145(3): 578-582

Gottlieb, I.; Xavier, S.ér.S.; Lima, J.ão.A.C. 2007: Atherosclerosis monitoring in the elderly using magnetic resonance imaging: is the extra step needed?. American Journal of Geriatric Cardiology 16(6): 363-368

Pejkov, H.; Kedev, S.; Panov, S.; Srbinovska-Kostovska, E.; Lang, I. 2013: Atherosclerosis of coronary blood vessels - local or systemic inflamation?. Prilozi 34(3): 5-11

Li, M.-l.; Xu, W.-h.; Song, L.; Feng, F.; You, H.; Ni, J.; Gao, S.; Cui, L.-y.; Jin, Z.-y. 2009: Atherosclerosis of middle cerebral artery: evaluation with high-resolution MR imaging at 3T. Atherosclerosis 204(2): 447-452

Ozkan, S.; Akay, T.H.; Gultekin, B.; Aslim, E.; Arslan, A.; Ozdemir, B.H.; Becit, N.; Tasdelen, A. 2007: Atherosclerosis of radial and internal thoracic arteries used in coronary bypass: atherosclerosis in arterial grafts. Journal of Cardiac Surgery 22(5): 385-389

Barbetseas, J.; Alexopoulos, N.; Brili, S.; Aggeli, C.; Chrysohoou, C.; Frogoudaki, A.; Vyssoulis, G.; Pitsavos, C.; Stefanadis, C. 2008: Atherosclerosis of the aorta in patients with acute thoracic aortic dissection. Circulation Journal: Official Journal of the Japanese Circulation Society 72(11): 1773-1776

Gorshunova, N.K.; Ukraintseva, D.N. 2012: Atherosclerosis of the common carotid artery in aged patients with arterial hypertension: characteristics of lipid peroxidation homeostasis. Advances in Gerontology 25(1): 100-104

Ambrosetti, M.; Diaco, T.; Febo, O.; Calisi, P.; Favretto, G.; Carlon, R.; Temporelli, P.L. 2012: Atherosclerosis of the lower extremities as a linked comorbidity in Patients Admitted for cardiac rehabilitation (THINKPAD): rationale, design, and study group. Monaldi Archives for Chest Disease 78(1): 8-12

Cohen, A. 2008: Atherosclerosis of the thoracic aorta further characterization for higher risk of vascular events. Journal of the American College of Cardiology 52(10): 862-864

Wang, X.; Wu, M.; Zhou, X.; Liu, H.; Zhang, Y.; Wang, H. 2018: Autologous Fat Used for Facial Filling can Lead to Massive Cerebral Infarction Through Middle Cerebral Artery or Facial Intracranial Branches. Journal of Craniofacial Surgery 29(5): 1341-1343

Barrett, J.R. 2012: Atherosclerosis predictor? Circulating levels of POPs linked to arterial effects. Environmental Health Perspectives 120(1): A34

Oliveira, F.Luisa.Ceragioli.; Patin, R.Vega.; Escrivão, M.Arlete.Meil.Schimith. 2010: Atherosclerosis prevention and treatment in children and adolescents. Expert Review of Cardiovascular Therapy 8(4): 513-528

Boireau, Aélie.; Le Bras, Hélène.; Jourdain, P.; Funck, Fçois. 2008: Atherosclerosis prevention at a heart unit. Revue de l'Infirmiere 2008(146): 38-40

Jové, M.; Pamplona, R.; Prat, J.; Arola, L.; Portero-Otín, M. 2013: Atherosclerosis prevention by nutritional factors: a meta-analysis in small animal models. Nutrition Metabolism and Cardiovascular Diseases: Nmcd 23(2): 84-93

Komatsu, A. 2012: Atherosclerosis prevention in youth. Annals of Vascular Diseases 5(4): 403-408

Medina-Ruiz, A. 2011: Atherosclerosis prevention starts in childhood: the obesity epidemic. Boletin de la Asociacion Medica de Puerto Rico 103(4): 72-76

Robinson, J.G.; Fox, K.M.; Bullano, M.F.; Grandy, S.; Bays, H.; Bazata, D.D.; Gavin, J.R.; Green, A.J.; Lewis, S.J.; Reed, M.L.; Robinson, J.G.; Rodbard, H.W.; Fanning, T. 2009: Atherosclerosis profile and incidence of cardiovascular events: a population-based survey. Bmc Cardiovascular Disorders 9: 46

Kopeć, G.; Podolec, P.; Podolec, J.; Rubiś, P.ł; Zmudka, K.; Tracz, W.ła. 2009: Atherosclerosis progression affects the relationship between endothelial function and aortic stiffness. Atherosclerosis 204(1): 250-254

Packard, R.é R.; Shi, G.-P. 2006: Atherosclerosis progression and monocyte emigration from plaque. Future Cardiology 2(4): 415-418

Jarauta, E.; Mateo-Gallego, R.; Bea, A.M.; Crespo, M.; Ballester, A.; Rubio, M.V.; Baila-Rueda, L.; Calmarza, P.; Cenarro, A.; de Groot, E.; Civeira, F. 2014: Atherosclerosis progression in patients with autosomal dominant hypercholesterolemia in clinical practice. Journal of Clinical Lipidology 8(4): 373-380

Ramonda, R.; Puato, M.; Punzi, L.; Rattazzi, M.; Zanon, M.; Balbi, G.; Ortolan, A.; Frallonardo, P.; Faggin, E.; Plebani, M.; Zaninotto, M.; Lorenzin, M.; Pauletto, P.; Doria, A. 2014: Atherosclerosis progression in psoriatic arthritis patients despite the treatment with tumor necrosis factor-alpha blockers: a two-year prospective observational study. Joint Bone Spine 81(5): 421-425

Lee, J.M.S.; Lindsay, A.C.; Kylintireas, I.; Choudhury, R.P. 2008: Atherosclerosis regression. Current Treatment Options in Cardiovascular Medicine 10(3): 187-194

Lee, J.M.S.; Choudhury, R.P. 2010: Atherosclerosis regression and high-density lipoproteins. Expert Review of Cardiovascular Therapy 8(9): 1325-1334

D'Addato, S.; Borghi, C. 2009: Atherosclerosis regression and plaque stabilization: comparison of therapeutic targets. Giornale Italiano di Cardiologia 10(11-12 Suppl 3: 13s-17s

Tsantila, N.; Karantonis, H.C.; Perrea, D.N.; Theocharis, S.E.; Iliopoulos, D.G.; Iatrou, C.; Antonopoulou, S.; Demopoulos, C.A. 2010: Atherosclerosis regression study in rabbits upon olive pomace polar lipid extract administration. Nutrition Metabolism and Cardiovascular Diseases: Nmcd 20(10): 740-747

Nicholls, S.J.; Tuzcu, E.M.; Nissen, S.E. 2007: Atherosclerosis regression: is low-density lipoprotein or high-density lipoprotein the answer?. Current Atherosclerosis Reports 9(4): 266-273

Maranghi, M.; Pugliese, F.; Cianci, R.; Colotto, M.; Durante, C.; Anatra, M.G.; Coletta, P.; Mercuri, S.; Rossetti, M.; Morano, S.; Filetti, S. 2010: Atherosclerosis renal artery stenosis and in-stent restenosis in a diabetic patient: Targeting on diabetic dyslipidemia is a key intervention. Journal of Endocrinological Investigation 33(4): 284-285

Lund, G.; Zaina, S. 2009: Atherosclerosis risk factors can impose aberrant DNA methylation patterns: a tale of traffic and homocysteine. Current Opinion in Lipidology 20(5): 448-449

Weiner, M.F.; Rosenberg, R.N.; Womack, K.B.; Svetlik, D.A.; Fuller, C.; Fields, J.; Hynan, L.S. 2008: Atherosclerosis risk factors in American Indians with Alzheimer disease: preliminary findings. Alzheimer disease and associated disorders 22(3): 245-248

Agarwal, S.; Elliott, J.R.; Manzi, S. 2009: Atherosclerosis risk factors in systemic lupus erythematosus. Current Rheumatology Reports 11(4): 241-247

Kniazewska, M.H.; Obuchowicz, A.K.; Wielkoszyński, T.; Zmudzińska-Kitczak, J.; Urban, K.; Marek, M.; Witanowska, J.; Sieroń-Stołtny, K. 2009: Atherosclerosis risk factors in young patients formerly treated for idiopathic nephrotic syndrome. Pediatric Nephrology 24(3): 549-554

Silva, L.R.; Stefanello, J.M.F.; Pizzi, J.; Timossi, L.S.; Leite, N. 2012: Atherosclerosis subclinical and inflammatory markers in obese and nonobese children and adolescents. Revista Brasileira de Epidemiologia 15(4): 804-816

Davidson, M.H.; Dembowski, E. 2008: Atherosclerosis surrogate imaging trials come of age: for better or for worse?. Current Cardiology Reports 10(6): 521-525

Rowlan, J.S.; Li, Q.; Manichaikul, A.; Wang, Q.; Matsumoto, A.H.; Shi, W. 2013: Atherosclerosis susceptibility Loci identified in an extremely atherosclerosis-resistant mouse strain. Journal of the American Heart Association 2(4): E000260

Edjoc, R.; Reid, R.D.; Sharma, M.; Fang, J. 2014: Atherosclerosis unplugged: potential mechanisms leading to the clinical manifestation of stroke caused by cigarette smoking. Journal of Stroke and Cerebrovascular Diseases: the Official Journal of National Stroke Association 23(3): 597

Jhala, H.T. 1947: Atherosclerosis with special reference to systemic embolic phenomena. Antiseptic 44(10): 638-644

Gorin, M.A.; Garcia-Roig, M.; Garcia-Buitrago, M.; Parra-Herran, C.; Jorda, M.; Ciancio, G. 2013: Atherosclerosis within the non-neoplastic margin of partial nephrectomy specimens: implications for medical management. World Journal of Urology 31(6): 1531-1534

Lippi, D.; D'Elios, M.M.; Gensini, G. 2007: Atherosclerosis, an historical approach. Medicina Nei Secoli 19(1): 273-283

Fiolaki, A.; Tsamis, K.I.; Milionis, H.J.; Kyritsis, A.P.; Kosmidou, M.; Giannopoulos, S. 2014: Atherosclerosis, biomarkers of atherosclerosis and Alzheimer's disease. International Journal of Neuroscience 124(1): 1-11

Pavlides, S.; Gutierrez-Pajares, J.L.; Danilo, C.; Lisanti, M.P.; Frank, P.G. 2012: Atherosclerosis, caveolae and caveolin-1. Advances in Experimental Medicine and Biology 729: 127-144

Gebbers, J.-O. 2007: Atherosclerosis, cholesterol, nutrition, and statins--a critical review. German Medical Science: Gms E-Journal 5: Doc04

Dolan, H.; Crain, B.; Troncoso, J.; Resnick, S.M.; Zonderman, A.B.; Obrien, R.J. 2010: Atherosclerosis, dementia, and Alzheimer disease in the Baltimore Longitudinal Study of Aging cohort. Annals of Neurology 68(2): 231-240

Tomkin, G.H. 2010: Atherosclerosis, diabetes and lipoproteins. Expert Review of Cardiovascular Therapy 8(7): 1015-1029

Bayley, R.H.; Halpert, B. 1948: Atherosclerosis, generalized. Journal of the Oklahoma State Medical Association 41(4): 130-133

Gorodeski, E.Z. 2011: Atherosclerosis, hormone therapy, and outcomes in younger postmenopausal women: waiting for more answers. Menopause 18(9): 935-936

Fazio, G.; Giovino, M.; Gullotti, A.; Bacarella, D.; Novo, G.; Novo, S. 2009: Atherosclerosis, inflammation and Chlamydia pneumoniae. World Journal of Cardiology 1(1): 31-40

Langheinrich, A.C.; Kampschulte, M.; Scheiter, F.; Dierkes, C.; Stieger, P.; Bohle, R.M.; Weidner, W. 2010: Atherosclerosis, inflammation and lipoprotein glomerulopathy in kidneys of apoE-/-/LDL-/- double knockout mice. Bmc Nephrology 11: 18

Goldschmidt-Clermont, P.J.; Dong, C.; Seo, D.M.; Velazquez, O.C. 2012: Atherosclerosis, inflammation, genetics, and stem cells: 2012 update. Current Atherosclerosis Reports 14(3): 201-210

Lund, G.; Zaina, S. 2007: Atherosclerosis, lipids, inflammation and epigenetics. Current Opinion in Lipidology 18(6): 699-701

Calderón, J.C.; Fernández, A.Z.; María de Jesús, A.I. 2008: Atherosclerosis, oxidative stress and physical activity. Review. Investigacion Clinica 49(3): 397-410

Alpsoy, S.; Akyuz, A.; Erfan, G.; Akkoyun, D.C.; Topcu, B.; Guzel, S.; Kaya, S.; Kulac, M. 2014: Atherosclerosis, some serum inflammatory markers in psoriasis. Giornale Italiano di Dermatologia e Venereologia: Organo Ufficiale Societa Italiana di Dermatologia e Sifilografia 149(2): 167-175

Liu, Y.; Chen, K.-J. 2012: Atherosclerosis, vascular aging and therapeutic strategies. Chinese Journal of Integrative Medicine 18(2): 83-87

Rigatelli, G. 2009: Atherosclerosis, venous thromboembolism and migraine: what are the associated risks?. Expert Review of Hematology 2(1): 37-39

Stamler, J.; Anderson, O.W.; Breslow, L.; Deboer, L.; Getting, V.A.; Lepper, M.; Stiles, M.H. 1964: Atherosclerosis--Community Services. A Listing of Research in the Cardiovascular Field 10: 748-760

King, D.E. 2011: Atherosclerosis--challenging the assumptions. Southern Medical Journal 104(12): 809-810

Schulz, C.; Massberg, S. 2014: Atherosclerosis--multiple pathways to lesional macrophages. Science Translational Medicine 6(239): 239ps2

Kirkland, C.R.; Hawayek, L.H.; Mutasim, D.F. 2010: Atherosclerosis-induced diffuse dermal angiomatosis with fatal outcome. Archives of Dermatology 146(6): 684-685

Tsai, T-Yu.; Chu, L-Han.; Lee, C-Lin.; Pan, T-Ming. 2009: Atherosclerosis-preventing activity of lactic acid bacteria-fermented milk-soymilk supplemented with Momordica charantia. Journal of Agricultural and Food Chemistry 57(5): 2065-2071

Wang, F.; Long, G.; Zhao, C.; Li, H.; Chaugai, S.; Wang, Y.; Chen, C.; Wang, D.W. 2014: Atherosclerosis-related circulating mi RNAs as novel and sensitive predictors for acute myocardial infarction. Plos one 9(9): E105734

Agrawal, A.; Hammond, D.J.; Singh, S.K. 2010: Atherosclerosis-related functions of C-reactive protein. Cardiovascular and Hematological Disorders Drug Targets 10(4): 235-240

Anderson, J.L.; Ashwell, C.M.; Smith, S.C.; Shine, R.; Smith, E.C.; Taylor, R.L. 2013: Atherosclerosis-susceptible and atherosclerosis-resistant pigeon aortic cells express different genes in vivo. Poultry Science 92(10): 2668-2680

Patel, S.; Celermajer, D.S.; Bao, S. 2008: Atherosclerosis-underlying inflammatory mechanisms and clinical implications. International Journal of Biochemistry and Cell Biology 40(4): 576-580

Ratnoff, O.D. 1964: Atherosclerosis. Coagulation Mechanisms. A Listing of Research in the Cardiovascular Field 10: 370-371

Insull, W. 1964: Atherosclerosis. Diagnostic Blood Lipids. A Listing of Research in the Cardiovascular Field 10: 387-389

Schindler, B. 2008: Atherosclerosis. do not measure triglycerides on an empty stomach. Medizinische Monatsschrift für Pharmazeuten 31(4): 151-152

Steen, D.L.; Cannon, C.P. 2012: Atherosclerosis. Effects of evacetrapib administered as monotherapy or in combination with statins. Reviews in Cardiovascular Medicine 13(1): E48-E51

Keys, A. 1964: Atherosclerosis. General Factors, Environmental--The Diet. A Listing of Research in the Cardiovascular Field 10: 347-348

Bruce, T.A.; Bing, R.J. 1964: Atherosclerosis. General Factors: Somatic: Hemodynamics. A Listing of Research in the Cardiovascular Field 10: 362-365

Epstein, F.H. 1964: Atherosclerosis. Genetic Factors. A Listing of Research in the Cardiovascular Field 10: 344-347

Gutstein, W.H. 1964: Atherosclerosis. Hemodynamics. A Listing of Research in the Cardiovascular Field 10: 365-367

Boucek, R.J. 1964: Atherosclerosis. Local Factors in the Arterial Wall--Connective Tissue Reactions. A Listing of Research in the Cardiovascular Field 10: 383-387

Geer, J.C. 1964: Atherosclerosis. Local Factors, Cytochemistry, and Fine Structure of Early Lesions. A Listing of Research in the Cardiovascular Field 10: 377-380

Robertson, A.L. 1964: Atherosclerosis. Local Factors, Cytogenetics and Cytochemistry, Ultrastructure of Early Lesions. A Listing of Research in the Cardiovascular Field 10: 375-377

Wissler, R.W. 1964: Atherosclerosis. Local Factors--Connective Tissue Reaction. A Listing of Research in the Cardiovascular Field 10: 382-383

Thomas, W.A. 1964: Atherosclerosis. Local Factors: Connective Tissue Reactions. A Listing of Research in the Cardiovascular Field 10: 380-382

Green, J.G. 1964: Atherosclerosis. Management of Dietary Changes. A Listing of Research in the Cardiovascular Field 10: 354-356

Furman, R.H. 1964: Atherosclerosis. Treatment, Hormones. A Listing of Research in the Cardiovascular Field 10: 402-404

Julian, O.C. 1964: Atherosclerosis. Treatment, Surgical: Endarterectomy. A Listing of Research in the Cardiovascular Field 10: 409-411

Green, J.G. 1964: Atherosclerosis. Treatment, Surgical: Intestinal Shunts for Reduction of Blood Lipid Levels. A Listing of Research in the Cardiovascular Field 10: 406-407

Debakey, M.E. 1964: Atherosclerosis. Treatment--Surgical: Prostheses. A Listing of Research in the Cardiovascular Field 10: 407-408

Upmacis, R.K. 2008: Atherosclerosis: a Link Between Lipid Intake and Protein Tyrosine Nitration. Lipid Insights 2: 75

Anogeianaki, A.; Angelucci, D.; Cianchetti, E.; D'Alessandro, M.; Maccauro, G.; Saggini, A.; Salini, V.; Caraffa, A.; Tete, S.; Conti, F.; Tripodi, D.; Shaik-Dasthagirisaheb, Y.B. 2011: Atherosclerosis: a classic inflammatory disease. International Journal of Immunopathology and Pharmacology 24(4): 817-825

Kulbertus, H.; Lancellotti, P. 2012: Atherosclerosis: a complex disease. Revue Medicale de Liege 67(5-6): 273-278

Ambade, V.Namdeorao.; Godbole, H.Vasant.; Batra, A.Krishnaram. 2008: Atherosclerosis: a medicolegal tool in exhumed decomposed bodies. American Journal of Forensic Medicine and Pathology 29(3): 279-280

Rapezzi, C.; Gallo, P. 2010: Atherosclerosis: a polidistrectual disease. Giornale Italiano di Cardiologia 11(12 Suppl 3: 43s-48s

Lund, G.; Zaina, S. 2011: Atherosclerosis: an epigenetic balancing act that goes wrong. Current Atherosclerosis Reports 13(3): 208-214

Xu, H.; Shi, D.; Chen, K. 2012: Atherosclerosis: an integrative East-west medicine perspective. Evidence-Based Complementary and Alternative Medicine: Ecam 2012: 148413

Getz, G.S.; Reardon, C.A. 2011: Atherosclerosis: beyond cholesterol. Current Opinion in Lipidology 22(6): 507-508

Eriksson, E.E. 2007: Atherosclerosis: cell biology and lipoproteins. Current Opinion in Lipidology 18(4): 476-478

Daugherty, A.; Rateri, D.L. 2008: Atherosclerosis: cell biology and lipoproteins. Current Opinion in Lipidology 19(3): 328-329

Wahle, K.W..J.; Heys, S.D. 2008: Atherosclerosis: cell biology and lipoproteins. Current Opinion in Lipidology 19(4): 435-437

Björkbacka, H. 2008: Atherosclerosis: cell biology and lipoproteins. Current Opinion in Lipidology 19(5): 548-549

Daugherty, A.; Lu, H.; Rateri, D.L. 2009: Atherosclerosis: cell biology and lipoproteins. Current Opinion in Lipidology 20(3): 260-261

Bengtsson, D.; Björkbacka, H. 2009: Atherosclerosis: cell biology and lipoproteins. Current Opinion in Lipidology 20(4): 355-356

Wigren, M.; Björkbacka, H. 2010: Atherosclerosis: cell biology and lipoproteins. Current Opinion in Lipidology 21(1): 97-98

Lievens, D.; Gerdes, N.; Schober, A.; Weber, C. 2010: Atherosclerosis: cell biology and lipoproteins. Current Opinion in Lipidology 21(3): 284-285

Björkbacka, H. 2011: Atherosclerosis: cell biology and lipoproteins. Current Opinion in Lipidology 22(1): 74-75

Lu, H.; Daugherty, A. 2012: Atherosclerosis: cell biology and lipoproteins. Current Opinion in Lipidology 23(3): 263-264

Lu, H.; Daugherty, A. 2013: Atherosclerosis: cell biology and lipoproteins. Current Opinion in Lipidology 24(1): 107-108

Lu, H.; Daugherty, A. 2014: Atherosclerosis: cell biology and lipoproteins. Current Opinion in Lipidology 24(5): 455-456

Lu, H.; Daugherty, A. 2014: Atherosclerosis: cell biology and lipoproteins. Current Opinion in Lipidology 25(2): 157-158

Zaina, S.; Lund, G. 2014: Atherosclerosis: cell biology and lipoproteins - epigenetics and oxidation in atherosclerosis. Current Opinion in Lipidology 25(3): 235-236

Foin, N.; Evans, P.; Krams, R. 2008: Atherosclerosis: cell biology and lipoproteins - new developments in imaging of inflammation of the vulnerable plaque. Current Opinion in Lipidology 19(1): 98-100

Aviram, M. 2012: Atherosclerosis: cell biology and lipoproteins - paraoxonases protect against atherosclerosis and diabetes development. Current Opinion in Lipidology 23(2): 169-171

Winkels, H.; Weber, C.; Lutgens, E.; Gerdes, N. 2014: Atherosclerosis: cell biology and lipoproteins focus on iNKT cells and CD40/CD40L in atherosclerosis and metabolic disorders. Current Opinion in Lipidology 25(5): 408-409

Aviram, M. 2011: Atherosclerosis: cell biology and lipoproteins--inflammation and oxidative stress in atherogenesis: protective role for paraoxonases. Current Opinion in Lipidology 22(3): 243-244

Karshovska, E.; Weber, C. 2012: Atherosclerosis: cell biology and lipoproteins--new mechanistic links in atherosclerosis: chemokines mediating the effects of lipids, platelets and dendritic cells. Current Opinion in Lipidology 23(4): 400-401

Aviram, M. 2010: Atherosclerosis: cell biology and lipoproteins--oxidative stress and paraoxonases regulate atherogenesis. Current Opinion in Lipidology 21(2): 163-164

Zaina, S.; Lund, G. 2013: Atherosclerosis: cell biology and lipoproteins--panoramic views of DNA methylation landscapes of atherosclerosis. Current Opinion in Lipidology 24(4): 369-370

Segers, D.; Weinberg, P.; Krams, R. 2008: Atherosclerosis: cell biology and lipoproteins--shear stress and inflammation in plaque formation: new evidence. Current Opinion in Lipidology 19(6): 627-628

Gerdes, N.; Winkels, H.; Weber, C. 2013: Atherosclerosis: cell biology and lipoproteins-focus on anti-inflammatory mechanisms as therapeutic options. Current Opinion in Lipidology 24(2): 187-188

Lobbes, M.B.I.; Miserus, R.-J.J.H.M.; Heeneman, S.; Passos, V.L.; Mutsaers, P.H.A.; Debernardi, N.; Misselwitz, B.; Post, M.; Daemen, M.J.A.P.; van Engelshoven, J.M.A.; Leiner, T.; Kooi, M.E. 2009: Atherosclerosis: contrast-enhanced MR imaging of vessel wall in rabbit model--comparison of gadofosveset and gadopentetate dimeglumine. Radiology 250(3): 682-691

Paraskevas, K.I.; Koutsias, S.; Giannoukas, A.D. 2014: Atherosclerosis: diagnose locally, treat globally. American Journal of Cardiology 113(3): 570-571

Kukharchuk, V.V. 2009: Atherosclerosis: disputable and unsolved problems in the first decade of the XXi century. Terapevticheskii Arkhiv 81(5): 14-20

Merched, A.J.; Ko, K.; Gotlinger, K.H.; Serhan, C.N.; Chan, L. 2008: Atherosclerosis: evidence for impairment of resolution of vascular inflammation governed by specific lipid mediators. Faseb Journal: Official Publication of the Federation of American Societies for Experimental Biology 22(10): 3595-3606

Riccioni, G.; Sblendorio, V. 2012: Atherosclerosis: from biology to pharmacological treatment. Journal of Geriatric Cardiology: Jgc 9(3): 305-317

Guilford, T.; Morris, D.; Gray, D.; Venketaraman, V. 2010: Atherosclerosis: pathogenesis and increased occurrence in individuals with HIV and Mycobacterium tuberculosis infection. Hiv/Aids 2: 211-218

Kiyohara, Y. 2013: Atherosclerosis: progress in diagnosis and treatments. Topics: I. Epidemiology; 1. Epidemiological evidence from the Hisayama study. Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 102(2): 274-281

Miura, K.; Ueshima, H. 2013: Atherosclerosis: progress in diagnosis and treatments. Topics: I. Epidemiology; 2. From the NIPPON DATA. Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 102(2): 282-288

Kuroda, J.; Kitazono, T. 2013: Atherosclerosis: progress in diagnosis and treatments. Topics: II. Atherosclerosis -promoting factors; pathogenesis and pathophysiology; 1. Risk factors for cerebrovascular disease and carotid atherosclerosis. Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 102(2): 289-296

Tanaka, K.; Sata, M. 2013: Atherosclerosis: progress in diagnosis and treatments. Topics: II. Atherosclerosis -promoting factors; pathogenesis and pathophysiology; 3. From basic research: focusing on large and peripheral vessels. Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 102(2): 305-312

Inaba, M.; Sugioka, K.; Ueda, M. 2013: Atherosclerosis: progress in diagnosis and treatments. Topics: II. Atherosclerosis-promoting factors; pathogenesis and pathophysiology; 2. Pathophysiology of coronary atherosclerosis. Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 102(2): 297-304

Yamashina, A. 2013: Atherosclerosis: progress in diagnosis and treatments. Topics: III. Progress in diagnosis of atherosclerosis; 1. Physical diagnosis of arteriosclerosis. Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 102(2): 313-317

Yamasaki, Y. 2013: Atherosclerosis: progress in diagnosis and treatments. Topics: III. Progress in diagnosis of atherosclerosis; 2. Progress in measurement of carotid intima-media thickness. Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 102(2): 318-324

Okada, M.; Matsunaga, N. 2013: Atherosclerosis: progress in diagnosis and treatments. Topics: III. Progress in diagnosis of atherosclerosis; 3. CT and MR imaging of atherosclerosis. Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 102(2): 325-334

Shimakura, A.; Takata, M. 2013: Atherosclerosis: progress in diagnosis and treatments. Topics: III. Progress in diagnosis of atherosclerosis; 4. Vascular function tests--CAVI. PWV, ABI. Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 102(2): 335-343

Hibi, K.; Honda, Y.; Kimura, K.; Umemura, S. 2013: Atherosclerosis: progress in diagnosis and treatments. Topics: III. Progress in diagnosis of atherosclerosis; 5. IVUS (intravascular ultrasound). Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 102(2): 344-353

Matsumaru, Y. 2013: Atherosclerosis: progress in diagnosis and treatments. Topics: IV. Progress in treatments of atherosclerosis: 1. Cerebral and cervical arteries. Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 102(2): 354-359

Endo, M.; Kimura, K. 2013: Atherosclerosis: progress in diagnosis and treatments. Topics: IV. Progress in treatments of atherosclerosis; 2. Coronary artery disease. Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 102(2): 360-370

Yamashita, T.; Tsutsui, H. 2013: Atherosclerosis: progress in diagnosis and treatments. Topics: IV. Progress in treatments of atherosclerosis; 4. Renal artery stenosis. Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 102(2): 381-391

Yokoi, H. 2013: Atherosclerosis: progress in diagnosis and treatments. Topics: IV. Progress in treatments of atherosclerosis; 5. Current management for patient with peripheral artery disease. Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 102(2): 392-398

Sumi, M.; Kanaoka, Y.; Ohki, T. 2013: Atherosclerosis: progress in dignosis and treatments. Topics: IV. Progress in treatments of atherosclerosis; 3. Endovascular aortic repair. Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 102(2): 371-380

King, V.L. 2009: Atherosclerosis: should we stop TWEAKing it?. Arteriosclerosis Thrombosis and Vascular Biology 29(12): 1982-1983

Nikita, K.S. 2013: Atherosclerosis: the evolving role of vascular image analysis. Computerized Medical Imaging and Graphics: the Official Journal of the Computerized Medical Imaging Society 37(1): 1-3

Giannoglou, G.D.; Chatzizisis, Y.S. 2012: Atherosclerosis: what are we looking for?. Angiology 63(5): 397-399

Roy, S. 2014: Atherosclerotic Cardiovascular Disease Risk and Evidence-based Management of Cholesterol. North American Journal of Medical Sciences 6(5): 191-198

Mailloux, L.U.; Husain, A. 2002: Atherosclerotic Ischemic Nephropathy as a Cause of Chronic Kidney Disease: What can be done to Prevent End-stage Renal Disease?. Saudi Journal of Kidney Diseases and Transplantation: An Official Publication of the Saudi Center for Organ Transplantation Saudi Arabia 13(3): 311-319

Segers, D.; Lipton, J.A.; Leenen, P.J.M.; Cheng, C.; Tempel, D.; Pasterkamp, G.; Moll, F.L.; de Crom, R.; Krams, R. 2011: Atherosclerotic Plaque Stability Is Affected by the Chemokine CXCL10 in Both Mice and Humans. International Journal of Inflammation 2011: 936109

Dell'Orbo, C.; Quacci, D.; Raspanti, M.; Congiu, T.; Reguzzoni, M.; Protasoni, M. 2010: Atherosclerotic alterations in human carotid observed by scanning electron microscopy. Italian Journal of Anatomy and Embryology 115(1-2): 53-58

Vehmas, T.; Hiltunen, A.; Kivisaari, L.; Leino-Arjas, P.äi. 2008: Atherosclerotic and pleural calcifications are related among asbestos-exposed workers. European Journal of Cardiovascular Prevention and Rehabilitation: Official Journal of the European Society of Cardiology Working Groups on Epidemiology and Prevention and Cardiac Rehabilitation and Exercise Physiology 15(5): 599-601

Higo, T.; Ueda, Y.; Oyabu, J.; Okada, K.; Nishio, M.; Hirata, A.; Kashiwase, K.; Ogasawara, N.; Hirotani, S.; Kodama, K. 2009: Atherosclerotic and thrombogenic neointima formed over sirolimus drug-eluting stent: an angioscopic study. JACC. Cardiovascular Imaging 2(5): 616-624

Sodi, A.; Giambene, B.; Marcucci, R.; Sofi, F.; Fedi, S.; Abbate, R.; Prisco, D.; Menchini, U. 2011: Atherosclerotic and thrombophilic risk factors in patients with ischemic central retinal vein occlusion. Retina 31(4): 724-729

Sodi, A.; Giambene, B.; Marcucci, R.; Sofi, F.; Bolli, P.; Abbate, R.; Prisco, D.; Menchini, U. 2008: Atherosclerotic and thrombophilic risk factors in patients with recurrent central retinal vein occlusion. European Journal of Ophthalmology 18(2): 233-238

Tabata, S.; Saito, H.; Takizawa, M.; Imagawa, T. 2007: Atherosclerotic aneurysm of the right subclavian artery: report of a case. Annals of Thoracic and Cardiovascular Surgery: Official Journal of the Association of Thoracic and Cardiovascular Surgeons of Asia 13(2): 139-142

Ali, T.; Biasi, L.; Hinchliffe, R.; Morgan, R.; Thompson, M.; Loftus, I. 2008: Atherosclerotic aneurysms. Comparisons between thoracic stentgrafts--how do we know which stent graft to select?. Acta Chirurgica Belgica 108(4): 386-392

Deif, R.; El-Sayed, M.; Allah, F.A.; Baligh, E.; El-Fayomy, N.M.; Ezzat, L.; Gamal, H. 2011: Atherosclerotic aortic arch plaques in acute ischemic stroke. Journal of Vascular and Interventional Neurology 4(1): 5-9

Faggioli, G.; Ferri, M.; Rapezzi, C.; Tonon, C.; Manzoli, L.; Stella, A. 2009: Atherosclerotic aortic lesions increase the risk of cerebral embolism during carotid stenting in patients with complex aortic arch anatomy. Journal of Vascular Surgery 49(1): 80-85

Yamana, K.; Ito, T.; Maekawa, A.; Yoshizumi, T.; Sunada, M.; Hoshino, S. 2010: Atherosclerotic arch aneurysm operations with perfusion toward the aortic valve. Annals of Thoracic Surgery 89(2): 435-439

Wang, Q.-j.; Wang, Y.; Cai, J.-m.; Ma, L.; Yang, L.; Cai, Y.-q. 2010: Atherosclerotic area measurement in the vascular wall of the carotid artery: comparison between 16-slice computed tomography angiography and high-resolution magnetic resonance imaging. Nan Fang Yi Ke da Xue Xue Bao 30(4): 742-745

Kim, T.H.; Choi, J.W.; Roh, H.G.; Moon, W.-J.; Moon, S.G.; Chun, Y.I.; Kim, H.Y. 2014: Atherosclerotic arterial wall change of non-stenotic intracracranial arteries on high-resolution MRi at 3.0T: Correlation with cerebrovascular risk factors and white matter hyperintensity. Clinical Neurology and Neurosurgery 126: 1-6

Morris-Stiff, G.; Coxon, M.; Ball, E.; Lewis, M.H. 2008: Atherosclerotic axillary artery aneurysm. Minerva Chirurgica 63(1): 61-63

Hong, S.N.; Gona, P.; Fontes, J.D.; Oyama, N.; Chan, R.H.; Kenchaiah, S.; Tsao, C.W.; Yeon, S.B.; Schnabel, R.B.; Keaney, J.F.; O'Donnell, C.J.; Benjamin, E.J.; Manning, W.J. 2013: Atherosclerotic biomarkers and aortic atherosclerosis by cardiovascular magnetic resonance imaging in the Framingham Heart Study. Journal of the American Heart Association 2(6): E000307

Wild, R.A. 2012: Atherosclerotic burden during the menopausal transition is a wakeup call. Menopause 19(1): 1-2

Rodés-Cabau, J.; Noël, M.; Marrero, A.; Rivest, D.; Mackey, A.; Houde, C.; Bédard, E.; Larose, E.; Verreault, S.; Peticlerc, M.; Pibarot, P.; Bogaty, P.; Bertrand, O.F. 2009: Atherosclerotic burden findings in young cryptogenic stroke patients with and without a patent foramen ovale. Stroke 40(2): 419-425

Kranjec, I. 2011: Atherosclerotic burden in coronary and peripheral arteries in patients with first clinical manifestation of coronary artery disease. Journal of Cardiovascular Medicine 12(4): 297-299

Bos, D.; Vernooij, M.W.; de Bruijn, R.ée.F.A.G.; Koudstaal, P.J.; Hofman, A.; Franco, O.H.; van der Lugt, A.; Ikram, M.A. 2015: Atherosclerotic calcification is related to a higher risk of dementia and cognitive decline. Alzheimer's and Dementia: the Journal of the Alzheimer's Association 11(6): 639

Bos, D.; Vernooij, M.W.; Elias-Smale, S.E.; Verhaaren, B.F.J.; Vrooman, H.A.; Hofman, A.; Niessen, W.J.; Witteman, J.C.M.; van der Lugt, A.; Ikram, M.A. 2012: Atherosclerotic calcification relates to cognitive function and to brain changes on magnetic resonance imaging. Alzheimer's and Dementia: the Journal of the Alzheimer's Association 8(5 Suppl): S104-S111

Mansour, A.A.; Ajeel, N.A. 2013: Atherosclerotic cardiovascular disease among patients with type 2 diabetes in Basrah. World Journal of Diabetes 4(3): 82-87

Hong, Y.M. 2010: Atherosclerotic cardiovascular disease beginning in childhood. Korean Circulation Journal 40(1): 1-9

Abdelfattah, A.; Allam, A.H.; Wann, S.; Thompson, R.C.; Abdel-Maksoud, G.; Badr, I.; Amer, H.A.R.; el-Din, A.e.-H.N.; Finch, C.E.; Miyamoto, M.I.; Sutherland, L.; Sutherland, J.D.; Thomas, G.S. 2013: Atherosclerotic cardiovascular disease in Egyptian women: 1570 BCE-2011 CE. International Journal of Cardiology 167(2): 570-574

Dave, A.J.; Fiorentino, D.; Lingala, B.; Krishnan, E.; Chung, L. 2014: Atherosclerotic cardiovascular disease in hospitalized patients with systemic sclerosis: higher mortality than patients with lupus and rheumatoid arthritis. Arthritis Care and Research 66(2): 323-327

Abu-Shakra, M.; Codish, S.; Zeller, L.; Wolak, T.; Sukenik, S. 2008: Atherosclerotic cardiovascular disease in systemic lupus erythematosus: the Beer Sheva experience. Israel Medical Association Journal: Imaj 10(1): 43-44

Paixao, A.R.M.; Ayers, C.R.; Berry, J.D.; de Lemos, J.A.; Khera, A. 2014: Atherosclerotic cardiovascular disease prevention: a comparison between the third adult treatment panel and the new 2013 Treatment of Blood Cholesterol Guidelines. Circulation. Cardiovascular Quality and Outcomes 7(5): 778-779

Kasemkijwattana, C.; Rungsinaporn, V.; Siripisitsak, T.; Kongmalai, P.; Boonprasert, R.; Charoenthamruksa, C.; Hongeng, S.; Wongkajornsilp, A.; Muangsomboon, S.; Chaipinyo, K.; Chansiri, K. 2016: Autologous Fibrin-Base Scaffold for Chondrocytes and Bone Marrow Mesenchymal Stem Cells Implantation: The Development and Comparison to Conventional Fibrin Glue. Journal of the Medical Association of Thailand 99 Suppl. 8: S99

Vlayen, J.; De Backer, G.; Peers, J.; Moldenaers, I.; Debruyne, H.; Simoens, S. 2008: Atherosclerotic cardiovascular diseases in Belgium: a cost-of-illness analysis. Cardiovascular Drugs and Therapy 22(6): 487-494

Park, S.-T.; Kim, J.K.; Yoon, K.H.; Park, S.-O.; Park, S.W.; Kim, J.S.; Kim, S.J.; Suh, D.C. 2010: Atherosclerotic carotid stenoses of apical versus body lesions in high-risk carotid stenting patients. AJNR. American Journal of Neuroradiology 31(6): 1106-1112

Woimant, F. 2010: Atherosclerotic carotid stenosis in women. Presse Medicale 39(2): 254-262

Cantú-Brito, C. 2009: Atherosclerotic carotid stenosis. how to decide endarterectomy versus stenting versus only medical treatment?. Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 61(1): 53-65

Gao, T.; Zhang, Z.; Yu, W.; Zhang, Z.; Wang, Y. 2009: Atherosclerotic carotid vulnerable plaque and subsequent stroke: a high-resolution MRi study. Cerebrovascular Diseases 27(4): 345-352

Akazawa, Y.; Matsuo, K.; Ueda, Y.; Nishio, M.; Hirata, A.; Asai, M.; Nemoto, T.; Wada, M.; Murakami, A.; Kashiwase, K.; Kodama, K. 2014: Atherosclerotic change at one year after implantation of Endeavor zotarolimus-eluting stent vs. everolimus-eluting stent. Circulation Journal: Official Journal of the Japanese Circulation Society 78(6): 1428-1436

Ghorashi, S.; Davari-Farid, S.; Tafrishinejad, A.; Khosraviani, K. 2012: Atherosclerotic changes in common carotid artery, common femoral artery, and ascending aorta/aortic arch in candidates for coronary artery bypass graft surgery. Angiology 63(8): 630

Kilic, I.D.; Di Mario, C. 2014: Atherosclerotic changes in coronary aneurysms post-Kawasaki disease: in vivo demonstration with near-infrared spectroscopy and intravascular ultrasound. European Heart Journal 35(37): 2506

Takahashi, W.; Fujii, H.; Ide, M.; Takagi, S.; Shinohara, Y. 2005: Atherosclerotic changes in intracranial and extracranial large arteries in apparently healthy persons with asymptomatic lacunar infarction. Journal of Stroke and Cerebrovascular Diseases: the Official Journal of National Stroke Association 14(1): 17-22

Mulić, S.; Selesković, H.; Basić, N.K.ć; Krizić, M.; Zerem, E.; Cickusić, A.; Kusljugić, Z.; Baraković, F.; Bećirović, E.; Krizić, N.; Hajdarović, A. 2008: Atherosclerotic changes on head and neck blood vessels in patients with systemic lupus erythematosus. Reumatizam 55(1): 19-21

Negi, S.; Anand, A. 2010: Atherosclerotic coronary heart disease-epidemiology, classification and management. Cardiovascular and Hematological Disorders Drug Targets 10(4): 257-261

Leach, C.; Bach, R.G. 2006: Atherosclerotic coronary plaque in a patient with the metabolic syndrome: assessment by lesion physiology and intravascular ultrasound virtual histology. Journal of the Cardiometabolic Syndrome 1(3): 225-227

Pitocco, D.; Marano, R.; Di Stasio, E.; Scavone, G.; Savino, G.; Zaccardi, F.; Rizzi, A.; Martini, F.; Musella, T.; Silvestri, V.; Costantini, F.; Galli, M.; Caputo, S.; Bonomo, L.; Ghirlanda, G. 2014: Atherosclerotic coronary plaque in subjects with diabetic neuropathy: the prognostic cardiovascular role of Charcot neuroarthropathy--a case-control study. Acta Diabetologica 51(4): 587-593

Al-Omran, M. 2012: Atherosclerotic disease and risk factor modification in Saudi Arabia: a call to action. Vascular Health and Risk Management 8: 349-355

Hannawi, S.; Haluska, B.; Marwick, T.H.; Thomas, R. 2007: Atherosclerotic disease is increased in recent-onset rheumatoid arthritis: a critical role for inflammation. Arthritis Research and Therapy 9(6): R116

Berthold, H.K.; Bestehorn, K.P.; Krone, W.; Gouni-Berthold, I. 2010: Atherosclerotic disease location and disparities in the control and treatment of cardiovascular risk factors in patients with Type 2 diabetes. Diabetic Medicine: a Journal of the British Diabetic Association 27(3): 303-308

Russo, C.; Jin, Z.; Rundek, T.; Homma, S.; Sacco, R.L.; Di Tullio, M.R. 2009: Atherosclerotic disease of the proximal aorta and the risk of vascular events in a population-based cohort: the Aortic Plaques and Risk of Ischemic Stroke (APRIS) study. Stroke 40(7): 2313-2318

El-Farahaty, R.M.; El-Mitwalli, A.; Azzam, H.; Wasel, Y.; Elrakhawy, M.M.; Hasaneen, B.Mohammed. 2015: Atherosclerotic effects of long-term old and new antiepileptic drugs monotherapy: a cross-sectional comparative study. Journal of Child Neurology 30(4): 451-457

Zycinska, K.; Wardyn, K.; Zielonka, T.M.; Nitsch-Osuch, A.; Smolarczyk, R.; Zarzycki, S.; Demkow, U.; Lukas, W.; Pirogowicz, I. 2013: Atherosclerotic factors in PR3 pulmonary vasculitis. Advances in Experimental Medicine and Biology 755: 283-286

Westein, E.; van der Meer, A.D.; Kuijpers, M.J.E.; Frimat, J.-P.; van den Berg, A.; Heemskerk, J.W.M. 2013: Atherosclerotic geometries exacerbate pathological thrombus formation poststenosis in a von Willebrand factor-dependent manner. Proceedings of the National Academy of Sciences of the United States of America 110(4): 1357-1362

Ragni, M.V.; Moore, C.G. 2011: Atherosclerotic heart disease: prevalence and risk factors in hospitalized men with haemophilia a. Haemophilia: the Official Journal of the World Federation of Hemophilia 17(6): 867-871

Tsuchiya, K.; Nitta, N.; Sonoda, A.; Otani, H.; Takahashi, M.; Murata, K.; Shiomi, M.; Tabata, Y.; Nohara, S. 2013: Atherosclerotic imaging using 4 types of superparamagnetic iron oxides: new possibilities for mannan-coated particles. European Journal of Radiology 82(11): 1919-1925

Van Wyk, S.; Prahl Wittberg, L.; Fuchs, L. 2014: Atherosclerotic indicators for blood-like fluids in 90-degree arterial-like bifurcations. Computers in Biology and Medicine 50: 56-69

Kohara, K.; Igase, M.; Tabara, Y.; Miki, T. 2012: Atherosclerotic indices for the prediction of cognitive impairment in a middle-aged to elderly general population: shimanami health promoting program study. Journal of the American Geriatrics Society 60(10): 1996-1997

Bural, G.G.; Torigian, D.A.; Basu, S.; Bozkurt, M.F.; Houseni, M.; Alavi, A. 2013: Atherosclerotic inflammatory activity in the aorta and its correlation with aging and gender as assessed by 18F-FDG-PET. Hellenic Journal of Nuclear Medicine 16(3): 164-168

Holmstedt, C.A.; Turan, T.N.; Chimowitz, M.I. 2013: Atherosclerotic intracranial arterial stenosis: risk factors, diagnosis, and treatment. LANCET. Neurology 12(11): 1106-1114

Paniugova, E.V.; Aleksandrova, E.N.; Nasonov, E.L.; Karpov, I.A. 2009: Atherosclerotic lesion of the vessels in patients with stable coronary artery disease: relations with concentration of C-reactive protein. Kardiologiia 49(4): 40-45

Bot, M.; Bot, I.; Lopez-Vales, R.én.; van de Lest, C.H.A.; Saulnier-Blache, J.S.éb.; Helms, J.B.; David, S.; van Berkel, T.J.C.; Biessen, E.A.L. 2010: Atherosclerotic lesion progression changes lysophosphatidic acid homeostasis to favor its accumulation. American Journal of Pathology 176(6): 3073-3084

Aliev, G.; Gasimov, E.; Obrenovich, M.E.; Fischbach, K.; Shenk, J.C.; Smith, M.A.; Perry, G. 2008: Atherosclerotic lesions and mitochondria DNA deletions in brain microvessels: implication in the pathogenesis of Alzheimer's disease. Vascular Health and Risk Management 4(3): 721-730

Wethal, T.; Nedregaard, B.år.; Andersen, R.; Fosså, A.; Lund, M.B.; Günther, A.; Kvaløy, S.; Fosså, S.D.; Kjekshus, J. 2014: Atherosclerotic lesions in lymphoma survivors treated with radiotherapy. RadioTherapy and Oncology: Journal of the European Society for Therapeutic Radiology and Oncology 110(3): 448-454

Bentzon, J.F.; Falk, E. 2010: Atherosclerotic lesions in mouse and man: is it the same disease?. Current Opinion in Lipidology 21(5): 434-440

Van Kets, V.; Liebenberg, L.; Wainwright, H.; Martin, L.; Gunston, G.; Alexander, R. 2011: Atherosclerotic lesions in the thoracic aorta: a South African anatomical and histological mortuary study. South African Medical Journal 101(6): 409-412

Vidjak, V.; Hebrang, A.; Brkljacić, B.; Brajsa, M.; Novacić, K.; Barada, A.; Skopljanac, A.; Erdelez, L.; Crncević, M.; Kucan, D.; Flegar-Mestrić, Z.; Vrhovski-Hebrang, D.; Roić, G. 2007: Atherosclerotic lesions of supra-aortic arteries in diabetic patients. Collegium Antropologicum 31(3): 723-732

Kuroiwa, Y.; Yamashita, A.; Miyati, T.; Furukoji, E.; Takahashi, M.; Azuma, T.; Sugimura, H.; Tamura, S.; Kawai, K.; Asada, Y. 2010: Atherosclerotic lesions rich in macrophages or smooth muscle cells discriminated in rabbit iliac arteries based on T1 relaxation time and lipid content. Academic Radiology 17(2): 230-238

Agilli, M.; Aydin, I.; Aydin, F.N. 2014: Atherosclerotic markers in obese and nonobese children and relationship with nighttime hypertension. Medical Principles and Practice: International Journal of the Kuwait University Health Science Centre 23(6): 584

Lohmann, C.; Schäfer, N.; von Lukowicz, T.; Sokrates Stein, M.A.; Borén, J.; Rütti, S.; Wahli, W.; Donath, M.Y.; Lüscher, T.F.; Matter, C.M. 2009: Atherosclerotic mice exhibit systemic inflammation in periadventitial and visceral adipose tissue, liver, and pancreatic islets. Atherosclerosis 207(2): 360-367

Fishbein, G.A.; Micheletti, R.G.; Currier, J.S.; Singer, E.; Fishbein, M.C. 2008: Atherosclerotic oxalosis in coronary arteries. Cardiovascular Pathology: the Official Journal of the Society for Cardiovascular Pathology 17(2): 117-123

La Grutta, L.; Runza, G.; Galia, M.; Maffei, E.; Lo Re, G.; Grassedonio, E.; Tedeschi, C.; Cademartiri, F.; Midiri, M. 2012: Atherosclerotic pattern of coronary myocardial bridging assessed with CT coronary angiography. International Journal of Cardiovascular Imaging 28(2): 405-414

Ebersberger, U.; Sudarski, S.; Schoepf, U.J.; Bamberg, F.; Tricarico, F.; Apfaltrer, P.; Blanke, P.; Schindler, A.; Makowski, M.R.; Headden, G.F.; Leber, A.W.; Hoffmann, E.; Vliegenthart, R. 2013: Atherosclerotic plaque burden in cocaine users with acute chest pain: analysis by coronary computed tomography angiography. Atherosclerosis 229(2): 443-448

Nakazato, R.; Otake, H.; Konishi, A.; Iwasaki, M.; Koo, B.-K.; Fukuya, H.; Shinke, T.; Hirata, K.-I.; Leipsic, J.; Berman, D.S.; Min, J.K. 2015: Atherosclerotic plaque characterization by CT angiography for identification of high-risk coronary artery lesions: a comparison to optical coherence tomography. European Heart Journal. Cardiovascular Imaging 16(4): 373-379

Tearney, G.J.; Bouma, B.E. 2002: Atherosclerotic plaque characterization by spatial and temporal speckle pattern analysis. Optics Letters 27(7): 533-535

Athanasiou, L.S.; Exarchos, T.P.; Naka, K.K.; Michalis, L.K.; Prati, F.; Fotiadis, D.I. 2011: Atherosclerotic plaque characterization in Optical Coherence Tomography images. Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference 2011: 4485-4488

Van Engelen, A.; Niessen, W.J.; Klein, S.; Groen, H.C.; Verhagen, H.J.M.; Wentzel, J.J.; van der Lugt, A.; de Bruijne, M. 2014: Atherosclerotic plaque component segmentation in combined carotid MRi and CTA data incorporating class label uncertainty. Plos one 9(4): E94840

Zhang, P.-F.; Su, H.-J.; Zhang, M.; Li, J.-F.; Liu, C.-X.; Ding, S.-F.; Miao, Y.; Chen, L.; Li, X.-N.; Yi, X.; Zhang, Y. 2011: Atherosclerotic plaque components characterization and macrophage infiltration identification by intravascular ultrasound elastography based on b-mode analysis: validation in vivo. International Journal of Cardiovascular Imaging 27(1): 39-49

Hamirani, Y.S.; Nasir, K.; Gopal, A.; Ahmadi, N.; Pal, R.; Flores, F.; Blumenthal, R.S.; Budoff, M.J. 2010: Atherosclerotic plaque composition among patients with stenotic coronary artery disease on noninvasive CT angiography. Coronary Artery Disease 21(4): 222-227

Obaid, D.R.; Calvert, P.A.; Gopalan, D.; Parker, R.A.; Hoole, S.P.; West, N.E.J.; Goddard, M.; Rudd, J.H.F.; Bennett, M.R. 2013: Atherosclerotic plaque composition and classification identified by coronary computed tomography: assessment of computed tomography-generated plaque maps compared with virtual histology intravascular ultrasound and histology. CIRCULATION. Cardiovascular Imaging 6(5): 655-664

Timaran, C.H.; Rosero, E.B.; Martinez, A.E.; Ilarraza, A.; Modrall, J.G.; Clagett, G.P. 2010: Atherosclerotic plaque composition assessed by virtual histology intravascular ultrasound and cerebral embolization after carotid stenting. Journal of Vascular Surgery 52(5): 1188-1194

Cormode, D.P.; Roessl, E.; Thran, A.; Skajaa, T.; Gordon, R.E.; Schlomka, J-Peter.; Fuster, V.; Fisher, E.A.; Mulder, W.J.M.; Proksa, R.; Fayad, Z.A. 2010: Atherosclerotic plaque composition: analysis with multicolor CT and targeted gold nanoparticles. Radiology 256(3): 774-782

Silvestre-Roig, C.; de Winther, M.P.; Weber, C.; Daemen, M.J.; Lutgens, E.; Soehnlein, O. 2014: Atherosclerotic plaque destabilization: mechanisms, models, and therapeutic strategies. Circulation Research 114(1): 214-226

Bui, Q.T.; Prempeh, M.; Wilensky, R.L. 2009: Atherosclerotic plaque development. International Journal of Biochemistry and Cell Biology 41(11): 2109-2113

Holm, P.W.; Slart, R.H.J.A.; Zeebregts, C.J.; Hillebrands, J.L.; Tio, Ré.A. 2009: Atherosclerotic plaque development and instability: a dual role for VEGF. Annals of Medicine 41(4): 257-264

Ni, M.; Wang, Y.; Zhang, M.; Zhang, P.F.; Ding, S.F.; Liu, C.X.; Liu, X.L.; Zhao, Y.X.; Zhang, Y. 2009: Atherosclerotic plaque disruption induced by stress and lipopolysaccharide in apolipoprotein e knockout mice. American Journal of Physiology. Heart and Circulatory Physiology 296(5): H1598-H1606

Nieuwstadt, H.A.; van der Lugt, A.; Kassar, Z.A.M.; Breeuwer, M.; van der Steen, A.F.W.; Gijsen, F.J.H. 2014: Atherosclerotic plaque fibrous cap assessment under an oblique scan plane orientation in carotid MRi. Quantitative Imaging in Medicine and Surgery 4(4): 216-224

Lin, Q.-F.; Luo, Y.-K.; Zhao, Z.-W.; Cai, W.; Zhen, X.-C.; Chen, L.-L. 2013: Atherosclerotic plaque identification by virtual histology intravascular ultrasound in a rabbit abdominal aorta model of vulnerable plaque. Experimental Biology and Medicine 238(11): 1223-1232

Van der Wall, E.E.; Schuijf, J.D.; Jukema, J.W.; Bax, J.J.; van der Laarse, A. 2009: Atherosclerotic plaque imaging by PET/CT; can inactive, active and mixed plaques be discerned?. International Journal of Cardiovascular Imaging 25(2): 141-144

Zhao, X.; Miller, Z.E.; Yuan, C. 2009: Atherosclerotic plaque imaging by carotid MRi. Current Cardiology Reports 11(1): 70-77

Kramer, C.M.; Narula, J. 2009: Atherosclerotic plaque imaging: the last frontier for cardiac magnetic resonance. JACC. Cardiovascular Imaging 2(7): 916-918

Selwaness, M.; van den Bouwhuijsen, Q.; van Onkelen, R.S.; Hofman, A.; Franco, O.H.; van der Lugt, A.; Wentzel, J.J.; Vernooij, M. 2014: Atherosclerotic plaque in the left carotid artery is more vulnerable than in the right. Stroke 45(11): 3226-3230

Chen, H.; Wu, T.; Kerwin, W.S.; Yuan, C. 2013: Atherosclerotic plaque inflammation quantification using dynamic contrast-enhanced (DCE) MRi. Quantitative Imaging in Medicine and Surgery 3(6): 298-301

Feng, T.; Yundai, C.; Ying, Z.; Jing, W.; Tao, Z. 2014: Atherosclerotic plaque morphology indicates clinical symptoms of plaque progression. Cardiology 129(4): 207-212

Kurabayashi, M. 2011: Atherosclerotic plaque of coronary artery and vascular smooth muscle cells. Nihon Rinsho. Japanese Journal of Clinical Medicine 69(Suppl 7): 107-112

Gao, T.; He, X.; Yu, W.; Zhang, Z.; Wang, Y. 2011: Atherosclerotic plaque pathohistology and classification with high-resolution MRi. Neurological Research 33(3): 325-330

Boussel, L.ïc.; Arora, S.; Rapp, J.; Rutt, B.; Huston, J.; Parker, D.; Yuan, C.; Bassiouny, H.; Saloner, D. 2009: Atherosclerotic plaque progression in carotid arteries: monitoring with high-spatial-resolution MR imaging--multicenter trial. Radiology 252(3): 789-796

Luz, A.é; Bisceglia, T.; Hughes, C.; Tammam, K.; Farah, B.; Fajadet, J. 2010: Atherosclerotic plaque prolapse between coronary stent struts visualized by optical coherence tomography. Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 29(1): 143-146

Arora, S.; Nicholls, S.J. 2008: Atherosclerotic plaque reduction: blood pressure, dyslipidemia, atherothrombosis. Drugs of Today 44(9): 711-718

Sastry, P.; Kaski, J.C. 2010: Atherosclerotic plaque regression - the role of statin therapy. Drugs of Today 46(8): 601-608

Shanmugam, N.; Román-Rego, A.; Ong, P.; Kaski, J.C. 2010: Atherosclerotic plaque regression: fact or fiction?. Cardiovascular Drugs and Therapy 24(4): 311-317

Halvorsen, B.; Otterdal, K.; Dahl, T.B.; Skjelland, M.; Gullestad, L.; Øie, E.; Aukrust, P.ål. 2008: Atherosclerotic plaque stability--what determines the fate of a plaque?. Progress in Cardiovascular Diseases 51(3): 183-194

De Weert, T.T.; Cretier, S.; Groen, H.C.; Homburg, P.; Cakir, H.; Wentzel, J.J.; Dippel, D.W.J.; van der Lugt, A. 2009: Atherosclerotic plaque surface morphology in the carotid bifurcation assessed with multidetector computed tomography angiography. Stroke 40(4): 1334-1340

Acharya, U.R.; Mookiah, M.R.K.; Vinitha Sree, S.; Afonso, D.; Sanches, J.; Shafique, S.; Nicolaides, A.; Pedro, L.M.; Fernandes E Fernandes, J.; Suri, J.S. 2013: Atherosclerotic plaque tissue characterization in 2D ultrasound longitudinal carotid scans for automated classification: a paradigm for stroke risk assessment. Medical and Biological Engineering and Computing 51(5): 513-523

Homburg, P.J.; Rozie, S.; van Gils, M.J.; Jansen, T.; de Weert, T.T.; Dippel, D.W.J.; van der Lugt, A. 2010: Atherosclerotic plaque ulceration in the symptomatic internal carotid artery is associated with nonlacunar ischemic stroke. Stroke 41(6): 1151-1156

Panayides, A.; Pattichis, M.S.; Pattichis, C.S.; Loizou, C.P.; Pantziaris, M.; Pitsillides, A. 2011: Atherosclerotic plaque ultrasound video encoding, wireless transmission, and quality assessment using H.264. IEEE Transactions on Information Technology in Biomedicine: a Publication of the IEEE Engineering in Medicine and Biology Society 15(3): 387-397

Su, H.; Gorodny, N.; Gomez, L.F.; Gangadharmath, U.B.; Mu, F.; Chen, G.; Walsh, J.C.; Szardenings, K.; Berman, D.S.; Kolb, H.C.; Tamarappoo, B.K. 2014: Atherosclerotic plaque uptake of a novel integrin tracer ¹⁸F-Flotegatide in a mouse model of atherosclerosis. Journal of Nuclear Cardiology: Official Publication of the American Society of Nuclear Cardiology 21(3): 553-562

Rozie, S.; de Weert, T.T.; de Monyé, C.; Homburg, P.J.; Tanghe, H.L.J.; Dippel, D.W.J.; van der Lugt, A. 2009: Atherosclerotic plaque volume and composition in symptomatic carotid arteries assessed with multidetector CT angiography; relationship with severity of stenosis and cardiovascular risk factors. European Radiology 19(9): 2294-2301

Van Lammeren, G.W.; Reichmann, B.L.; Moll, F.L.; Bots, M.L.; de Kleijn, D.P.V.; de Vries, J.-P.P.M.; Pasterkamp, G.; de Borst, G.J. 2011: Atherosclerotic plaque vulnerability as an explanation for the increased risk of stroke in elderly undergoing carotid artery stenting. Stroke 42(9): 2550-2555

Falk, E.; Thim, T.; Kristensen, I.B. 2009: Atherosclerotic plaque, adventitia, perivascular fat, and carotid imaging. JACC. Cardiovascular Imaging 2(2): 183-186

Shimada, K.; Mikami, Y.; Murayama, T.; Yokode, M.; Fujita, M.; Kita, T.; Kishimoto, C. 2011: Atherosclerotic plaques induced by marble-burying behavior are stabilized by exercise training in experimental atherosclerosis. International Journal of Cardiology 151(3): 284-289

Frerix, M.; Stegbauer, J.; Kreuter, A.; Weiner, S.Markus. 2014: Atherosclerotic plaques occur in absence of intima-media thickening in both systemic sclerosis and systemic lupus erythematosus: a duplexsonography study of carotid and femoral arteries and follow-up for cardiovascular events. Arthritis Research and Therapy 16(1): R54

Kolata, G.B. 1976: Atherosclerotic plaques: competing theories guide research. Science 194(4265): 592-594

Brucker, Nália.; Charão, M.F.; Moro, A.M.; Ferrari, P.; Bubols, G.; Sauer, E.; Fracasso, R.; Durgante, J.; Thiesen, Fávia.V.; Duarte, M.M.; Gioda, A.; Castro, I.; Saldiva, P.H.; Garcia, S.C. 2014: Atherosclerotic process in taxi drivers occupationally exposed to air pollution and co-morbidities. Environmental Research 131: 31-38

Lee, W.-S.; Kim, S.-W.; Hong, S.-A.; Lee, T.-J.; Park, E.-S.; Kim, H.-J.; Lee, K.J.; Kim, T.H.; Kim, C.J.; Ryu, W.S. 2009: Atherosclerotic progression attenuates the expression of Nogo-B in autopsied coronary artery: pathology and virtual histology intravascular ultrasound analysis. Journal of Korean Medical Science 24(4): 596-604

Kawaguchi, S.; Watanabe, M.; Hachimaru, T.; Nakahara, H. 2010: Atherosclerotic pseudoaneurysm of the left subclavian artery: a case report. Annals of Thoracic and Cardiovascular Surgery: Official Journal of the Association of Thoracic and Cardiovascular Surgeons of Asia 16(5): 376-379

Afsar, B.; Elsurer, R. 2010: Atherosclerotic renal artery disease and heart failure: questions in mind. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 25(7): 2385; Author Reply 2385

Meier, P.; Haesler, E.; Teta, D.; Qanadli, S.Dine.; Burnier, M. 2009: Atherosclerotic renal artery disease diagnosis update. Nephrologie and Therapeutique 5(1): 1-12

Meier, P.; Haesler, E.; Teta, D.; Qanadli, S.Dine.; Burnier, M. 2009: Atherosclerotic renal artery disease management update. Nephrologie and Therapeutique 5(1): 13-24

Margey, R.; Hynes, B.G.; Moran, D.; Kiernan, T.J.; Jaff, M.R. 2011: Atherosclerotic renal artery stenosis and renal artery stenting: an evolving therapeutic option. Expert Review of Cardiovascular Therapy 9(10): 1347-1360

Choi, S.S. 2014: Atherosclerotic renal artery stenosis and revascularization. Expert Review of Cardiovascular Therapy 12(12): 1419-1425

Webb, T.N.; Ramratnam, M.; Evans, R.W.; Orchard, T.; Pacella, J.; Erkan, E. 2014: Atherosclerotic renal artery stenosis as a cause for hypertension in an adolescent patient. Pediatric Nephrology 29(8): 1457-1460

Madder, R.D.; Safian, R.D. 2010: Atherosclerotic renal artery stenosis, the oculostenotic reflex, and therapeutic nihilism. CIRCULATION. Cardiovascular Interventions 3(6): 526-527

Srivastava, S.; Lip, G.Y.H. 2007: Atherosclerotic renal artery stenosis--do we really know what to do?. Blood Pressure 16(5): 288-290

Guron, G.; Jönsson, K.Z.; Saeed, A.; Nowakowska-Fortuna, E.; Jensen, G.; Herlitz, H. 2012: Atherosclerotic renal artery stenosis: Revascularization is of benefit--on the right patient and on the correct indication. Lakartidningen 109(29-31): 1354-1355

Shetty, R.; Amin, M.S.; Jovin, I.S. 2009: Atherosclerotic renal artery stenosis: current therapy and future developments. American Heart Journal 158(2): 154-162

Textor, S.C. 2011: Atherosclerotic renal artery stenosis: flaws in estimated glomerular filtration rate and the problem of progressive kidney injury. CIRCULATION. Cardiovascular Interventions 4(3): 213-215

Karagiannis, A.; Tziomalos, K.; Anagnostis, P.; Gossios, T.; Athyros, V.G. 2009: Atherosclerotic renal artery stenosis: medical therapy alone or in combination with revascularization?. Angiology 60(4): 397-402

Textor, S.C. 2008: Atherosclerotic renal artery stenosis: overtreated but underrated?. Journal of the American Society of Nephrology: Jasn 19(4): 656-659

Seddon, M.; Saw, J. 2011: Atherosclerotic renal artery stenosis: review of pathophysiology, clinical trial evidence, and management strategies. Canadian Journal of Cardiology 27(4): 468-480

Meier, P. 2011: Atherosclerotic renal artery stenosis: update on management strategies. Current Opinion in Cardiology 26(6): 463-471

Whitlow, P.L. 2008: Atherosclerotic renal artery stenosis: where's Waldo?. JACC. Cardiovascular Interventions 1(3): 293-294

Phan, O.; Burnier, M.; Waeber, B. 2008: Atherosclerotic renal stenosis: indications for revascularisation. Revue Medicale Suisse 4(170): 1918-1920; 1922-1923

Davis, R.P.; Pearce, J.D.; Craven, T.E.; Moore, P.S.; Edwards, M.S.; Godshall, C.J.; Hansen, K.J. 2009: Atherosclerotic renovascular disease among hypertensive adults. Journal of Vascular Surgery 50(3): 564-570; 571.E1-3; Discussion 571

Mui, K.-W.; Woittiez, A.-J.; Navis, G. 2007: Atherosclerotic renovascular disease and renal impairment: can we predict the effect of intervention?. Current Hypertension Reports 9(2): 140-147

Chrysochou, C.; Kalra, P.A. 2010: Atherosclerotic renovascular disease and the heart. Journal of Renal Care 36(Suppl 1): 146-153

Chung, W.; Kim, S. 2010: Atherosclerotic renovascular hypertension : lessons from recent clinical studies. Electrolyte and Blood Pressure: e and Bp 8(2): 87-91

Chaudhary, K.; Botdorf, J.; Whaley-Connell, A. 2011: Atherosclerotic renovascular hypertension: current trends in diagnosis and management. Missouri Medicine 108(1): 37-41

Jakubus, T.; Michalska-Jakubus, M.łg.; Lukawski, K.; Janowska, A.; Czuczwar, S.ła.J. 2009: Atherosclerotic risk among children taking antiepileptic drugs. Pharmacological Reports: Pr 61(3): 411-423

Kantermann, T.; Duboutay, F.ço.; Haubruge, D.; Kerkhofs, M.; Schmidt-Trucksäss, A.; Skene, D.J. 2013: Atherosclerotic risk and social jetlag in rotating shift-workers: first evidence from a pilot study. Work 46(3): 273-282

Hurks, R.; Vink, A.; Hoefer, I.E.; de Vries, J-Paul.P.M.; Schoneveld, A.H.; Schermerhorn, M.L.; den Ruijter, H.M.; Pasterkamp, G.; Moll, F.L. 2014: Atherosclerotic risk factors and atherosclerotic postoperative events are associated with low inflammation in abdominal aortic aneurysms. Atherosclerosis 235(2): 632-641

Sereg, M.ár.; Szappanos, A.; Toke, J.; Karlinger, K.; Feldman, K.; Kaszper, E.; Varga, I.; Gláz, E.; Rácz, K.ár.; Tóth, M.ós. 2009: Atherosclerotic risk factors and complications in patients with non-functioning adrenal adenomas treated with or without adrenalectomy: a long-term follow-up study. European Journal of Endocrinology 160(4): 647-655

Ozkan, U.; Oguzkurt, L.; Tercan, F. 2009: Atherosclerotic risk factors and segmental distribution in symptomatic peripheral artery disease. Journal of Vascular and Interventional Radiology: Jvir 20(4): 437-441

Rutkovskaia, N.V.; Savoct'ianova, I.I.; Barbarash, O.L. 2014: Atherosclerotic risk factors in development of bioprosthetic valve failure. Kardiologiia 54(6): 76-80

Acharya, U.R.; Sree, S.V.; Krishnan, M.M.R.; Molinari, F.; Saba, L.; Ho, S.Y.S.; Ahuja, A.T.; Ho, S.C.; Nicolaides, A.; Suri, J.S. 2012: Atherosclerotic risk stratification strategy for carotid arteries using texture-based features. Ultrasound in Medicine and Biology 38(6): 899-915

Xue, M.-z.; Li, Y.-j.; Gao, X.-g.; Zhang, C.-f. 2011: Atherosclerotic stenosis of intracranial and extracranial cerebral arteries in patients with cerebral infarction and the correlative factors. Zhonghua Yi Xue Za Zhi 91(11): 762-765

Hills, N.K.; Fullerton, H.J. 2011: Atherosclerotic stroke in children? a public health red flag. Annals of Neurology 70(5): 675-676

Van Soest, G.; Goderie, T.é; Regar, E.; Koljenović, S.; van Leenders, G.L.J.H.; Gonzalo, N.; van Noorden, S.; Okamura, T.; Bouma, B.E.; Tearney, G.J.; Oosterhuis, J.W.; Serruys, P.W.; van der Steen, A.F.W. 2010: Atherosclerotic tissue characterization in vivo by optical coherence tomography attenuation imaging. Journal of Biomedical Optics 15(1): 011105

Bartoloni, E.; Alunno, A.; Luccioli, F.; Moscatelli, S.; Biscontini, D.; Santoboni, G.; Gerli, R. 2010: Atherosclerotic vascular damage and rheumatoid arthritis: a complex but intriguing link. Expert Review of Cardiovascular Therapy 8(9): 1309-1316

Yokote, K.; Saito, Y. 2006: Atherosclerotic vascular disease and its prevention in metabolic syndrome. Nihon Rinsho. Japanese Journal of Clinical Medicine 64 Suppl. 9: 30-34

Tokgözoğlu, L.; Bariş Kaya, E.ün. 2008: Atherosclerotic vascular disease and risk factors in Turkey: from past to present. Journal of Atherosclerosis and Thrombosis 15(6): 286-291

Van Leuven, S.I.; Sankatsing, R.R.; Vermeulen, J.N.; Kastelein, J.J.P.; Reiss, P.; Stroes, E.S.G. 2007: Atherosclerotic vascular disease in HIV: it is not just antiretroviral therapy that hurts the heart!. Current Opinion in HIV and Aids 2(4): 324-331

Chen, X.Y.; Thomas, G.N.; Chen, Y.K.; Chan, J.C.N.; Wong, K.S. 2010: Atherosclerotic vascular disease rather than metabolic syndrome predicts ischemic stroke in diabetic patients. Cerebrovascular Diseases 30(4): 374-379

Urowitz, M.B.; Gladman, D.; Ibañez, D.; Bae, S.C.; Sanchez-Guerrero, J.; Gordon, C.; Clarke, A.; Bernatsky, S.; Fortin, P.R.; Hanly, J.G.; Wallace, D.J.; Isenberg, D.; Rahman, A.; Alarcón, G.S.; Merrill, J.T.; Ginzler, E.; Khamashta, M.; Nived, O.; Sturfelt, G.; Bruce, I.N.; Steinsson, K.; Manzi, S.; Ramsey-Goldman, R.; Dooley, M.A.; Zoma, A.; Kalunian, K.; Ramos, M.; Van Vollenhoven, R.F.; Aranow, C.; Stoll, T.; Petri, M.; Maddison, P. 2010: Atherosclerotic vascular events in a multinational inception cohort of systemic lupus erythematosus. Arthritis Care and Research 62(6): 881-887

Herzog, C.A.; Shroff, G.R. 2014: Atherosclerotic versus nonatherosclerotic evaluation: the Yin and Yang of cardiovascular imaging in advanced chronic kidney disease. JACC. Cardiovascular Imaging 7(7): 729-732

Breyne, J.; Juthier, F.; Corseaux, D.; Marechaux, S.; Zawadzki, C.; Jeanpierre, E.; Ung, A.; Ennezat, P.-V.; Susen, S.; Van Belle, E.; Le Marec, H.é; Vincentelli, A.é; Le Tourneau, T.; Jude, B. 2010: Atherosclerotic-like process in aortic stenosis: activation of the tissue factor-thrombin pathway and potential role through osteopontin alteration. Atherosclerosis 213(2): 369-376

Depta, J.P.; Bhatt, D.L. 2010: Atherothrombosis and atrial fibrillation: Important and often overlapping clinical syndromes. Thrombosis and Haemostasis 104(4): 657-663

Nwose, E.U.; Jelinek, H.F.; Richards, R.S.; Tinley, P.; Kerr, P.G. 2009: Atherothrombosis and oxidative stress: the connection and correlation in diabetes. Redox Report: Communications in Free Radical Research 14(2): 55-60

Arora, R.; Rai, F. 2009: Atherothrombosis and the management of the vulnerable vascular patient. American Journal of Therapeutics 16(1): 24-34

Steg, P.G.; Dorman, S.H.; Amarenco, P. 2011: Atherothrombosis and the role of antiplatelet therapy. Journal of Thrombosis and Haemostasis: Jth 9(Suppl 1): 325-332

Jurcut, R.; Florian, A.; Deleanu, D.; Arsenescu, I.; Jurcut, C.; Coriu, D.; Ginghina, C. 2011: Atherothrombosis in 2 vascular territories in a young woman: importance of thrombophilia testing. Clinical and Applied Thrombosis/Hemostasis: Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 17(1): 108-113

Dodani, S. 2010: Atherothrombosis in South asians: implications of atherosclerotic and inflammatory markers. Open Cardiovascular Medicine Journal 4: 45-50

Mafrici, A.; Proietti, R. 2010: Atherothrombosis in patients with type 2 diabetes mellitus: an overview of pathophysiology. Giornale Italiano di Cardiologia 11(6): 467-477

Joven, J. 2000: Atherothrombosis in the nephrotic syndrome. Saudi Journal of Kidney Diseases and Transplantation: An Official Publication of the Saudi Center for Organ Transplantation Saudi Arabia 11(3): 303-314

Emmerich, J. 2007: Atherothrombosis risk factors: too many and too little. Journal of Thrombosis and Haemostasis: Jth 5(9): 1793-1794

Mohler, E.R. 2007: Atherothrombosis--wave goodbye to combined anticoagulation and antiplatelet therapy?. New England Journal of Medicine 357(3): 293-296

Kesteloot, H. 2009: Atherothrombosis: a vanishing disease?. Acta Cardiologica 64(5): 581-582

Castillo, J.é; Blanco, M. 2009: Atherothrombosis: an excessively globalizing concept?. Medicina Clinica 132(Suppl 2): 2-4

Stoupel, E. 2008: Atherothrombosis: environmental links. Journal of Basic and Clinical Physiology and Pharmacology 19(1): 37-47

Bokarev, I.N.; Popova, L.V. 2008: Atherothrombosis: state-of-the-art review and approaches to the problem. Klinicheskaia Meditsina 86(8): 4-12

Nakajima, M.; Hirano, T.; Itoh, K.; Uchino, M. 2008: Atherothrombotic brain infarction in a patient with pachydermoperiostosis. Modern Rheumatology 18(3): 281-284

Cimminiello, C.; Zaninelli, A.; Carolei, A.; Sacco, S.; Toni, D.; Gensini, G. 2012: Atherothrombotic burden and medium-term prognosis in patients with acute ischemic stroke: findings of the SIRIO study. Cerebrovascular Diseases 33(4): 341-347

Del Rincón, I. 2009: Atherothrombotic comorbidity in the rheumatic diseases. The evidence becomes clearer. What should clinicians do?. Arthritis and Rheumatism 61(10): 1284-1286

Grines, C.; Cho, L. 2008: Atherothrombotic disease and the role of antiplatelet therapy in women. Journal of Women's Health 17(1): 35-46

Berglund, S.; Södergren, A.; Wållberg Jonsson, S.; Rantapää Dahlqvist, S. 2009: Atherothrombotic events in rheumatoid arthritis are predicted by homocysteine - a six-year follow-up study. Clinical and Experimental Rheumatology 27(5): 822-825

Benbir, G.; Uluduz, D.; Ince, B.; Bozluolcay, M. 2007: Atherothrombotic ischemic stroke in patients with atrial fibrillation. Clinical Neurology and Neurosurgery 109(6): 485-490

Oyama, H.; Kito, A.; Maki, H.; Hattori, K.; Noda, T.; Wada, K. 2013: Atherothrombotic lesion of the middle cerebral artery: report of 21 cases with stenotic and obstructive lesions. Nagoya Journal of Medical Science 75(1-2): 41-46

Panwar, R.B.; Gupta, R.; Gupta, B.K.; Raja, S.; Vaishnav, J.; Khatri, M.; Agrawal, A. 2011: Atherothrombotic risk factors and premature coronary heart disease in India: a case-control study. Indian Journal of Medical Research 134: 26-32

Badimon, L.; Hernández Vera, R.; Vilahur, G. 2013: Atherothrombotic risk in obesity. Hamostaseologie 33(4): 259-268

DeSena, H.C.; Ramaciotti, C.; Nugent, A.W. 2012: Atherotome dislodgement and successful retrieval during cutting balloon pulmonary angioplasty. CIRCULATION. Cardiovascular Interventions 5(3): E37-E38

Le Corre, S.ép.S.; Berchel, M.; Couthon-Gourvès, H.él.èn.; Haelters, J.-P.; Jaffrès, P.-A. 2014: Atherton-Todd reaction: mechanism, scope and applications. Beilstein Journal of Organic Chemistry 10: 1166-1196

Taylor, J. 1912: Athetoid Movements. Proceedings of the Royal Society of Medicine 5(Sect Study Dis Child): 141-142

Whipham, T.R. 1914: Athetoid Movements in both Hands. Proceedings of the Royal Society of Medicine 7(Sect Study Dis Child): 63

Starling, E. 1938: Athetosis following Acute Specific Fevers. Proceedings of the Royal Society of Medicine 31(10): 1160-1161

Morgan, B. 1930: Athetosis in a Boy aged 4 years. Proceedings of the Royal Society of Medicine 23(11): 1582

Napon, C.; Diallo, O.; Kabore, J. 2009: Athetosis in relation with intracranial tuberculomas in a patient from Burkina Faso. Medecine Tropicale: Revue du Corps de Sante Colonial 69(5): 513-515

Zou, J.-f.; Bai, J.; Sun, S.-q. 2007: Athetosis induced by acute benzene and deltamethrin poisoning in one patient. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 25(10): 615-616

Fearnsides, E.G. 1913: Athetosis of Left Hand with Tremor of Right Hand. Proceedings of the Royal Society of Medicine 6(Neurol Sect): 81-84

Yoshida, S.; Hayakawa, K.; Oishi, K.; Mori, S.; Kanda, T.; Yamori, Y.; Yoshida, N.; Hirota, H.; Iwami, M.; Okano, S.; Matsushita, H. 2011: Athetotic and spastic cerebral palsy: anatomic characterization based on diffusion-tensor imaging. Radiology 260(2): 511-520

Leslie, C. 1988: Social research and health care planning in South Asia-part 11. Ancient Science of Life 8(2): 75-91

Berthelot, G.; Tafflet, M.; El Helou, N.; Len, S.ép.; Escolano, S.; Guillaume, M.; Nassif, H.; Tolaïni, J.; Thibault, V.ér.; Desgorces, F.ço.D.; Hermine, O.; Toussaint, J.-F.ço. 2010: Athlete atypicity on the edge of human achievement: performances stagnate after the last peak, in 1988. Plos one 5(1): E8800

Lonsdale, C.; Hodge, K.; Rose, E. 2009: Athlete burnout in elite sport: a self-determination perspective. Journal of Sports Sciences 27(8): 785-795

Brown, C.N.; Guskiewicz, K.M.; Bleiberg, J. 2007: Athlete characteristics and outcome scores for computerized neuropsychological assessment: a preliminary analysis. Journal of Athletic Training 42(4): 515-523

Sheard, P.W.; Smith, P.M.; Paine, T.J. 2009: Athlete compliance to therapist requested contraction intensity during proprioceptive neuromuscular facilitation. Manual Therapy 14(5): 539-543

Bragg, M.A.; Yanamadala, S.; Roberto, C.A.; Harris, J.L.; Brownell, K.D. 2013: Athlete endorsements in food marketing. Pediatrics 132(5): 805-810

Anonymous 2000: Athlete physicians. virtual mentor: VM 2(10)

Faber, L.; van Buuren, F. 2008: Athlete screening for occult cardiac disease: no risk, no fun?. Journal of the American College of Cardiology 51(10): 1040-1041

Mazanov, J.; Backhouse, S.; Connor, J.; Hemphill, D.; Quirk, F. 2014: Athlete support personnel and anti-doping: Knowledge, attitudes, and ethical stance. Scandinavian Journal of Medicine and Science in Sports 24(5): 846-856

Burnett, P. 1941: Athlete's Foot. Canadian Medical Association Journal 44(2): 198

Mesquita, I.; Rosado, A.; Januário, N.; Barroja, E. 2008: Athlete's Retention of a Coach's Instruction Before a Judo Competition. Journal of Sports Science and Medicine 7(3): 402-407

Lippi, G.; Plebani, M. 2011: Athlete's biological passport: to test or not to test?. Clinical Chemistry and Laboratory Medicine 49(9): 1393-1395

Matelot, D.; Schnell, Fédéric.; Kervio, G.; Thillaye du Boullay, N.; Carré, Fçois. 2013: Athlete's bradycardia may be a multifactorial mechanism. Journal of Applied Physiology 114(12): 1755-1756

Uttal, J. 1947: Athlete's foot: a new and effective treatment. Medical World 160(10): 609

Baggish, A.L.; Wood, M.J. 2011: Athlete's heart and cardiovascular care of the athlete: scientific and clinical update. Circulation 123(23): 2723-2735

Horowitz, I.; Cafri, C.; Zeller, L.; Vodonos, A.; Perry, Z.H.; Kobal, S.L. 2014: Athlete's heart in Israel: fact or fiction. Israel Medical Association Journal: Imaj 16(1): 46-49

Griffet, V.; Finet, G.; Di Filippo, S.; Lantelme, P.; Caignault, J.-R.; Guérard, S. 2013: Athlete's heart in the young: electrocardiographic and echocardiographic patterns in 107 French athletes. Annales de Cardiologie et d'Angeiologie 62(2): 116-121

Pagourelias, E.D.; Efthimiadis, G.K.; Kouidi, E.; Fragakis, N.; Athyros, V.G.; Geleris, P. 2011: Athlete's heart or hypertrophic cardiomyopathy: the dilemma is still there. American Journal of Cardiology 108(12): 1841-1842

Godon, P.; Griffet, V.; Vinsonneau, U.; Caignault, J.R.; Prevosto, J.M.; Quiniou, G.; Guerard, S. 2009: Athlete's heart or hypertrophic cardiomyopathy: usefulness of N-terminal pro-brain natriuretic peptide. International Journal of Cardiology 137(1): 72-74

Carré, F.ço. 2012: Athlete's heart or hypertrophic cardiomyopathy?. Presse Medicale 41(6 Part 1): 608-612

Chevalier, L.; Kervio, G.ël.; Corneloup, L.; Vincent, M.-P.; Baudot, C.; Rebeyrol, J.-L.; Merle, F.; Gencel, L.; Carré, F.ço. 2013: Athlete's heart patterns in elite rugby players: effects of training specificities. Archives of Cardiovascular Diseases 106(2): 72-78

Popović, D.; Mazić, S.; Nesić, D.; Velkovski, S.; Stojiljković, S.; Sćepanović, L.; Mitrović, D.; Ostojić, M.C. 2007: Athlete's heart syndrome. Srpski Arhiv Za Celokupno Lekarstvo 135(3-4): 222-229

Kreso, A.; Arslanagić, A. 2008: Athlete's heart syndrome and echocardiographic changes. Bosnian Journal of Basic Medical Sciences 8(2): 116-120

Rigamonti, F.; Monnard, S.; Ziltener, J.-L.; Meyer, P. 2012: Athlete's heart: frontier between physiology and pathology. Revue Medicale Suisse 8(349): 1496-1500

La Gerche, A.; Taylor, A.J.; Prior, D.L. 2009: Athlete's heart: the potential for multimodality imaging to address the critical remaining questions. Jacc. Cardiovascular Imaging 2(3): 350-363

Chernyavsky, V.S.; Davidov, T.; Trooskin, S.Z.; Boyarsky, A. 2011: Athlete's hernia--a true, early direct inguinal hernia: diagnosis, pathophysiology, and surgical treatment. American Surgeon 77(11): 1472-1476

Uchiyama, M.; Tsuboi, R.; Mitsuhashi, Y. 2009: Athlete's nodule. Journal of Dermatology 36(11): 608-611

Kieliszak, C.R.; Junkins-Hopkins, J.M. 2015: Athlete's nodule in a figure skater: an unusual presentation. American Journal of Dermatopathology 37(2): E21-E25

Van de Sande, D.A.J.P.; Hoogsteen, J.; Liem, I.H.; Kemps, H.M.C. 2014: Athlete's syndrome X. International Journal of Cardiology 177(2): E49-E50

Anonymous 1928: Athletes not Invariably Long-Lived. California and western medicine 29(3): 194-195

Link, M.S.; Estes, N.A.Mark. 2010: Athletes and arrhythmias. Journal of Cardiovascular Electrophysiology 21(10): 1184-1189

Whinder, F. 2013: Athletes and asthma. Lancet. Respiratory Medicine 1(4): 292

Güldenpenning, I.; Steinke, A.; Koester, D.; Schack, T. 2013: Athletes and novices are differently capable to recognize feint and non-feint actions. Experimental Brain Research 230(3): 333-343

Dick, R.W.; Berning, J.R.; Dawson, W.; Ginsburg, R.D.; Miller, C.; Shybut, G.T. 2013: Athletes and the arts--the role of sports medicine in the performing arts. Current Sports Medicine Reports 12(6): 397-403

King, N.M.P.; Robeson, R. 2013: Athletes are Guinea pigs. American Journal of Bioethics: Ajob 13(10): 13-14

Subasic, K. 2010: Athletes at risk for sudden cardiac death. Journal of School Nursing: the Official Publication of the National Association of School Nurses 26(1): 18-25

Thing, L.F.; Ronglan, L.T. 2015: Athletes confessions: the sports biography as an interaction ritual. Scandinavian Journal of Medicine and Science in Sports 25(2): 280-288

Jeyamohan, S.; Harrop, J.S.; Vaccaro, A.; Sharan, A.D. 2008: Athletes returning to play after cervical spine or neurobrachial injury. Current Reviews in Musculoskeletal Medicine 1(3-4): 175-179

Pelliccia, A.; Dipaolo, F.M. 2011: Athletes with abnormal repolarization pattern and structurally normal heart can participate in competitive sport a lifelong experience. Journal of the American College of Cardiology 58(8): 883-884

Hartgens, F.; Hoogeveen, A.R.; Brink, P.R.G. 2008: Athletes with exercise-related pain at the medial side of the lower leg. Nederlands Tijdschrift Voor Geneeskunde 152(33): 1839-1843

Le Goux, P. 2012: Athletes with osteoarthritis: assessment and care. Soins; la Revue de Reference Infirmiere 768: 42-44

Galvin, J.M. 2008: Athletes with repolarization abnormalities. New England Journal of Medicine 358(21): 2296-2297; Author Reply 2297-2298

Knowles, B.D.; Pleacher, M.D. 2012: Athletes with seizure disorders. Current Sports Medicine Reports 11(1): 16-20

Fagard, R.H. 2007: Athletes with systemic hypertension. Cardiology Clinics 25(3): 441-448 Vii